<SEC-DOCUMENT>0001193125-23-004873.txt : 20230109
<SEC-HEADER>0001193125-23-004873.hdr.sgml : 20230109
<ACCEPTANCE-DATETIME>20230109172734
ACCESSION NUMBER:		0001193125-23-004873
CONFORMED SUBMISSION TYPE:	POS EX
PUBLIC DOCUMENT COUNT:		18
FILED AS OF DATE:		20230109
DATE AS OF CHANGE:		20230109
EFFECTIVENESS DATE:		20230109

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BLACKROCK FLOATING RATE INCOME TRUST
		CENTRAL INDEX KEY:			0001287480
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		POS EX
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-266318
		FILM NUMBER:		23519009

	BUSINESS ADDRESS:	
		STREET 1:		100 BELLEVUE PARKWAY
		CITY:			WILMINGTON
		STATE:			DE
		ZIP:			19809-3700
		BUSINESS PHONE:		(800) 882-0052

	MAIL ADDRESS:	
		STREET 1:		100 BELLEVUE PARKWAY
		CITY:			WILMINGTON
		STATE:			DE
		ZIP:			19809-3700

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BLACKROCK GLOBAL FLOATING RATE INCOME TRUST
		DATE OF NAME CHANGE:	20040528

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BLACKROCK VARIABLE RATE & INFLATION PROTECTED SECURITIES
		DATE OF NAME CHANGE:	20040416
</SEC-HEADER>
<DOCUMENT>
<TYPE>POS EX
<SEQUENCE>1
<FILENAME>d421862dposex.htm
<DESCRIPTION>BLACKROCK FLOATING RATE INCOME TRUST
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:cik0001287480="http://www.blackrockfloatingrateincometrust.com/20230109" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:cef="http://xbrl.sec.gov/cef/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>BlackRock Floating Rate Income Trust</title>
<meta content="text/html; charset=UTF-8" http-equiv="Content-Type"/>
</head>
<body><div style='display: none'><ix:header><ix:hidden><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="P01_09_2023To01_09_2023">0001287480</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="P01_09_2023To01_09_2023">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="cik0001287480-20230109.xsd" /><link:linkbaseRef xlink:type="simple" xlink:href="cik0001287480-20230109_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" /><link:linkbaseRef xlink:type="simple" xlink:href="cik0001287480-20230109_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" /><link:linkbaseRef xlink:type="simple" xlink:href="cik0001287480-20230109_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" /></ix:references><ix:resources><xbrli:context id="P01_09_2023To01_09_2023" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001287480</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-09</xbrli:startDate> <xbrli:endDate>2023-01-09</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_09_2023To01_09_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001287480</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis" >dei:BusinessContactMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-09</xbrli:startDate> <xbrli:endDate>2023-01-09</xbrli:endDate> </xbrli:period> </xbrli:context></ix:resources></ix:header></div><div><div style="background-color:white;display: inline;"><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">As filed with the Securities and Exchange Commission on January&#160;9, 2023 </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:right">Securities Act File <div style="white-space:nowrap;display:inline;">No.&#160;<ix:nonNumeric name="dei:EntityFileNumber" contextRef="P01_09_2023To01_09_2023">333-266318</ix:nonNumeric></div> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:right">Investment Company Act File <div style="white-space:nowrap;display:inline;">No.&#160;<ix:nonNumeric name="dei:InvestmentCompanyActFileNumber" contextRef="P01_09_2023To01_09_2023">811-21566</ix:nonNumeric></div> </div><div style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div><div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div><div style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">U.S. SECURITIES AND EXCHANGE COMMISSION </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549 </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <div style="white-space:nowrap;display:inline;"><ix:nonNumeric name="dei:DocumentType" contextRef="P01_09_2023To01_09_2023">N-2</ix:nonNumeric></div> </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registration Statement </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center"><div style="font-style:italic;display:inline;">under </div></div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:97%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:2%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center;"><div style="font-size:12pt;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">the Securities Act of 1933</div></div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><ix:nonNumeric name="dei:DocumentRegistrationStatement" contextRef="P01_09_2023To01_09_2023" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center;"><div style="font-size:12pt;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"><div style="white-space:nowrap;display:inline;">Pre-Effective</div> Amendment No.</div></div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><ix:nonNumeric name="dei:PreEffectiveAmendment" contextRef="P01_09_2023To01_09_2023" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center;"><div style="font-size:12pt;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Post-Effective Amendment No.&#160;<ix:nonNumeric name="dei:PostEffectiveAmendmentNumber" contextRef="P01_09_2023To01_09_2023">1</ix:nonNumeric></div></div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><ix:nonNumeric name="dei:PostEffectiveAmendment" contextRef="P01_09_2023To01_09_2023" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center;"><div style="font-weight:bold;display:inline;">and/or</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom;text-align:center;"><div style="font-size:18pt;display:inline;"><div style="font-weight:bold;display:inline;">Registration Statement</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;text-align:center;"><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center"><div style="font-style:italic;display:inline;">Under</div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center"><div style="font-style:italic;display:inline;">the Investment Company Act of 1940</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><ix:nonNumeric name="dei:InvestmentCompanyActRegistration" contextRef="P01_09_2023To01_09_2023" format="ixt:fixed-true">&#9746;</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;text-align:center;"><div style="font-size:12pt;display:inline;"><div style="font-weight:bold;display:inline;">Amendment No.&#160;<ix:nonNumeric name="dei:InvestmentCompanyRegistrationAmendmentNumber" contextRef="P01_09_2023To01_09_2023">9</ix:nonNumeric></div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><ix:nonNumeric name="dei:InvestmentCompanyRegistrationAmendment" contextRef="P01_09_2023To01_09_2023" format="ixt:fixed-true">&#9746;</ix:nonNumeric></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="P01_09_2023To01_09_2023">BlackRock Floating Rate Income Trust</ix:nonNumeric> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact Name of Registrant as Specified in Charter) </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="P01_09_2023To01_09_2023">100 Bellevue Parkway</ix:nonNumeric> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="P01_09_2023To01_09_2023">Wilmington</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="P01_09_2023To01_09_2023" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="P01_09_2023To01_09_2023">19809</ix:nonNumeric> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of Principal Executive Offices) </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s Telephone Number, including Area Code: (<ix:nonNumeric name="dei:CityAreaCode" contextRef="P01_09_2023To01_09_2023">800</ix:nonNumeric>) <div style="white-space:nowrap;display:inline;"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="P01_09_2023To01_09_2023">882-0052</ix:nonNumeric></div> </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:ContactPersonnelName" contextRef="P01_09_2023To01_09_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">John M. Perlowski, President</ix:nonNumeric> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">BlackRock Floating Rate Income Trust </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="P01_09_2023To01_09_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">55 East 52nd Street</ix:nonNumeric> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="P01_09_2023To01_09_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">New York</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="P01_09_2023To01_09_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis" format="ixt-sec:stateprovnameen">New York</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="P01_09_2023To01_09_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">10055</ix:nonNumeric> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Name and Address of Agent for Service) </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><div style="font-style:italic;display:inline;">Copies of information to: </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Margery K. Neale, Esq. </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Elliot J. Gluck, Esq. </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Willkie Farr&#160;&amp; Gallagher LLP </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">787 Seventh Avenue </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">New York, New York 10019 </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-weight:bold;display:inline;">Approximate Date of Commencement of Proposed Public Offering:</div> <ix:nonNumeric name="dei:ApproximateDateOfCommencementOfProposedSaleToThePublic" contextRef="P01_09_2023To01_09_2023">From time to time after the effective date of this Registration Statement.</ix:nonNumeric> </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, check the following box&#160;&#160;<ix:nonNumeric name="dei:DividendOrInterestReinvestmentPlanOnly" contextRef="P01_09_2023To01_09_2023" format="ixt:fixed-false">&#9744;</ix:nonNumeric> </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If any securities being registered on this Form will be offered on a delayed or continuous basis in reliance on Rule 415 under the Securities Act of 1933 (&#8220;Securities Act&#8221;), other than securities offered in connection with a dividend reinvestment plan, check the following box&#160;&#160;<ix:nonNumeric name="dei:DelayedOrContinuousOffering" contextRef="P01_09_2023To01_09_2023" format="ixt:fixed-true">&#9746;</ix:nonNumeric> </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If this Form is a registration statement pursuant to General Instruction A.2 or a post-effective amendment thereto, check the following box&#160;&#160;<ix:nonNumeric name="cef:PrimaryShelfFlag" contextRef="P01_09_2023To01_09_2023" format="ixt:fixed-true">&#9746;</ix:nonNumeric> </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If this Form is a registration statement pursuant to General Instruction B or a post-effective amendment thereto that will become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box&#160;&#160;<ix:nonNumeric name="dei:EffectiveUponFiling462e" contextRef="P01_09_2023To01_09_2023" format="ixt:fixed-false">&#9744;</ix:nonNumeric> </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction B to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box&#160;&#160;<ix:nonNumeric name="dei:AdditionalSecuritiesEffective413b" contextRef="P01_09_2023To01_09_2023" format="ixt:fixed-false">&#9744;</ix:nonNumeric> </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">It is proposed that this filing will become effective (check appropriate box): </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;"><ix:nonNumeric name="dei:EffectiveWhenDeclaredSection8c" contextRef="P01_09_2023To01_09_2023" format="ixt:fixed-false">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">when declared effective pursuant to Section&#160;8(c) of the Securities Act. </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If appropriate, check the following box: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;"><ix:nonNumeric name="dei:NewEffectiveDateForPreviousFiling" contextRef="P01_09_2023To01_09_2023" format="ixt:fixed-false">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">This [post-effective] amendment designates a new effective date for a previously filed [post-effective amendment] [registration statement]. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;"><ix:nonNumeric name="dei:AdditionalSecurities462b" contextRef="P01_09_2023To01_09_2023" format="ixt:fixed-false">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">This Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, and the Securities Act registration statement number of the earlier effective registration statement for the same offering is:<div style="text-decoration:underline;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;"><ix:nonNumeric name="dei:NoSubstantiveChanges462c" contextRef="P01_09_2023To01_09_2023" format="ixt:fixed-false">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">This Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, and the Securities Act registration statement number of the earlier effective registration statement for the same offering is:<div style="text-decoration:underline;display:inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;"><ix:nonNumeric name="dei:ExhibitsOnly462d" contextRef="P01_09_2023To01_09_2023" format="ixt:fixed-true">&#9746;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">This Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, and the Securities Act registration statement number of the earlier effective registration statement for the same offering <div style="white-space:nowrap;display:inline;">is:&#160;<ix:nonNumeric name="dei:ExhibitsOnly462dFileNumber" contextRef="P01_09_2023To01_09_2023">333-266318</ix:nonNumeric>.</div> </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check each box that appropriately characterizes the Registrant: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;"><ix:nonNumeric name="cef:RegisteredClosedEndFundFlag" contextRef="P01_09_2023To01_09_2023" format="ixt:fixed-true">&#9746;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Registered <div style="white-space:nowrap;display:inline;">Closed-End</div> Fund <div style="white-space:nowrap;display:inline;">(closed-end</div> company that is registered under the Investment Company Act of 1940 (the &#8220;Investment Company Act&#8221;)). </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;"><ix:nonNumeric name="cef:BusinessDevelopmentCompanyFlag" contextRef="P01_09_2023To01_09_2023" format="ixt:fixed-false">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Business Development Company <div style="white-space:nowrap;display:inline;">(closed-end</div> company that intends or has elected to be regulated as a business development company under the Investment Company Act). </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;"><ix:nonNumeric name="cef:IntervalFundFlag" contextRef="P01_09_2023To01_09_2023" format="ixt:fixed-false">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Interval Fund (Registered <div style="white-space:nowrap;display:inline;">Closed-End</div> Fund or a Business Development Company that makes periodic repurchase offers under Rule <div style="white-space:nowrap;display:inline;">23c-3</div> under the Investment Company Act). </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;"><ix:nonNumeric name="cef:PrimaryShelfQualifiedFlag" contextRef="P01_09_2023To01_09_2023" format="ixt:fixed-true">&#9746;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">A.2 Qualified (qualified to register securities pursuant to General Instruction A.2 of this Form). </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;"><div style="display:inline;"><ix:nonNumeric name="dei:EntityWellKnownSeasonedIssuer" contextRef="P01_09_2023To01_09_2023" format="ixt-sec:yesnoballotbox">&#9744;</ix:nonNumeric></div></td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Well-Known Seasoned Issuer (as defined by Rule 405 under the Securities Act). </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;"><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="P01_09_2023To01_09_2023" format="ixt:fixed-false">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Emerging Growth Company (as defined by Rule <div style="white-space:nowrap;display:inline;">12b-2</div> under the Securities and Exchange Act of 1934). </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;"><div style="display:inline;">&#9744;</div></td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">If an Emerging Growth Company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;7(a)(2)(B) of the Securities Act. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;"><ix:nonNumeric name="cef:NewCefOrBdcRegistrantFlag" contextRef="P01_09_2023To01_09_2023" format="ixt:fixed-false">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">New Registrant (registered or regulated under the Investment Company Act for less than 12 calendar months preceding this filing). </div></td></tr></table><div style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</div></div></div> <div><div style="background-color:white;display: inline;"><div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div><div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div></div><div></div></div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EXPLANATORY NOTE </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Post-Effective Amendment No.&#160;1 to the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-2</span> (File Nos. <span style="white-space:nowrap">333-266318</span> and <span style="white-space:nowrap">811-21566)</span> is being filed pursuant to Rule 462(d) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), solely for the purpose of filing exhibits to the Registration Statement. Accordingly, this Post-Effective Amendment No.&#160;1 consists only of a facing page, this explanatory note and Part C of the Registration Statement setting forth the exhibits to the Registration Statement. This Post-Effective Amendment No.&#160;1 does not modify any other part of the Registration Statement. Pursuant to Rule 462(d) under the Securities Act, this Post-Effective Amendment No.&#160;1 shall become effective immediately upon filing with the Securities and Exchange Commission. The contents of the Registration Statement are hereby incorporated by reference. </p>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">PART C </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Other Information </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#160;25. Financial Statements and Exhibits </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The agreements included or incorporated by reference as exhibits to this Registration Statement contain representations and warranties by each of the parties to the applicable agreement. These representations and warranties were made solely for the benefit of the other parties to the applicable agreement and (i)&#160;were not intended to be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be inaccurate; (ii)&#160;may have been qualified in such agreement by disclosures that were made to the other party in connection with the negotiation of the applicable agreement; (iii)&#160;may apply contract standards of &#8220;materiality&#8221; that are different from &#8220;materiality&#8221; under the applicable securities laws; and (iv)&#160;were made only as of the date of the applicable agreement or such other date or dates as may be specified in the agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Registrant acknowledges that, notwithstanding the inclusion of the foregoing cautionary statements, it is responsible for considering whether additional specific disclosures of material information regarding material contractual provisions are required to make the statements in this Registration Statement not misleading. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td style="width:8%"></td>

<td style="vertical-align:bottom;width:2%"></td>
<td style="width:87%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">(1)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" colspan="3"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financial Statements</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><a href="http://www.sec.gov/Archives/edgar/data/0001287480/000119312522065626/d293808dncsr.htm#tx298913_15">Part A: The annual report to the Trust&#8217;s shareholders for the fiscal year ended December&#160;31, 2021 (the &#8220;2021 Annual Report&#8221;) is incorporated herein by reference. </a></p> <p style="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><a href="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001287480/000119312522236310/d373786dncsrs.htm#tx379530_12">Part A: The semi-annual report to the Trust&#8217;s shareholders for the fiscal period ended June&#160;30, 2022 (the &#8220;2022 Semi-Annual Report&#8221;) is incorporated herein by reference. </a></p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><a href="http://www.sec.gov/Archives/edgar/data/0001287480/000119312522065626/d293808dncsr.htm#tx298913_15">Part B: Audited financial statements and financial highlights for the fiscal year ended December&#160;31, 2021 and related Report of Independent Registered Public Accounting Firm are incorporated herein by reference to the 2021 Annual Report. </a></p> <p style="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><a href="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001287480/000119312522236310/d373786dncsrs.htm#tx379530_12">Part B: Unaudited financial statements and financial highlights for the fiscal period ended June&#160;30, 2022 are incorporated herein by reference to the 2022 Semi-Annual Report. </a></p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(2)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Exhibits</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(a)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="http://www.sec.gov/Archives/edgar/data/1287480/000095017204001329/s482177.txt">Amended and Restated Agreement and Declaration of Trust is incorporated herein by reference to Exhibit (a)<span style="text-decoration:underline"></span>&#160;to <span style="white-space:nowrap">Pre-Effective</span> Amendment No.<span style="text-decoration:underline"></span>&#160;1 to the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-2</span> (File No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-114662),</span> as filed with the Securities and Exchange Commission on May<span style="text-decoration:underline"></span>&#160;27, 2004.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;(b)(1)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="http://www.sec.gov/Archives/edgar/data/1287480/000119312522200963/d383966dex99b1.htm">Amended and Restated Bylaws, effective as of October<span style="text-decoration:underline"></span>&#160;28, 2016, are incorporated herein by reference to Exhibit (b)(1) to the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-2</span> (File No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-266318),</span> as filed with the Securities and Exchange Commission on July<span style="text-decoration:underline"></span>&#160;25, 2022</a>.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;(b)(2)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="http://www.sec.gov/Archives/edgar/data/0001287480/000119312522200963/d383966dex99b2.htm">Amendment No.<span style="text-decoration:underline"></span>&#160;1 to the Amended and Restated Bylaws, dated November<span style="text-decoration:underline"></span>&#160;19, 2020, is incorporated herein by reference to Exhibit (b)(2) to the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-2</span> (File No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-266318),</span> as filed with the Securities and Exchange Commission on July<span style="text-decoration:underline"></span>&#160;25, 2022</a>.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(c)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Inapplicable</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;(d)(1)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="http://www.sec.gov/Archives/edgar/data/1287480/000095017204001329/s482177.txt">Article VI (Shares of Beneficial Interest) and Article X (Shareholders) of the Amended and Restated Agreement and Declaration of Trust is incorporated herein by reference to Exhibit (a)<span style="text-decoration:underline"></span>&#160;to <span style="white-space:nowrap">Pre-Effective</span> Amendment No.<span style="text-decoration:underline"></span>&#160;1 to the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-2</span> (File No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-114662),</span> as filed with the Securities and Exchange Commission on May<span style="text-decoration:underline"></span>&#160;27, 2004.</a></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">C-1 </p>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom"></td>
<td style="width:6%"></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:87%"></td></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;(d)(2)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="http://www.sec.gov/Archives/edgar/data/1287480/000119312522200963/d383966dex99b1.htm">Article I (Shareholder Meetings) of the Amended and Restated Bylaws, effective as of October<span style="text-decoration:underline"></span>&#160;28, 2016, is incorporated herein by reference to Exhibit (b)(1) to the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-2</span> (File No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-266318),</span> as filed with the Securities and Exchange Commission on July<span style="text-decoration:underline"></span>&#160;25, 2022.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;(d)(3)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">&#160;&#160;&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="http://www.sec.gov/Archives/edgar/data/1287480/000104746904027252/a2140038zex-99_d.htm">Form of Specimen Certificate is incorporated herein by reference to Exhibit (d)<span style="text-decoration:underline"></span>&#160;to <span style="white-space:nowrap">Pre-Effective</span> Amendment No.<span style="text-decoration:underline"></span>&#160;3 to the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-2</span> (File No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-114662),</span> as filed with the Securities and Exchange Commission on August<span style="text-decoration:underline"></span>&#160;25, 2004.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(e)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="http://www.sec.gov/Archives/edgar/data/1287480/000104746904027252/a2140038zex-99_e.htm">Form of Automatic Dividend Reinvestment Plan is incorporated herein by reference to Exhibit (e)<span style="text-decoration:underline"></span>&#160;to <span style="white-space:nowrap">Pre-Effective</span> Amendment No.<span style="text-decoration:underline"></span>&#160;3 to the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-2</span> (File No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-114662),</span> as filed with the Securities and Exchange Commission on August<span style="text-decoration:underline"></span>&#160;25, 2004.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(f)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Inapplicable</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;(g)(1)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="http://www.sec.gov/Archives/edgar/data/1287480/000104746904027252/a2140038zex-99_g1.htm">Form of Investment Management Agreement is incorporated herein by reference to Exhibit (g)(1) to <span style="white-space:nowrap">Pre-Effective</span> Amendment No.<span style="text-decoration:underline"></span>&#160;3 to the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-2</span> (File No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-114662),</span> as filed with the Securities and Exchange Commission on August<span style="text-decoration:underline"></span>&#160;25, 2004. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;(g)(2)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="http://www.sec.gov/Archives/edgar/data/1287480/000119312522200963/d383966dex99g2.htm">Form of <span style="white-space:nowrap">Sub-Investment</span> Advisory Agreement with BlackRock International Limited, dated March<span style="text-decoration:underline"></span>&#160;2, 2020, is incorporated herein by reference to Exhibit (g)(2) to the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-2</span> (File No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-266318),</span> as filed with the Securities and Exchange Commission on July<span style="text-decoration:underline"></span>&#160;25, 2022</a>.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;(g)(3)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="http://www.sec.gov/Archives/edgar/data/1562818/000119312522007562/d282893dex99g4.htm">Amended and Restated Master Advisory Fee Waiver Agreement is incorporated herein by reference to Exhibit (g)(4) to the Registration Statement on Form <span style="white-space:nowrap">N-2</span> of BlackRock Multi-Sector Income Trust (File No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-262119),</span> as filed with the Securities and Exchange Commission on January<span style="text-decoration:underline"></span>&#160;12, 2022.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;(g)(4)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="http://www.sec.gov/Archives/edgar/data/1562818/000119312522007562/d282893dex99g5.htm">Amendment No.<span style="text-decoration:underline"></span>&#160;1 to Amended and Restated Master Advisory Fee Waiver Agreement is incorporated herein by reference to Exhibit (g)(5) to the Registration Statement on Form <span style="white-space:nowrap">N-2</span> of BlackRock Multi-Sector Income Trust (File No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-262119),</span> as filed with the Securities and Exchange Commission on January<span style="text-decoration:underline"></span>&#160;12, 2022.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;(g)(5)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="http://www.sec.gov/Archives/edgar/data/1562818/000119312522007562/d282893dex99g6.htm">Amendment No.<span style="text-decoration:underline"></span>&#160;2 to Amended and Restated Master Advisory Fee Waiver Agreement is incorporated herein by reference to Exhibit (g)(6) to the Registration Statement on Form <span style="white-space:nowrap">N-2</span> of BlackRock Multi-Sector Income Trust (File No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-262119),</span> as filed with the Securities and Exchange Commission on January<span style="text-decoration:underline"></span>&#160;12, 2022.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;(g)(6)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="http://www.sec.gov/Archives/edgar/data/1562818/000119312522007562/d282893dex99g7.htm">Amendment No.<span style="text-decoration:underline"></span>&#160;3 to Amended and Restated Master Advisory Fee Waiver Agreement is incorporated herein by reference to Exhibit (g)(7) to the Registration Statement on Form <span style="white-space:nowrap">N-2</span> of BlackRock Multi-Sector Income Trust (File No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-262119),</span> as filed with the Securities and Exchange Commission on January<span style="text-decoration:underline"></span>&#160;12, 2022</a>.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;(g)(7)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="http://www.sec.gov/Archives/edgar/data/1562818/000119312522007562/d282893dex99g8.htm">Amendment No.<span style="text-decoration:underline"></span>&#160;4 to Amended and Restated Master Advisory Fee Waiver Agreement is incorporated herein by reference to Exhibit (g)(8) to the Registration Statement on Form <span style="white-space:nowrap">N-2</span> of BlackRock Multi-Sector Income Trust (File No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-262119),</span> as filed with the Securities and Exchange Commission on January<span style="text-decoration:underline"></span>&#160;12, 2022</a>.</td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">C-2 </p>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom"></td>
<td style="width:6%"></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:87%"></td></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;(g)(8)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="http://www.sec.gov/Archives/edgar/data/1832871/000119312522204326/d791219dex99g7.htm">Amendment No.<span style="text-decoration:underline"></span>&#160;5 to Amended and Restated Master Advisory Fee Waiver Agreement is incorporated herein by reference to Exhibit (g)(7) to the Registration Statement on Form <span style="white-space:nowrap">N-2</span> of BlackRock 2037 Municipal Target Term Trust (File No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-250205),</span> as filed with the Securities and Exchange Commission on July<span style="text-decoration:underline"></span>&#160;28, 2022.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;(g)(9)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">&#160;&#160;&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="http://www.sec.gov/Archives/edgar/data/1832871/000119312522204326/d791219dex99g8.htm">Form of Amendment No.<span style="text-decoration:underline"></span>&#160;6 to Amended and Restated Master Advisory Fee Wavier Agreement is incorporated herein by reference to Exhibit (g)(8) to the Registration Statement on Form <span style="white-space:nowrap">N-2</span> of BlackRock 2037 Municipal Target Term Trust (File No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-250205),</span> as filed with the Securities and Exchange Commission on July<span style="text-decoration:underline"></span>&#160;28, 2022.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;(h)(1)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="d421862dex99h1.htm">Distribution Agreement between the Registrant and BlackRock Investments, LLC is filed herewith. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;(h)(2)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="d421862dex99h2.htm"><span style="white-space:nowrap">Sub-Placement</span> Agent Agreement between BlackRock Investments, LLC and UBS Securities LLC is filed herewith. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(i)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="http://www.sec.gov/Archives/edgar/data/1562818/000119312522007562/d282893dex99i.htm">Form of BlackRock Fixed-Income Complex Third Amended and Restated Deferred Compensation Plan is incorporated herein by reference to Exhibit (i)<span style="text-decoration:underline"></span>&#160;to the Registration Statement on Form <span style="white-space:nowrap">N-2</span> of BlackRock Multi-Sector Income Trust (File No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-262119),</span> as filed with the Securities and Exchange Commission on January<span style="text-decoration:underline"></span>&#160;12, 2022. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(j)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="http://www.sec.gov/Archives/edgar/data/1562818/000119312522007562/d282893dex99j.htm">Form of Master Custodian Agreement is incorporated herein by reference to Exhibit (j)<span style="text-decoration:underline"></span>&#160;to the Registration Statement on Form <span style="white-space:nowrap">N-2</span> of BlackRock Multi-Sector Income Trust (File No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-262119),</span> as filed with the Securities and Exchange Commission on January<span style="text-decoration:underline"></span>&#160;12, 2022</a>.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;(k)(1)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="http://www.sec.gov/Archives/edgar/data/1562818/000119312522007562/d282893dex99k1.htm">Form of Amended and Restated Transfer Agency and Service Agreement is incorporated herein by reference to Exhibit (k)(1) to the Registration Statement on Form <span style="white-space:nowrap">N-2</span> of BlackRock Multi-Sector Income Trust (File No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-262119),</span> as filed with the Securities and Exchange Commission on January<span style="text-decoration:underline"></span>&#160;12, 2022</a>.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;(k)(2)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="http://www.sec.gov/Archives/edgar/data/1562818/000119312522007562/d282893dex99k2.htm">Form of Administration and Accounting Services Agreement is incorporated herein by reference to Exhibit (k)(2) to the Registration Statement on Form <span style="white-space:nowrap">N-2</span> of BlackRock Multi-Sector Income Trust (File No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-262119),</span> as filed with the Securities and Exchange Commission on January<span style="text-decoration:underline"></span>&#160;12, 2022</a>.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;(k)(3)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="http://www.sec.gov/Archives/edgar/data/1287480/000119312522313172/d383966dex99k3.htm">Amended and Restated Credit Agreement between the Registrant and State Street Bank and Trust Company is incorporated herein by reference to Exhibit (k)(3) of <span style="white-space:nowrap">Pre-Effective</span> Amendment No.<span style="text-decoration:underline"></span>&#160;1 to the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-2</span> (File No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-266318),</span> as filed with the Securities and Exchange Commission on December<span style="text-decoration:underline"></span>&#160;28, 2022.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;(k)(4)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="http://www.sec.gov/Archives/edgar/data/1287480/000119312522313172/d383966dex99k4.htm">Amendment No.<span style="text-decoration:underline"></span>&#160;1 to the Amended and Restated Credit Agreement between the Registrant and State Street Bank and Trust Company is incorporated herein by reference to Exhibit (k)(4) of <span style="white-space:nowrap">Pre-Effective</span> Amendment No.<span style="text-decoration:underline"></span>&#160;1 to the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-2</span> (File No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-266318),</span> as filed with the Securities and Exchange Commission on December<span style="text-decoration:underline"></span>&#160;28, 2022.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;(k)(5)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="http://www.sec.gov/Archives/edgar/data/1287480/000119312522313172/d383966dex99k5.htm">Amendment No.<span style="text-decoration:underline"></span>&#160;2 to the Amended and Restated Credit Agreement between the Registrant and State Street Bank and Trust Company is incorporated herein by reference to Exhibit (k)(5) of <span style="white-space:nowrap">Pre-Effective</span> Amendment No.<span style="text-decoration:underline"></span>&#160;1 to the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-2</span> (File No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-266318),</span> as filed with the Securities and Exchange Commission on December<span style="text-decoration:underline"></span>&#160;28, 2022.</a></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">C-3 </p>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom"></td>
<td style="width:6%"></td>

<td style="vertical-align:bottom;width:3%"></td>
<td style="width:89%"></td></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;(k)(6)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="http://www.sec.gov/Archives/edgar/data/1287480/000119312522313172/d383966dex99k6.htm">Amendment No.<span style="text-decoration:underline"></span>&#160;3 to the Amended and Restated Credit Agreement between the Registrant and State Street Bank and Trust Company is incorporated herein by reference to Exhibit (k)(6) of <span style="white-space:nowrap">Pre-Effective</span> Amendment No.<span style="text-decoration:underline"></span>&#160;1 to the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-2</span> (File No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-266318),</span> as filed with the Securities and Exchange Commission on December<span style="text-decoration:underline"></span>&#160;28, 2022.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;(k)(7)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">&#160;&#160;&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="http://www.sec.gov/Archives/edgar/data/1287480/000119312522313172/d383966dex99k7.htm">Amendment No.<span style="text-decoration:underline"></span>&#160;4 to the Amended and Restated Credit Agreement between the Registrant and State Street Bank and Trust Company is incorporated herein by reference to Exhibit (k)(7) of <span style="white-space:nowrap">Pre-Effective</span> Amendment No.<span style="text-decoration:underline"></span>&#160;1 to the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-2</span> (File No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-266318),</span> as filed with the Securities and Exchange Commission on December<span style="text-decoration:underline"></span>&#160;28, 2022.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;(k)(8)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="d421862dex99k8.htm">Form of Ninth Amended and Restated Securities Lending Agreement between the Registrant and BlackRock Investment Management, LLC is filed herewith.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;(k)(9)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="http://www.sec.gov/Archives/edgar/data/1528988/000119312522063292/d294767dex99k4.htm">BlackRock<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;Closed-End</span><span style="text-decoration:underline"></span>&#160;Rule<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;12d1-4</span><span style="text-decoration:underline"></span>&#160;Fund of Funds Investment Agreement between the Registrant and each existing and future series of Advisors Disciplined Trust, dated as of January<span style="text-decoration:underline"></span>&#160;19, 2022 is incorporated herein by reference to Exhibit (k)(4) to the Registration Statement on Form<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;N-2</span><span style="text-decoration:underline"></span>&#160;of BlackRock Utilities, Infrastructure<span style="text-decoration:underline"></span>&#160;&amp; Power Opportunities Trust (File<span style="text-decoration:underline"></span>&#160;No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-262272),</span><span style="text-decoration:underline"></span>&#160;as filed with the Securities and Exchange Commission on March<span style="text-decoration:underline"></span>&#160;3, 2022.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;(k)(10)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="http://www.sec.gov/Archives/edgar/data/1528988/000119312522063292/d294767dex99k5.htm">BlackRock<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;Closed-End</span><span style="text-decoration:underline"></span>&#160;Rule<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;12d1-4</span><span style="text-decoration:underline"></span>&#160;Fund of Funds Investment Agreement between the Registrant, Rydex Dynamic Funds, Rydex Series Funds, Rydex Variable Trust, Guggenheim Funds Trust, Guggenheim Variable Funds Trust, Guggenheim Strategy Funds Trust, Transparent Value Trust, Guggenheim Active Allocation Fund, Guggenheim Energy<span style="text-decoration:underline"></span>&#160;&amp; Income Fund, Guggenheim Strategic Opportunities Fund, Guggenheim Taxable Municipal Bond<span style="text-decoration:underline"></span>&#160;&amp; Investment Grade Debt Trust and Guggenheim Unit Investment Trusts (Guggenheim Defined Portfolios), dated as of January<span style="text-decoration:underline"></span>&#160;19, 2022 is incorporated herein by reference to Exhibit (k)(5) to the Registration Statement on Form<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;N-2</span><span style="text-decoration:underline"></span>&#160;of BlackRock Utilities, Infrastructure<span style="text-decoration:underline"></span>&#160;&amp; Power Opportunities Trust (File<span style="text-decoration:underline"></span>&#160;No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-262272),</span><span style="text-decoration:underline"></span>&#160;as filed with the Securities and Exchange Commission on March<span style="text-decoration:underline"></span>&#160;3, 2022.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;(k)(11)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="http://www.sec.gov/Archives/edgar/data/1528988/000119312522063292/d294767dex99k6.htm">BlackRock<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;Closed-End</span><span style="text-decoration:underline"></span>&#160;Rule<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;12d1-4</span><span style="text-decoration:underline"></span>&#160;Fund of Funds Investment Agreement between the Registrant, FT Series and First Trust Exchange-Traded Fund VIII dated as of January<span style="text-decoration:underline"></span>&#160;19, 2022 is incorporated herein by reference to Exhibit (k)(6) to the Registration Statement on Form<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;N-2</span><span style="text-decoration:underline"></span>&#160;of BlackRock Utilities, Infrastructure<span style="text-decoration:underline"></span>&#160;&amp; Power Opportunities Trust (File<span style="text-decoration:underline"></span>&#160;No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-262272),</span><span style="text-decoration:underline"></span>&#160;as filed with the Securities and Exchange Commission on March<span style="text-decoration:underline"></span>&#160;3, 2022.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;(k)(12)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="http://www.sec.gov/Archives/edgar/data/1528988/000119312522063292/d294767dex99k7.htm">BlackRock<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;Closed-End</span><span style="text-decoration:underline"></span>&#160;Rule<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;12d1-4</span><span style="text-decoration:underline"></span>&#160;Fund of Funds Investment Agreement between the Registrant, RiverNorth Funds, RiverNorth/DoubleLine Strategic Opportunity Fund, Inc., RiverNorth Specialty Finance Corporation, RiverNorth Opportunistic Municipal Income Fund, Inc., RiverNorth Managed Duration Municipal Income Fund, Inc., RiverNorth Managed Duration Municipal Income Fund II, Inc., RiverNorth Flexible Municipal Income Fund, Inc. and RiverNorth Flexible Municipal Income Fund II, Inc. dated as of January<span style="text-decoration:underline"></span>&#160;19, 2022 is incorporated herein by reference to Exhibit (k)(7) to the Registration Statement on Form<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;N-2</span><span style="text-decoration:underline"></span>&#160;of BlackRock Utilities, Infrastructure<span style="text-decoration:underline"></span>&#160;&amp; Power Opportunities Trust (File<span style="text-decoration:underline"></span>&#160;No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-262272),</span><span style="text-decoration:underline"></span>&#160;as filed with the Securities and Exchange Commission on March<span style="text-decoration:underline"></span>&#160;3, 2022.</a></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">C-4 </p>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom"></td>
<td style="width:6%"></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:87%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;(k)(13)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="http://www.sec.gov/Archives/edgar/data/1528988/000119312522063292/d294767dex99k8.htm">BlackRock<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;Closed-End</span><span style="text-decoration:underline"></span>&#160;Rule<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;12d1-4</span><span style="text-decoration:underline"></span>&#160;Fund of Funds Investment Agreement between the Registrant, Thrivent Mutual Funds and Thrivent Series Fund, Inc. dated as of January<span style="text-decoration:underline"></span>&#160;26, 2022 is incorporated herein by reference to Exhibit (k)(8) to the Registration Statement on Form<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;N-2</span><span style="text-decoration:underline"></span>&#160;of BlackRock Utilities, Infrastructure<span style="text-decoration:underline"></span>&#160;&amp; Power Opportunities Trust (File<span style="text-decoration:underline"></span>&#160;No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-262272),</span><span style="text-decoration:underline"></span>&#160;as filed with the Securities and Exchange Commission on March<span style="text-decoration:underline"></span>&#160;3, 2022.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;(l)(1)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">&#160;&#160;&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="http://www.sec.gov/Archives/edgar/data/1287480/000119312522313172/d383966dex99l.htm">Opinion and Consent of Counsel to the Registrant is incorporated herein by reference to Exhibit (l)<span style="text-decoration:underline"></span>&#160;of <span style="white-space:nowrap">Pre-Effective</span> Amendment No.<span style="text-decoration:underline"></span>&#160;1 to the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-2</span> (File No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-266318),</span> as filed with the Securities and Exchange Commission on December<span style="text-decoration:underline"></span>&#160;28, 2022.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;(l)(2)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="d421862dex99l2.htm">Opinion and Consent of Counsel to the Registrant is filed herewith. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(m)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Inapplicable</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(n)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="http://www.sec.gov/Archives/edgar/data/1287480/000119312522313172/d383966dex99n.htm">Independent Registered Public Accounting Firm Consent is incorporated herein by reference to Exhibit (n)<span style="text-decoration:underline"></span>&#160;of <span style="white-space:nowrap">Pre-Effective</span> Amendment No.<span style="text-decoration:underline"></span>&#160;1 to the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-2</span> (File No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-266318),</span> as filed with the Securities and Exchange Commission on December<span style="text-decoration:underline"></span>&#160;28, 2022.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(o)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Inapplicable</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(p)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Inapplicable</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(q)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Inapplicable</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(r)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="d421862dex99r.htm">Code of Ethics of the Registrant, BlackRock Advisors, LLC, BlackRock International Limited and BlackRock (Singapore) Limited is filed herewith.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;(s)(1)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="http://www.sec.gov/Archives/edgar/data/1287480/000119312522200963/d383966dexfilingfees.htm">Calculation of Filing Fee Tables (Shelf Registration Statement) is incorporated herein by reference to Exhibit (s)<span style="text-decoration:underline"></span>&#160;of the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-2</span> (File No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-266318),</span> as filed with the Securities and Exchange Commission on July<span style="text-decoration:underline"></span>&#160;25, 2022</a>.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;(s)(2)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="http://www.sec.gov/Archives/edgar/data/1287480/000119312522313172/d383966dexfilingfees.htm">Calculation of Filing Fee Tables (Shelf Registration Statement) is incorporated herein by reference to Exhibit (s)(2) of <span style="white-space:nowrap">Pre-Effective</span> Amendment No.<span style="text-decoration:underline"></span>&#160;1 to the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-2</span> (File No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-266318),</span> as filed with the Securities and Exchange Commission on December<span style="text-decoration:underline"></span>&#160;28, 2022.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;(s)(3)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="d421862dex99s3.htm">Calculation of Filing Fee Tables (Final Prospectus Dated January&#160;9, 2023) is filed herewith. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(t)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><a href="http://www.sec.gov/Archives/edgar/data/1287480/000119312522200963/d383966dex99t.htm">Power of Attorney is incorporated herein by reference to Exhibit (t)<span style="text-decoration:underline"></span>&#160;of the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-2</span> (File No.<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;333-266318),</span> as filed with the Securities and Exchange Commission on July<span style="text-decoration:underline"></span>&#160;25, 2022</a>.</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#160;26. Marketing Arrangements </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information contained under the section entitled &#8220;Plan of Distribution&#8221; in the Prospectus is incorporated by reference, and any information concerning any underwriters will be contained in the accompanying Prospectus Supplement, if any. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#160;27. Other Expenses of Issuance and Distribution </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth the estimated expenses to be incurred in connection with the offering described in this Registration Statement: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">


<tr>

<td style="width:87%"></td>

<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Registration fee</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11,446</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">NYSE listing fee</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,500</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounting fees and expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Legal fees and expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">70,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FINRA fee</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">19,021</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">106,967</td>
<td style="white-space:nowrap;vertical-align:bottom">(1)&#160;</td></tr>
</table> <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Estimate is based on the aggregate estimated expenses to be incurred during a three year shelf offering period. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">C-5 </p>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#160;28. Persons Controlled by or Under Common Control </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">None. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#160;29. Number of Holders of Securities </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&#160;14, 2022: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:68%;border:0;margin:0 auto">


<tr>

<td style="width:69%"></td>

<td style="vertical-align:bottom;width:28%"></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:9pt; font-family:Times New Roman;font-weight:bold">Title of Class</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Number&#160;of&#160;Record&#160;Holders</span></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common Shares of Beneficial Interest</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">12</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#160;30. Indemnification </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Article V of the Registrant&#8217;s Agreement and Declaration of Trust provides as follows: </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.1 <span style="text-decoration:underline">No Personal Liability of Shareholders, Trustees, etc</span>. No Shareholder of the Trust shall be subject in such capacity to any personal liability whatsoever to any Person in connection with Trust Property or the acts, obligations or affairs of the Trust. Shareholders shall have the same limitation of personal liability as is extended to stockholders of a private corporation for profit incorporated under the Delaware General Corporation Law. No Trustee or officer of the Trust shall be subject in such capacity to any personal liability whatsoever to any Person, save only liability to the Trust or its Shareholders arising from bad faith, willful misfeasance, gross negligence or reckless disregard for his duty to such Person; and, subject to the foregoing exception, all such Persons shall look solely to the Trust Property for satisfaction of claims of any nature arising in connection with the affairs of the Trust. If any Shareholder, Trustee or officer, as such, of the Trust, is made a party to any suit or proceeding to enforce any such liability, subject to the foregoing exception, he shall not, on account thereof, be held to any personal liability. Any repeal or modification of this Section&#160;5.1 shall not adversely affect any right or protection of a Trustee or officer of the Trust existing at the time of such repeal or modification with respect to acts or omissions occurring prior to such repeal or modification. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.2 <span style="text-decoration:underline">Mandatory Indemnification</span>. (a)&#160;The Trust hereby agrees to indemnify each person who at any time serves as a Trustee or officer of the Trust (each such person being an &#8220;indemnitee&#8221;) against any liabilities and expenses, including amounts paid in satisfaction of judgments, in compromise or as fines and penalties, and reasonable counsel fees reasonably incurred by such indemnitee in connection with the defense or disposition of any action, suit or other proceeding, whether civil or criminal, before any court or administrative or investigative body in which he may be or may have been involved as a party or otherwise or with which he may be or may have been threatened, while acting in any capacity set forth in this Article V by reason of his having acted in any such capacity, except with respect to any matter as to which he shall not have acted in good faith in the reasonable belief that his action was in the best interest of the Trust or, in the case of any criminal proceeding, as to which he shall have had reasonable cause to believe that the conduct was unlawful, provided, however, that no indemnitee shall be indemnified hereunder against any liability to any person or any expense of such indemnitee arising by reason of (i)&#160;willful misfeasance, (ii)&#160;bad faith, (iii)&#160;gross negligence, or (iv)&#160;reckless disregard of the duties involved in the conduct of his position (the conduct referred to in such clauses (i)&#160;through (iv) being sometimes referred to herein as &#8220;disabling conduct&#8221;). Notwithstanding the foregoing, with respect to any action, suit or other proceeding voluntarily prosecuted by any indemnitee as plaintiff, indemnification shall be mandatory only if the prosecution of such action, suit or other proceeding by such indemnitee (1)&#160;was authorized by a majority of the Trustees or (2)&#160;was instituted by the indemnitee to enforce his or her rights to indemnification hereunder in a case in which the indemnitee is found to be entitled to such indemnification. The rights to indemnification set forth in this Declaration shall continue as to a person who has ceased to be a Trustee or officer </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">C-6 </p>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">of the Trust and shall inure to the benefit of his or her heirs, executors and personal and legal representatives. No amendment or restatement of this Declaration or repeal of any of its provisions shall limit or eliminate any of the benefits provided to any person who at any time is or was a Trustee or officer of the Trust or otherwise entitled to indemnification hereunder in respect of any act or omission that occurred prior to such amendment, restatement or repeal. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding the foregoing, no indemnification shall be made hereunder unless there has been a determination (i)&#160;by a final decision on the merits by a court or other body of competent jurisdiction before whom the issue of entitlement to indemnification hereunder was brought that such indemnitee is entitled to indemnification hereunder or, (ii)&#160;in the absence of such a decision, by (1)&#160;a majority vote of a quorum of those Trustees who are neither &#8220;interested persons&#8221; of the Trust (as defined in Section&#160;2(a)(19) of the 1940 Act) nor parties to the proceeding (&#8220;Disinterested <span style="white-space:nowrap">Non-Party</span> Trustees&#8221;), that the indemnitee is entitled to indemnification hereunder, or (2)&#160;if such quorum is not obtainable or even if obtainable, if such majority so directs, independent legal counsel in a written opinion concludes that the indemnitee should be entitled to indemnification hereunder. All determinations to make advance payments in connection with the expense of defending any proceeding shall be authorized and made in accordance with the immediately succeeding paragraph (c)&#160;below. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) The Trust shall make advance payments in connection with the expenses of defending any action with respect to which indemnification might be sought hereunder if the Trust receives a written affirmation by the indemnitee of the indemnitee&#8217;s good faith belief that the standards of conduct necessary for indemnification have been met and a written undertaking to reimburse the Trust unless it is subsequently determined that the indemnitee is entitled to such indemnification and if a majority of the Trustees determine that the applicable standards of conduct necessary for indemnification appear to have been met. In addition, at least one of the following conditions must be met: (i)&#160;the indemnitee shall provide adequate security for his undertaking, (ii)&#160;the Trust shall be insured against losses arising by reason of any lawful advances, or (iii)&#160;a majority of a quorum of the Disinterested <span style="white-space:nowrap">Non-Party</span> Trustees, or if a majority vote of such quorum so direct, independent legal counsel in a written opinion, shall conclude, based on a review of readily available facts (as opposed to a full trial-type inquiry), that there is substantial reason to believe that the indemnitee ultimately will be found entitled to indemnification. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) The rights accruing to any indemnitee under these provisions shall not exclude any other right which any person may have or hereafter acquire under this Declaration, the <span style="white-space:nowrap">By-Laws</span> of the Trust, any statute, agreement, vote of stockholders or Trustees who are &#8220;disinterested persons&#8221; (as defined in Section&#160;2(a)(19) of the 1940 Act) or any other right to which he or she may be lawfully entitled. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(e) Subject to any limitations provided by the 1940 Act and this Declaration, the Trust shall have the power and authority to indemnify and provide for the advance payment of expenses to employees, agents and other Persons providing services to the Trust or serving in any capacity at the request of the Trust to the full extent corporations incorporated under the Delaware General Corporation Law may indemnify or provide for the advance payment of expenses for such Persons, provided that such indemnification has been approved by a majority of the Trustees. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.3 <span style="text-decoration:underline">No Bond Required of Trustees</span>. No Trustee shall, as such, be obligated to give any bond or other security for the performance of any of his duties hereunder. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.4 <span style="text-decoration:underline">No Duty of Investigation; No Notice in Trust Instruments, etc</span>. No purchaser, lender, transfer agent or other person dealing with the Trustees or with any officer, employee or agent of the Trust shall be bound to make any inquiry concerning the validity of any transaction purporting to be made by the Trustees or by said officer, employee or agent or be liable for the application of money or property paid, loaned, or delivered to or on the order of the Trustees or of said officer, employee or agent. Every obligation, contract, undertaking, instrument, certificate, Share, other security of the Trust, and every other act or thing whatsoever executed in connection with the Trust shall be conclusively taken to have been executed or done by the executors thereof only in their capacity as Trustees under this Declaration or in their capacity as officers, employees or agents of the Trust. The Trustees may maintain insurance for the protection of the Trust Property, its Shareholders, Trustees, officers, employees and agents in such amount as the Trustees shall deem adequate to cover possible tort liability, and such other insurance as the Trustees in their sole judgment shall deem advisable or is required by the 1940 Act. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">C-7 </p>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.5 <span style="text-decoration:underline">Reliance on Experts, etc</span>. Each Trustee and officer or employee of the Trust shall, in the performance of its duties, be fully and completely justified and protected with regard to any act or any failure to act resulting from reliance in good faith upon the books of account or other records of the Trust, upon an opinion of counsel, or upon reports made to the Trust by any of the Trust&#8217;s officers or employees or by any advisor, administrator, manager, distributor, selected dealer, accountant, appraiser or other expert or consultant selected with reasonable care by the Trustees, officers or employees of the Trust, regardless of whether such counsel or expert may also be a Trustee. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Registrant has also entered into an agreement with Trustees and officers of the Registrant entitled to indemnification under the Agreement and Declaration of Trust pursuant to which the Registrant has agreed to advance expenses and costs incurred by the indemnitee in connection with any matter in respect of which indemnification might be sought pursuant to the Agreement and Declaration of Trust to the maximum extent permitted by law. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Reference is also made to: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Sections 10 and 11 of the Registrant&#8217;s Investment Management Agreement, a form of which is filed as Exhibit (g)(1) to <span style="white-space:nowrap">Pre-Effective</span> Amendment No.&#160;3 to the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-2</span> (File <span style="white-space:nowrap">No.&#160;333-114662),</span> as filed with the Securities and Exchange Commission on August&#160;25, 2004. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Sections 9 and 10 of the Registrant&#8217;s <span style="white-space:nowrap">Sub-Investment</span> Advisory Agreement, a form of which is filed as Exhibit (g)(2) to the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-2</span> (File <span style="white-space:nowrap">No.&#160;333-266318),</span> as filed with the Securities and Exchange Commission on July&#160;25, 2022. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, the Registrant and the other funds in the BlackRock Fixed-Income Complex jointly maintain, at their own expense, E&amp;O/D&amp;O insurance policies for the benefit of its Trustees, officers and certain affiliated persons. The Registrant pays a pro rata portion of the premium on such insurance policies. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#160;31. Business and Other Connections of Investment Adviser </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Advisors, LLC, a limited liability company formed under the laws of Delaware (the &#8220;Advisor&#8221;), acts as investment adviser to the Registrant. The Registrant is fulfilling the requirement of this Item 31 to provide a list of the officers and directors of the Advisor, together with information as to any other business, profession, vocation or employment of a substantial nature engaged in by the Advisor or those officers and directors during the past two years, by incorporating by reference the information contained in the Form ADV of the Advisor filed with the Securities and Exchange Commission pursuant to the Investment Advisers Act of 1940 (Commission File <span style="white-space:nowrap">No.&#160;801-47710).</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock International Limited (&#8220;BIL&#8221;) acts as <span style="white-space:nowrap">sub-adviser</span> for a number of affiliated registered investment companies advised by BlackRock Advisors, LLC. The address of each of these registered investment companies is 100 Bellevue Parkway, Wilmington, Delaware 19809. The address of BIL is Exchange Place One, 1 Semple Street, Edinburgh, EH3 8BL, United Kingdom. The list required by this Item 31 about officers and directors of BIL, together with information as to any other business, profession, vocation or employment of a substantial nature engaged in by such officers and directors during the past two years, is incorporated by reference to Schedules A and D of Form ADV, filed by BIL pursuant to the Investment Advisers Act of 1940 (SEC File <span style="white-space:nowrap">No.&#160;801-51087).</span> </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#160;32. Location of Accounts and Records </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Omitted pursuant to the Instruction to Item 32 of Form <span style="white-space:nowrap">N-2.</span> </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#160;33. Management Services </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Not applicable </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#160;34. Undertakings </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Not applicable. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">C-8 </p>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(2)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Not applicable. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(3)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The securities being registered will be offered on a delayed or continuous basis in reliance on Rule 415 under the Securities Act of 1933. Accordingly, the Registrant undertakes: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(a)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">to file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">to include any prospectus required by Section&#160;10(a)(3) of the Securities Act of 1933; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(2)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">to reflect in the prospectus any facts or events after the effective date of the registration statement (or the most recent post- effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(3)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">to include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(b)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">that for the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(c)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">to remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(d)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">that, for the purpose of determining liability under the Securities Act of 1933 to any purchaser: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">if the Registrant is relying on Rule 430B [17 CFR 230.430B]: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:13%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(A)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Each prospectus filed by the Registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:13%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(B)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (x), or (xi)&#160;for the purpose of providing the information required by Section&#160;10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date; </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">C-9 </p>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(2)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">or if the Registrant is subject to Rule 430C [17 CFR 230.430C]: each prospectus filed pursuant to Rule 424(b) under the Securities Act of 1933 as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(e)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">that for the purpose of determining liability of the Registrant under the Securities Act of 1933 to any purchaser in the initial distribution of securities: The undersigned Registrant undertakes that in a primary offering of securities of the undersigned Registrant pursuant to this Registration Statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned Registrant will be a seller to the purchaser and will be considered to offer or sell such securities to the purchaser: (1)&#160;any preliminary prospectus or prospectus of the undersigned Registrant relating to the offering required to be filed pursuant to Rule 424 under the Securities Act of 1933; (2) free writing prospectus relating to the offering prepared by or on behalf of the undersigned Registrant or used or referred to by the undersigned Registrant; (3)&#160;the portion of any other free writing prospectus or advertisement pursuant to Rule 482 under the Securities Act of 1933 relating to the offering containing material information about the undersigned Registrant or its securities provided by or on behalf of the undersigned Registrant; and (4)&#160;any other communication that is an offer in the offering made by the undersigned Registrant to the purchaser. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(4)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">If applicable: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(a)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">For the purposes of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed as part of a registration statement in reliance upon Rule 430A and contained in the form of prospectus filed by the Registrant under Rule 424(b)(1) under the Securities Act of 1933 shall be deemed to be part of the Registration Statement as of the time it was declared effective. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(b)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">For the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of the securities at that time shall be deemed to be the initial bona fide offering thereof. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">C-10 </p>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(5)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the Registrant&#8217;s annual report pursuant to Section&#160;13(a) or Section&#160;15(d) of the Securities Exchange Act of 1934 that is incorporated by reference into the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(6)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(7)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The Registrant undertakes to send by first class mail or other means designed to ensure equally prompt delivery, within two business days of receipt of a written or oral request, any prospectus or Statement of Additional Information. </p></td></tr></table> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">C-11 </p>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933 and the Investment Company Act of 1940, the Trust has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of New York, and State of New York, on the 9th day of January, 2023. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border:0;margin-left:auto">


<tr>

<td style="width:7%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:92%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3">BLACKROCK FLOATING RATE INCOME TRUST</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">By:</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top">/s/ John M. Perlowski</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">John M. Perlowski</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">President and Chief Executive Officer</td></tr>
</table></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed below by the following persons in the capacities and on the dates indicated. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:38%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:44%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:16%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Signature</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date</p></td></tr>


<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">/s/ John M. Perlowski</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:center">(John M. Perlowski)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">Trustee, President and Chief Executive Officer</p> <p style="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">(Principal Executive Officer)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap" align="center">January&#160;9, 2023</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">/s/ Trent Walker</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:center">(Trent Walker)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">Chief Financial Officer</p> <p style="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">(Principal Financial and Accounting Officer)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap" align="center">January&#160;9, 2023</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">CYNTHIA L. EGAN*</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:center">(Cynthia L. Egan)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">Trustee</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">FRANK J. FABOZZI*</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:center">(Frank J. Fabozzi)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">Trustee</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">LORENZO A. FLORES*</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:center">(Lorenzo A. Flores)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">Trustee</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">STAYCE D. HARRIS*</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:center">(Stayce D. Harris)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">Trustee</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">J. PHILLIP HOLLOMAN*</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:center">(J. Phillip Holloman)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">Trustee</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">R. GLENN HUBBARD*</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:center">(R. Glenn Hubbard)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">Trustee</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">W. CARL KESTER*</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:center">(W. Carl Kester)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">Trustee</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">CATHERINE A. LYNCH*</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:center">(Catherine A. Lynch)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">Trustee</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">ROBERT FAIRBAIRN*</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:center">(Robert Fairbairn)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">Trustee</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">*By: /s/ Janey Ahn</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:center">(Janey Ahn, <span style="white-space:nowrap"><span style="white-space:nowrap">Attorney-In-Fact)</span></span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap" align="center">January&#160;9, 2023</td></tr>
</table>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EXHIBIT INDEX </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:9%"></td>
<td style="width:90%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Exhibit&#160;Number</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(h)(1)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="d421862dex99h1.htm">Distribution Agreement between the Registrant and BlackRock Investments, LLC </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(h)(2)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="d421862dex99h2.htm"><span style="white-space:nowrap">Sub-Placement</span> Agent Agreement between BlackRock Investments, LLC and UBS Securities LLC </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(k)(8)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="d421862dex99k8.htm">Form of Ninth Amended and Restated Securities Lending Agreement between the Registrant and BlackRock Investment Management, LLC</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(l)(2)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="d421862dex99l2.htm">Opinion and Consent of Counsel to the Registrant </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(r)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="d421862dex99r.htm">Code of Ethics of the Registrant, BlackRock Advisors, LLC, BlackRock International Limited and BlackRock (Singapore) Limited </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(s)(3)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="d421862dex99s3.htm">Calculation of Filing Fee Tables (Final Prospectus Dated January&#160;9, 2023) </a></td></tr>
</table>
</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(H)(1)
<SEQUENCE>2
<FILENAME>d421862dex99h1.htm
<DESCRIPTION>DISTRIBUTION AGREEMENT BETWEEN THE REGISTRANT AND BLACKROCK INVESTMENTS
<TEXT>
<HTML><HEAD>
<TITLE>Distribution Agreement between the Registrant and BlackRock Investments</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Exhibit (h)(1) </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">DISTRIBUTION AGREEMENT </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This
DISTRIBUTION AGREEMENT (the &#147;<U>Agreement</U>&#148;) is made as of January&nbsp;9, 2023 by and between BlackRock Floating Rate Income Trust, a Delaware statutory trust (the &#147;<U>Fund</U>&#148;), and BlackRock Investments, LLC, a Delaware
limited liability company (the &#147;<U>Distributor</U>&#148;). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>WITNESSETH</U>: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Fund is registered under the Investment Company Act of 1940, as amended, and the rules and regulations thereunder (collectively
called the &#147;<U>Investment Company Act</U>&#148;), as a diversified, <FONT STYLE="white-space:nowrap">closed-end,</FONT> management investment company; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Fund has filed, or may from time to time file, one or more registration statements on Form
<FONT STYLE="white-space:nowrap">N-2</FONT> pursuant to the Investment Company Act and the Securities Act of 1933, as amended, and the rules and regulations thereunder (collectively called the &#147;<U>Securities Act</U>&#148;), to register
additional common shares of beneficial interest (&#147;<U>common shares</U>&#148;) of the Fund, which may be issued and sold from time to time through various specified transactions, including <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">at-the-market</FONT></FONT> (&#147;<U>ATM</U>&#148;) offerings pursuant to Rule 415 under the Securities Act; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Distributor is registered as a broker-dealer under the provisions of the Securities Exchange Act of 1934 (the &#147;<U>Exchange
Act</U>&#148;) and is a member in good standing of the Financial Industry Regulatory Authority, Inc. (&#147;<U>FINRA</U>&#148;); and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Fund and the Distributor wish to enter into an agreement with each other with respect to ATM offerings, from time to time, of the
Fund&#146;s common shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW THEREFORE, the parties agree as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1. <U>Appointment of the Distributor; ATM Offerings</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Subject to the terms and conditions of this Agreement, the Fund hereby appoints the Distributor as its principal underwriter and placement
agent for the common shares of the Fund to be offered pursuant to a Registration Statement (as defined below) through ATM offerings from time to time (the &#147;<U>Shares</U>&#148;) and the Fund agrees that it will issue such Shares as the
Distributor may sell. The Distributor agrees to use reasonable efforts to identify opportunities for the sale of Shares, but the Distributor is not obligated to sell any specific number of the Shares (though the Distributor will only be authorized
to sell on any Offering Date (as defined below) the maximum number of Shares agreed to with the Fund pursuant to Section&nbsp;1(d) hereof) or purchase any Shares for its own account. The Shares will only be sold on such days as shall be agreed to by
the Distributor and the Fund (each, an &#147;<U>Offering Date</U>&#148;). The Distributor hereby accepts such appointment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The
Distributor acknowledges that Shares will be offered and sold only as set forth from time to time in a Registration Statement including, without limitation, pricing of Shares, handling of investor funds and payment of sales commissions. </P>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Fund may suspend or terminate any ATM offering of its Shares at any time. Upon notice to
the Distributor of the terms of such suspension or termination, the Distributor shall suspend the ATM offering of Shares in accordance with such terms until the Fund notifies the Distributor that such ATM offering may be resumed; <U>provided</U>,
<U>however</U>, that such suspension or termination shall not affect or impair the parties&#146; respective obligations with respect to the Shares sold hereunder prior to the giving of such notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The price per Share shall be determined by the Fund together with the Distributor by reference to trades on the Fund&#146;s primary
exchange. In no event shall the price per Share be less than the current net asset value per Share plus the per Share amount of the commission to be paid to the Distributor (the &#147;<U>Minimum Price</U>&#148;). The Fund may establish a minimum
sales price per Share on any Offering Date in excess of the Minimum Price (the &#147;<U>Minimum Sales Price</U>&#148;), and the Fund shall communicate such Minimum Sales Price to the Distributor. The Fund shall have sole discretion to establish a
Minimum Sales Price for any Offering Date and may consider, among other factors, the degree to which the Fund&#146;s market price per Share exceeds its net asset value per Share, and the amount of assets the Fund desires to raise through ATM
offerings. The Distributor shall suspend the sale of Shares if the per share price of the Shares is less than the Minimum Price or the Minimum Sales Price. The Distributor shall, together with the Fund, determine the maximum number of Shares to be
sold by the Distributor for any Offering Date, and the Distributor shall not be authorized to sell Shares on any Offering Date in excess of such maximum. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Distributor will confirm to the Fund, following the close of trading on the Fund&#146;s primary exchange on each Offering Date for the
Shares, the number of Shares sold, the time of sale, the gross sales price per Share and the compensation payable to the Distributor, or to which the Distributor is entitled with respect to such sales. The Fund reserves the right to reject any order
in whole or in part. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Settlement for sales of the Shares pursuant to this Section&nbsp;1 will occur on the second business day
following the date on which such sales are made (each such day, a &#147;<U>Settlement Date</U>&#148;). On each Settlement Date, the Shares sold through the Distributor for settlement on such date shall be delivered by the Fund to the Distributor
against payment of the gross sales proceeds for the sale of such Shares, less the Distributor&#146;s sales commission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) In selling
Shares, the Distributor shall act solely as an agent of the Fund and not as principal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2. <U>Representations and Warranties
by the Fund</U>. The Fund represents, warrants to and agrees with the Distributor, as of the date hereof and as of each Offering Date and Settlement Date, that: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) A shelf registration statement on Form <FONT STYLE="white-space:nowrap">N-2</FONT> (File
<FONT STYLE="white-space:nowrap">No.&nbsp;333-266318</FONT> and <FONT STYLE="white-space:nowrap">811-21566)</FONT> (the &#147;<U>Registration Statement</U>&#148;) (i) has been prepared by the Fund in conformity with the requirements of the
Securities Act and the Investment Company Act in all material respects, (ii)&nbsp;has been filed with the U.S. Securities and Exchange Commission (the &#147;<U>Commission</U>&#148;) under the Securities Act and the Investment Company Act; the
Registration Statement sets forth the terms of the offering, sale and plan of distribution of the Shares and contains additional information concerning the Fund and its business, and (iii)&nbsp;heretofore became, and is, effective; no stop order of
the Commission preventing or suspending the use of the Prospectus (as defined below), or the effectiveness of the Registration Statement, has been issued, and no proceedings for such purpose have been instituted or, to the Fund&#146;s knowledge,
have been threatened by the Commission. Except where the context otherwise requires, &#147;<U>Registration Statement</U>,&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;2&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
as used herein, means, collectively, the various parts of the Registration Statement pertaining to the offering and sale of Shares, as amended, at the time of effectiveness for purposes of
Section&nbsp;11 of the Securities Act (the &#147;<U>Effective Time</U>&#148;), as such section applies to the Distributor, including (1)&nbsp;all documents filed as a part thereof or incorporated or deemed to be incorporated by reference therein,
(2)&nbsp;any information contained or incorporated by reference in a prospectus filed with the Commission pursuant to Rule 424(b)(2) and/or Rule 424(b)(5) under the Securities Act, to the extent such information is deemed pursuant to Rule 430B or
Rule 430C under the Securities Act to be part of the Registration Statement at the Effective Time, and (3)&nbsp;any registration statement filed to register the offer and sale of Shares pursuant to Rule 462(b) under the Securities Act. Except where
the context otherwise requires, &#147;<U>Prospectus</U>,&#148; as used herein, means a final prospectus, including the related statement of additional information, relating to the Shares, filed by the Fund with the Commission pursuant to Rule
424(b)(2) and/or Rule 424(b)(5) under the Securities Act, in the form furnished by the Fund to the Distributor in connection with the offering of the Shares, together with, if applicable, any final prospectus supplement relating to the Shares
attached to or used with such final prospectus, filed by the Fund with the Commission pursuant to Rule 424(b)(2) and/or Rule 424(b)(5) under the Securities Act, in the form furnished by the Fund to the Distributor in connection with the offering of
the Shares. Any reference herein to the Registration Statement or the Prospectus shall be deemed to refer to and include the documents, if any, incorporated by reference, or deemed to be incorporated by reference, therein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Fund is duly registered under the Investment Company Act as a <FONT STYLE="white-space:nowrap">closed-end</FONT> management investment
company. A notification of registration of the Fund as an investment company under the Investment Company Act on Form <FONT STYLE="white-space:nowrap">N-8A</FONT> (the &#147;<U>Investment Company Act Notification</U>&#148;) has been prepared by the
Fund in conformity with the Investment Company Act and has been filed with the Commission and, at the time of filing thereof and at the time of filing any amendment or supplement thereto, conformed in all material respects with all applicable
provisions of the Investment Company Act. The Fund has not received any notice in writing from the Commission pursuant to Section&nbsp;8(e) of the Investment Company Act with respect to the Investment Company Act Notification or the Registration
Statement (or any amendment or supplement to either of them). No person is serving or acting as an officer, Trustee (as defined below) or investment adviser of the Fund except in accordance with the provisions of the Investment Company Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Registration Statement, the Investment Company Act Notification and the Prospectus as from time to time amended or supplemented each
complied when it became effective or was filed (as the case may be), complies as of the date hereof and, as amended or supplemented, will comply, at each time of purchase of Shares in connection with the ATM offerings, and at all times during which
a prospectus is required by the Securities Act to be delivered in connection with any sale of Shares, in all material respects, with the requirements of the Securities Act and the Investment Company Act; the Registration Statement did not, as of the
Effective Time, contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading; at no time during the period that begins on the earlier of the
date of the Prospectus and the date the Prospectus was filed with the Commission and ends at the later of the time of purchase of Shares in connection with the ATM offerings, and the end of the period during which a prospectus is required by the
Securities Act to be delivered in connection with any sale of Shares did or will the Prospectus, as from time to time amended or supplemented, include an untrue statement of a material fact or omit to state a material fact necessary in order to make
the statements therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U>, <U>however</U>, that the Fund does not make any representation or warranty with respect to any statement contained in the
Registration Statement or the Prospectus in reliance upon and in conformity with information furnished in writing by the Distributor or any <FONT STYLE="white-space:nowrap">sub-placement</FONT> agents (as defined below), or on the Distributor&#146;s
or any <FONT STYLE="white-space:nowrap">sub-placement</FONT> agent&#146;s behalf, to the Fund expressly for use in the Registration Statement or the Prospectus (the &#147;<U>Agent Provided Information</U>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;3&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The financial statements incorporated by reference in the Registration Statement or the
Prospectus, together with the related notes and schedules, present fairly the financial position of the Fund as of the dates indicated and the results of operations, cash flows and changes in shareholders&#146; equity of the Fund for the periods
specified and have been prepared in compliance in all material respects with the requirements of the Securities Act, the Investment Company Act and the Exchange Act, and in conformity in all material respects with U.S. generally accepted accounting
principles applied on a consistent basis during the periods involved; the other financial and statistical data contained or incorporated by reference in the Registration Statement or the Prospectus are accurately and fairly presented, in all
material respects, and prepared on a basis consistent with the financial statements and books and records of the Fund in all material respects; there are no financial statements that are required to be included or incorporated by reference in the
Registration Statement or the Prospectus by the Securities Act, the Investment Company Act or the Exchange Act that are not included or incorporated by reference as required; and the Fund does not have any material liabilities or obligations, direct
or contingent (including any <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet obligations), not described in the Registration Statement (excluding the exhibits thereto). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) As of the date of this Agreement, the Fund has an authorized and outstanding capitalization as set forth in the Registration Statement and
the Prospectus and, with respect to any issuance and sale under this Agreement, the Fund shall have as of the date of the most recent amendment or supplement to the Registration Statement or Prospectus, an authorized and outstanding capitalization
as set forth in the Registration Statement and the Prospectus; all of the issued and outstanding shares of capital stock, including the Shares, of the Fund have been duly authorized and validly issued and are fully paid and <FONT
STYLE="white-space:nowrap">non-assessable</FONT> (except as described below and in the Registration Statement), have been issued in material compliance with all applicable securities laws and were not issued in violation of any preemptive right,
resale right, right of first refusal or similar right; the Shares will be duly listed, and admitted and authorized for trading, subject to official notice of issuance, on the exchange on which the Fund&#146;s Shares are listed and primarily trade
(the &#147;<U>Stock Exchange</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The Fund has been duly formed, is validly existing and is in good standing under the laws of
Delaware, with full power and authority to own, lease and operate and conduct its business as described in the Registration Statement and the Prospectus and to issue, sell and deliver the Shares as contemplated herein. The Fund is duly qualified to
do business as a foreign entity and is in good standing in each jurisdiction where the conduct of its business requires such qualification, except where the failure to be so qualified and in good standing would not, individually or in the aggregate,
have a material adverse effect on the business, properties, financial condition or results of operations of the Fund. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) The Shares have
been duly and validly authorized and, when issued and delivered against payment therefor as provided herein, will be duly and validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> (except as described below and in the
Registration Statement) and free of statutory and contractual preemptive rights, resale rights, rights of first refusal and similar rights; the Shares, when issued and delivered against payment therefor as provided herein, will be free of any
restriction upon the voting or transfer thereof pursuant to the Fund&#146;s agreement and declaration of trust, as amended or supplemented, bylaws, as amended or supplemented, or any agreement or other instrument to which the Fund is a party. The
capital stock of the Fund, including the Shares, conforms in all material respects to each description thereof, if any, contained or incorporated by reference in the Registration Statement or the Prospectus; and the certificates for the Shares, if
any, are in due and proper form. The Fund is in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;4&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
material compliance with the rules of the Stock Exchange, including, without limitation, the requirements for continued listing of the Shares on the Stock Exchange and the Fund has not received
any written notice from the Stock Exchange regarding the delisting of the Shares from the Stock Exchange. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) No approval, authorization,
consent or order of or filing with any federal, state, local or foreign governmental or regulatory commission, board, body, authority or agency, or of or with any self-regulatory organization or other
<FONT STYLE="white-space:nowrap">non-governmental</FONT> regulatory authority (including, without limitation, the Stock Exchange), or approval of the shareholders of the Fund that has not already been obtained, is required in connection with the
issuance and sale of the Shares or the consummation by the Fund of the transactions contemplated hereby, other than (i)&nbsp;the registration of the Shares under the Securities Act, which has been effected, (ii)&nbsp;the listing of the Shares with
the Stock Exchange, upon official notice of issuance, (iii)&nbsp;any necessary qualification under the securities or blue sky laws of the various jurisdictions in which the Shares are being offered by the Fund or (iv)&nbsp;any necessary
qualification pursuant to the rules of FINRA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3. <U>Duties of the Fund</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Fund shall take, from time to time, but subject always to any necessary approval of the Board of Trustees of the Fund (each a
&#147;<U>Trustee</U>,&#148; and together the &#147;<U>Board</U>&#148;) or of its shareholders, all necessary action to fix the number of authorized Shares, to the end that the Fund will have a number of authorized but unissued Shares at least equal
to the number of Shares registered for sale under the Securities Act and available for sale pursuant to the Registration Statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)
For purposes of the ATM offerings of Shares, the Fund will furnish to the Distributor copies of its most recent amendment to its Registration Statement for a particular ATM offering, its most recent Prospectus and all amendments and supplements
thereto, and other documentation the Distributor may reasonably request for use in the ATM offerings of Shares. The Distributor is authorized to furnish to prospective investors only such information concerning the Fund and the ATM offerings of
Shares as may be contained in the Registration Statement, the Prospectus, the Fund&#146;s publicly available formation documents, or any other documents (including sales material), if expressly approved by the Fund for such purpose. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Fund shall furnish to the Distributor copies of all financial statements of the Fund which the Distributor may reasonably request for
use in connection with its duties hereunder, and this shall include, upon request by the Distributor, one certified copy of all financial statements prepared for the Fund by independent public accountants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Fund shall use its best efforts to qualify and maintain, to the extent required by applicable law, the qualification of Shares for
sale under the securities laws of such jurisdictions as the Distributor and the Fund may approve. Any such qualification may be withheld, terminated or withdrawn by the Fund at any time in its discretion. The expense of qualification and maintenance
of qualification shall be borne by the Fund. The Distributor shall furnish such information and other material relating to its affairs and activities as may be required by the Fund in connection with such qualification. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Fund will furnish, in reasonable quantities upon request by the Distributor, copies of its annual and interim reports. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The Fund will furnish the Distributor with such other documents as it may reasonably require, from time to time, for the purpose of
enabling it to perform its duties as contemplated by this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;5&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4. <U>Duties of the Distributor</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Distributor shall devote reasonable time and effort to its duties hereunder. The services of the Distributor to the Fund hereunder are
not to be deemed exclusive and nothing herein contained shall prevent the Distributor from entering into like arrangements with other investment companies so long as the performance of its obligations with respect to the Fund hereunder is not
impaired thereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In performing its duties hereunder, the Distributor shall comply with the requirements of all applicable laws
relating to the sale of securities in all material respects. Neither the Distributor nor any <FONT STYLE="white-space:nowrap">sub-placement</FONT> agent having an agreement to offer and sell Shares pursuant to Section&nbsp;5 hereof nor any other
person is authorized by the Fund to give any information or to make any representations, other than those contained in its Registration Statement, Prospectus and any sales literature specifically approved for such use by the Fund. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Distributor shall adopt and follow procedures, as approved by the officers of the Fund, for the confirmation of sales to selected
dealers, the collection of amounts payable by selected dealers on such sales, and the cancellation of unsettled transactions, as may be necessary to comply with the requirements of FINRA applicable to sales of Shares, as such requirements may from
time to time exist. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Distributor shall prepare or review, and file with federal and state agencies or other organizations as
required by federal, state, or other applicable laws and regulations, all sales literature (advertisements, brochures and shareholder communications) prepared in connection with the ATM offerings for the Fund. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Distributor agrees to supply the following additional services, together with such other services as set forth throughout this
Agreement: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">handling inquiries from <FONT STYLE="white-space:nowrap">sub-placement</FONT> agents regarding the Fund;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">assisting in the enhancement of communications between <FONT STYLE="white-space:nowrap">sub-placement</FONT>
agents and the Fund; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">communicating the Minimum Price or Minimum Sales Price to any
<FONT STYLE="white-space:nowrap">sub-placement</FONT> agents and instructing any <FONT STYLE="white-space:nowrap">sub-placement</FONT> agents not to sell Shares if such sales cannot be effected at or above the Minimum Price or the Minimum Sales
Price; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">communicating the maximum amount of Shares to be sold on any Offering Date to any <FONT
STYLE="white-space:nowrap">sub-placement</FONT> agents; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">notifying any <FONT STYLE="white-space:nowrap">sub-placement</FONT> agents of any suspension or termination of
the ATM offerings of Shares, together with any corresponding resumption of the ATM offerings of Shares; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">coordinating delivery of any Shares sold through <FONT STYLE="white-space:nowrap">sub-placement</FONT> agents
to such <FONT STYLE="white-space:nowrap">sub-placement</FONT> agents on the Settlement Date against payment of the gross sales proceeds for the sale of such Shares, less any applicable <FONT STYLE="white-space:nowrap">sub-placement</FONT> agent
selling commission; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">delivering the Fund&#146;s Prospectus to any <FONT STYLE="white-space:nowrap">sub-placement</FONT> agents;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">identifying potential <FONT STYLE="white-space:nowrap">sub-placement</FONT> agents; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;6&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">monitoring the performance of <FONT STYLE="white-space:nowrap">sub-placement</FONT> agents;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">providing any necessary reconciliation, accounting and recordkeeping services in respect of the ATM offerings
of Shares, including with respect to the underwriting compensation paid by the Fund to the Distributor in respect thereof; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">11.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">providing such other information, assistance and services as may be reasonably requested by the Fund.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The Distributor shall report to the Board at least quarterly, or more frequently as requested by the Board,
regarding: (i)&nbsp;the nature of the services provided by the Distributor hereunder; (ii)&nbsp;the amount of compensation <FONT STYLE="white-space:nowrap">sub-placement</FONT> agents, if any, are entitled to retain or be paid by the Distributor;
and (iii)&nbsp;the aggregate amount of underwriting compensation paid by the Fund to the Distributor in respect of the ATM offerings of Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) The Distributor represents and warrants to the Fund that it has all necessary licenses to perform the services contemplated hereunder and
will perform such services in compliance with all applicable rules and regulations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) The Distributor shall make such initial and
ongoing inquiry with respect to any <FONT STYLE="white-space:nowrap">sub-placement</FONT> agents as shall be necessary to obtain appropriate assurances from any such <FONT STYLE="white-space:nowrap">sub-placement</FONT> agents with respect to the
respective <FONT STYLE="white-space:nowrap">sub-placement</FONT> agents&#146; licensing, performance of services in respect of the Fund, compliance programs and such other matters as may be customary, necessary or desirable in respect of such <FONT
STYLE="white-space:nowrap">sub-placement</FONT> agents&#146; participation in the ATM offerings of Shares, or as may be requested by the Fund. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5. <U>Agreements with <FONT STYLE="white-space:nowrap">Sub-Placement</FONT> Agents</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Distributor may enter into selected dealer agreements, on such terms and conditions as the Distributor determines are not inconsistent
with this Agreement, with broker-dealers to act as the Distributor&#146;s agents to effect the sale of the Shares in the ATM offerings. Such selected broker-dealers (&#147;<U><FONT STYLE="white-space:nowrap">sub-placement</FONT> agents</U>&#148;)
shall sell Shares only at market prices subject to the Minimum Price and the Minimum Sales Price. This Agreement shall not be construed as authorizing any dealer or other person to accept orders for sale on the Fund&#146;s behalf or to otherwise act
as the Fund&#146;s agent for any purpose. The Distributor shall not be responsible for the acts of other dealers or agents except as and to the extent that they shall be acting for the Distributor or under the Distributor&#146;s direction or
authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Distributor shall offer and sell Shares only to such <FONT STYLE="white-space:nowrap">sub-placement</FONT> agents who
are acting as brokers or dealers who are members in good standing of FINRA and who agree to abide by the rules of FINRA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The
Distributor shall obtain appropriate assurance from any <FONT STYLE="white-space:nowrap">sub-placement</FONT> agents which it engages of the compliance by such <FONT STYLE="white-space:nowrap">sub-placement</FONT> agents with applicable federal and
state securities laws and the rules of FINRA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6. <U>Sales Commission</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Fund shall pay the Distributor, or the Distributor shall be entitled to retain, an amount equal to 1.00% of the gross sales price per
Share of the Shares sold. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;7&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Distributor may pay to <FONT STYLE="white-space:nowrap">sub-placement</FONT> agents such <FONT
STYLE="white-space:nowrap">sub-placement</FONT> agent commissions as the Distributor shall deem advisable, or may authorize such <FONT STYLE="white-space:nowrap">sub-placement</FONT> agents to retain such
<FONT STYLE="white-space:nowrap">sub-placement</FONT> agent commissions from the gross sales proceeds from the sale of such Shares, which shall be payable or retained, as the case may be, from the commissions payable or retained, as the case may be,
to or by the Distributor under Section&nbsp;6(a) above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Fund hereby represents and warrants to the Distributor that (i)&nbsp;the
terms of this Agreement, (ii)&nbsp;the fees and expenses associated with this Agreement, and (iii)&nbsp;any benefits accruing to the Distributor or to the Fund&#146;s investment adviser or sponsor or another affiliate of the Fund in connection with
this Agreement, including but not limited to any fee waivers, conversion cost reimbursements, <FONT STYLE="white-space:nowrap">up-front</FONT> payments, signing payments or periodic payments relating to this Agreement have been fully disclosed to
the Board and that, if required by applicable law, the Board has approved or will approve the terms of this Agreement, any such fees and expenses, and any such benefits. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7. <U>Payment of Expenses</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Fund shall bear all of its own costs and expenses, including fees and disbursements of its counsel and auditors, in connection with
the preparation of its Prospectus, Statement of Additional Information, if any, the preparation and filing of any required registration statements under the Securities Act and/or the Investment Company Act, and all amendments and supplements
thereto, and in connection with any fees and expenses incurred with respect to any filing requirements of FINRA and preparing and mailing annual and interim reports and proxy materials to shareholders (including but not limited to the expense of
setting in type any such Registration Statement, Prospectus, interim reports or proxy materials). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Fund shall bear any cost and
expenses of qualification of the Shares for sale pursuant to this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Distributor shall bear all expenses incurred by it
in connection with its duties and activities under this Agreement, including the compensation of <FONT STYLE="white-space:nowrap">sub-placement</FONT> agents for sales of the Fund&#146;s Shares and fees and expenses of Distributor&#146;s counsel
(except for any FINRA filing fees or &#147;blue sky&#148; fees paid on behalf of the Fund or the Distributor by such counsel). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8. <U>Limitation of Liability; Indemnification</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Distributor shall not be liable for any error of judgment or mistake of law or for any loss suffered by the Fund in connection with
the matters to which this Agreement relates, except a loss resulting from willful misfeasance, bad faith or gross negligence on its part in the performance of its duties or from reckless disregard by it of its obligations and duties under this
Agreement. Notwithstanding anything in this Agreement to the contrary, the Distributor&#146;s cumulative liability to the Fund and any person or entity claiming through the Fund for all losses, claims, suits, controversies, breaches and damages of
any nature whatsoever arising out of or relating to this Agreement, and regardless of the form of action or legal theory, shall not exceed an amount equal to the greatest amount of fees received by the Distributor for services provided under this
Agreement during a particular six (6)&nbsp;consecutive month period. The Distributor shall not be liable for any damages arising out of any action or omission to act by any prior service provider of the Fund or for any failure to discover any such
error or omission (provided that this sentence shall not apply where the Distributor was the prior service provider). Notwithstanding anything in this Agreement to the contrary, the Distributor shall not be liable for any consequential, incidental,
exemplary, punitive, special or indirect damages, whether or not the likelihood of such damages was known by the Distributor. Notwithstanding anything in this Agreement to the contrary, the Distributor shall not be liable for damages occurring
directly or indirectly by reason of circumstances beyond its reasonable control. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;8&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Fund agrees that it will indemnify, defend and hold harmless the Distributor, its several
officers, and directors, and any person who controls the Distributor within the meaning of Section&nbsp;15 of the Securities Act, from and against any losses, claims, damages or liabilities, joint or several, to which the Distributor, its several
officers, and directors, and any person who controls the Distributor within the meaning of Section&nbsp;15 of the Securities Act, may become subject under the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities (or
actions or proceedings in respect thereof)&nbsp;(i) arise out of, or are based upon any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, the Prospectus or in any application or other document
executed by or on behalf of the Fund or are based upon information furnished by or on behalf of the Fund filed in any state in order to qualify the Shares under the securities or blue sky laws thereof (&#147;<U>Blue Sky application</U>&#148;) or
arise out of, or are based upon, the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading; or (ii)&nbsp;arise out of, or are based upon, any breach of
the representations, warranties or covenants of the Fund contained in this Agreement, and the Fund will reimburse the Distributor, its several officers, and directors, and any person who controls the Distributor within the meaning of Section&nbsp;15
of the Securities Act, for any legal or other expenses reasonably incurred by the Distributor, its several officers, and directors, and any person who controls the Distributor within the meaning of Section&nbsp;15 of the Securities Act, in
investigating, defending or preparing to defend any such action, proceeding or claim described above in this Section&nbsp;8(b); <U>provided</U>, <U>however</U>, that the Fund shall not be liable in any case to the extent that such loss, claim,
damage or liability arises out of, or is based upon, any untrue statement, alleged untrue statement, or omission or alleged omission made in the Registration Statement, the Prospectus or any Blue Sky application with respect to the Fund in reliance
upon and in conformity with any Agent Provided Information, or arising out of the failure of the Distributor or any <FONT STYLE="white-space:nowrap">sub-placement</FONT> agent to deliver a current Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Fund shall not indemnify any person pursuant to this Section&nbsp;8 unless the court or other body before which the proceeding was
brought has rendered a final decision on the merits that such person was not liable by reason of his or her willful misfeasance, bad faith or gross negligence in the performance of his or her duties, or his or her reckless disregard of any
obligations and duties, under this Agreement (&#147;<U>disabling conduct</U>&#148;) or, in the absence of such a decision, a reasonable determination (based upon a review of the facts) that such person was not liable by reason of disabling conduct
has been made by the vote of a majority of a quorum of the Trustees of the Fund who are neither &#147;<U>interested parties</U>&#148; (as defined in the Investment Company Act) nor parties to the proceeding, or by independent legal counsel in a
written opinion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Distributor will indemnify and hold harmless the Fund and its several officers and Trustees, and any person who
controls the Fund within the meaning of Section&nbsp;15 of the Securities Act, from and against any losses, claims, damages or liabilities, joint or several, to which any of them may become subject under the Securities Act or otherwise, insofar as
such losses, claims, damages or liabilities (or actions or proceedings in respect thereof) arise out of, or are based upon, any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, the Prospectus
or any Blue Sky application, or arise out of, or are based upon, the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, which statement or omission
was made in reliance upon and in conformity with information furnished in writing to the Fund or any of its several officers and Trustees by or on behalf of the Distributor specifically for inclusion therein, and will reimburse the Fund and its
several officers, Trustees and such controlling persons for any legal or other expenses reasonably incurred by any of them in investigating, defending or preparing to defend any such action, proceeding or claim. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;9&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) This Section&nbsp;8 shall survive any termination of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9. <U>Duration and Termination of this Agreement</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) This Agreement shall become effective as of the date first above written and shall remain in force for two years thereafter and thereafter
continue from year to year, but only so long as such continuance is specifically approved at least annually (i)&nbsp;by the Trustees or by the vote of a majority of the outstanding voting securities of the Fund, and (ii)&nbsp;by the vote of a
majority of those Trustees who are not parties to this Agreement or interested persons of any such party cast in person at a meeting called for the purpose of voting on such approval. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) This Agreement may be terminated at any time, without the payment of any penalty, by the Trustees or by vote of a majority of the
outstanding voting securities of the Fund, or by the Distributor, on sixty days&#146; written notice to the other party. This Agreement shall automatically terminate in the event of its assignment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The terms &#147;<U>vote of a majority of the outstanding voting securities</U>,&#148; &#147;<U>assignment</U>,&#148; &#147;<U>affiliated
person</U>&#148; and &#147;<U>interested person</U>,&#148; when used in this Agreement, shall have the respective meanings specified in the Investment Company Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;10. <U>Amendments of this Agreement</U>. This Agreement may be amended by the parties only if such amendment is specifically
approved (i)&nbsp;by the Trustees or by the vote of a majority of the outstanding voting securities of the Fund and (ii)&nbsp;by the vote of a majority of those Trustees of the Fund who are not parties to this Agreement or interested persons of any
such party cast in person at a meeting called for the purpose of voting on such approval. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;11. <U>Governing Law</U>. This
Agreement and any claim, counterclaim or dispute of any kind or nature whatsoever arising out of or in any way relating to this Agreement, directly or indirectly, shall be governed by, and construed in accordance with, the internal laws of the State
of New York. To the extent that the applicable law of the State of New York, or any of the provisions herein, conflict with the applicable provisions of the Investment Company Act, the latter shall control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;12. <U>Customer Identification Program Notice</U>. To help the U.S. government fight the funding of terrorism and money
laundering activities, U.S. federal law requires each financial institution to obtain, verify, and record certain information that identifies each person who initially opens an account with that financial institution on or after October&nbsp;1,
2003. Consistent with this requirement, the Distributor will request (or already has requested) the Fund&#146;s name, address and taxpayer identification number or other government-issued identification number. The Distributor may also ask (and may
have already asked) for additional identifying information, and the Distributor may take steps (and may have already taken steps) to verify the authenticity and accuracy of these data elements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;13. <U>Miscellaneous</U>. The captions in this Agreement are included for convenience of reference only and in no way define or
delimit any of the provisions hereof or otherwise affect their construction or effect. If any provision of this Agreement shall be held or made invalid by a court decision, statute, rule or otherwise, the remainder of this Agreement shall not be
affected thereby. This Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;10&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;14. <U>Proprietary and Confidential Information</U>. The Distributor agrees on
behalf of itself and its employees to treat confidentially and as proprietary information of the Fund all records and other information relative to the Fund and prior, present or potential shareholders, and not to use such records and information
for any purpose other than performance of its responsibilities and duties hereunder, except after prior notification to and approval in writing by the Fund, which approval shall not be unreasonably withheld and shall not be required where the
Distributor may be exposed to civil or criminal contempt proceedings for failure to comply, when requested to divulge such information by duly constituted authorities, or when so requested by the Fund. The provisions of this Section&nbsp;14 shall
survive termination of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything in this Agreement to the contrary, each party hereto agrees that:
(i)&nbsp;any Nonpublic Personal Information, as defined under Section&nbsp;248.3(t) of Regulation <FONT STYLE="white-space:nowrap">S-P</FONT> (&#147;<U>Regulation <FONT STYLE="white-space:nowrap">S-P</FONT></U>&#148;), promulgated under the
Gramm-Leach-Bliley Act (the &#147;<U>Act</U>&#148;), disclosed by a party hereunder is for the specific purpose of permitting the other party to perform the services set forth in this Agreement, and (ii)&nbsp;with respect to such information, each
party will comply with Regulation <FONT STYLE="white-space:nowrap">S-P</FONT> and the Act and will not disclose any Nonpublic Personal Information received in connection with this Agreement to any other party, except to the extent as necessary to
carry out the services set forth in this Agreement or as otherwise permitted by Regulation <FONT STYLE="white-space:nowrap">S-P</FONT> or the Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;11&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first
above written. This Agreement may be executed by the parties hereto in any number of counterparts, all of which shall constitute one and the same instrument.</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">BLACKROCK FLOATING RATE INCOME&nbsp;TRUST</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Janey Ahn</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Name:&nbsp;&nbsp;&nbsp;Janey Ahn</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Title:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Secretary</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">BLACKROCK INVESTMENTS, LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jonathan Diorio</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Name:&nbsp;&nbsp;&nbsp;Jonathan Diorio</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Title:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Managing Director</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Signature Page to
BlackRock Floating Rate Income Trust Distribution Agreement </P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(H)(2)
<SEQUENCE>3
<FILENAME>d421862dex99h2.htm
<DESCRIPTION>SUB-PLACEMENT AGENT AGREEMENT BETWEEN BLACKROCK INVESTMENTS, LLC AND UBS
<TEXT>
<HTML><HEAD>
<TITLE>Sub-Placement Agent Agreement between BlackRock Investments, LLC and UBS</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Exhibit (h)(2) </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">SUB-PLACEMENT</FONT> AGENT AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">BlackRock Investments, LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55
East 52nd Street, New York, New York 10055 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">January&nbsp;9, 2023 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">UBS Securities LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1285 Avenue of the Americas </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10019 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">RE:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">At-the-Market</FONT></FONT> Offerings by
BlackRock Floating Rate Income Trust </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From time to time BlackRock Investments, LLC (the &#147;<I>Distributor</I>,&#148; &#147;<I>we</I>&#148; or &#147;<I>us</I>&#148;) will act as
manager of registered <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">at-the-market</FONT></FONT> offerings by BlackRock Floating Rate Income Trust, a Delaware statutory trust (the &#147;<I>Fund</I>&#148;), of up to 11,000,000
common shares (the &#147;<I>Shares</I>&#148;) of beneficial interest, par value $0.001 per share, of the Fund (the &#147;<I>Common Shares</I>&#148;). In the case of such offerings, the Fund has agreed with the Distributor to issue and sell through
or to the Distributor, as sales agent and/or principal, the Shares (the &#147;<I>Distribution Agreement</I>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We hereby agree to
retain UBS Securities LLC (the &#147;<I>Agent</I>&#148; or &#147;<I>you</I>&#148;) as a <FONT STYLE="white-space:nowrap">sub-placement</FONT> agent with respect to the offerings of the Shares to be issued and sold by the Fund (the
&#147;<I>Offerings</I>&#148;) as the Fund and the Distributor may indicate from time to time, and you agree to act in such capacity, all upon, and subject to, the terms and conditions set forth below: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION 1.&nbsp;<U>Description of Offerings</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;The Shares are to be sold on a daily basis or otherwise as shall be agreed to by the Fund and the Distributor on any day (each, an
&#147;<I>Offering Date</I>&#148;) that is a trading day for the exchange on which the Fund&#146;s Shares are listed and primarily trade (the &#147;<I>Stock Exchange</I>&#148;) (other than a day on which the Stock Exchange is scheduled to close prior
to its regular weekday closing time).&nbsp;Promptly after the Fund and the Distributor have determined the maximum amount of the Shares to be sold by the Distributor for any Offering Date, which shall not in any event exceed the amount available for
issuance under the currently effective Registration Statement (as defined below) (the &#147;<I>Maximum Daily Amount</I>&#148;), and the minimum price per Share below which the Shares may not be sold by the Agent on any Offering Date (the
&#147;<I>Minimum Daily Price</I>&#148;), the Distributor shall advise the Agent of the Maximum Daily Amount and the Minimum Daily Price.&nbsp;Subject to the terms and conditions hereof, the Agent shall use its reasonable best efforts to sell all of
the Shares designated in accordance with the plan of distribution set forth in the Prospectus; provided, however, that in no event shall the Agent sell Shares in excess of the Maximum Daily Amount or for a price per Share below the Minimum Daily
Price.&nbsp;The gross sales price of the Shares sold under this Section&nbsp;1(a) shall be the market price at which the Agent sells such Shares. </P>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;Notwithstanding the foregoing, the Distributor or the Fund may instruct the Agent by
telephone (confirmed promptly by <FONT STYLE="white-space:nowrap">e-mail</FONT> or telecopy) of a revised Minimum Daily Price and/or a revised Maximum Daily Amount and the Agent shall not sell Shares for a price per Share below such revised Minimum
Daily Price, or in a quantity in excess of such revised Maximum Daily Amount, after the giving of such notice.&nbsp;In addition, the Distributor or the Fund may, upon notice to the Agent by telephone (confirmed promptly by <FONT
STYLE="white-space:nowrap">e-mail</FONT> or telecopy), suspend the offering of the Shares at any time; provided, however, that such suspension or termination shall not affect or impair the parties&#146; respective obligations with respect to the
Shares sold hereunder prior to the giving of such notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;The Agent agrees not to make any sales of the Shares pursuant to this
Section&nbsp;1, other than through transactions for which compliance with Rule 153 under the Securities Act of 1933, as amended (collectively with the rules and regulations thereunder, the &#147;<I>Securities Act</I>&#148;), will satisfy the
prospectus delivery requirements of Section&nbsp;5(b)(2) of the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;The compensation to the Agent, as a <FONT
STYLE="white-space:nowrap">sub-placement</FONT> agent for each sale of the Shares pursuant to this Section&nbsp;1, shall be the Applicable Selling Agent Commission with respect to the Shares sold, multiplied by the Gross Sales Proceeds (the
&#147;<I>Agent Compensation</I>&#148;), as further described in the Addendum to this <FONT STYLE="white-space:nowrap">Sub-Placement</FONT> Agent Agreement (the &#147;<I>Agreement</I>&#148;).&nbsp;The Agent shall not be responsible for any fees
imposed by any governmental or self-regulatory organization on the Fund or the Distributor in respect of such sales.&nbsp;The Distributor may pay the Agent Compensation to the Agent, or may authorize the Agent to retain the Agent Compensation from
the Gross Sales Proceeds.&nbsp;The Agent Compensation shall be payable solely out of the compensation the Distributor receives from the Fund pursuant to the Distribution Agreement (the &#147;<I>Related Compensation</I>&#148;).&nbsp;Notwithstanding
anything to the contrary in any other provision of this Agreement (or, for the avoidance of doubt, in the Addendum hereto), the Distributor shall have no obligation to pay any portion of the Agent Compensation to the Agent, or authorize the
retention by the Agent of any portion of the Agent Compensation from the Gross Sales Proceeds, until the Distributor receives at least an equivalent amount of Related Compensation, and the Distributor&#146;s obligation to the Agent for the Agent
Compensation is limited solely to amounts payable out of the Related Compensation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;The Agent shall provide written confirmation
to the Distributor following the close of trading on the Stock Exchange on each Offering Date setting forth for each sale the number of Shares sold, the time of sale, the Gross Sales Price (as defined in the Addendum to this Agreement) per Share,
and the compensation that the Agent is owed with respect to such sales. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;Settlement for sales of the Shares pursuant to this
Section&nbsp;1 will occur on the second business day following the date on which such sales are made (each such day, a &#147;<I>Settlement Date</I>&#148;), unless otherwise agreed to in writing by the parties hereto.&nbsp;On each Settlement Date,
the Shares sold through the Agent for settlement on such date shall be delivered by the Distributor to the Agent against payment of the Gross Sales Proceeds for the sale of such Shares.&nbsp;Settlement for all such Shares shall be effected by free
delivery of the Shares to the Agent&#146;s account at The Depository Trust Company in return for payments in same day funds delivered to the account(s) designated by the Distributor.&nbsp;If the Distributor shall default on its obligation to deliver
the Shares on any Settlement Date, subject to the terms of Section&nbsp;5 herein, the Distributor shall (A)&nbsp;hold the Agent harmless against any reasonable loss, claim or damage arising from or as a result of such
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;2&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
default by the Distributor and (B)&nbsp;pay the Agent any commission to which it would otherwise be entitled absent such default.&nbsp;If the Agent breaches this Agreement by failing to deliver
proceeds on any Settlement Date for the Shares delivered by the Distributor, subject to the terms of Section&nbsp;5 herein, the Agent shall (A)&nbsp;hold the Distributor harmless against any reasonable loss, claim or damage arising from or as a
result of such default by the Agent, (B)&nbsp;deliver such proceeds to the Distributor as soon as practicable and (C)&nbsp;pay the Distributor interest based on the effective overnight Federal Funds rate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;In connection with this Agreement and the Offerings, the Distributor shall, no more than once per calendar quarter in which the Fund
and the Distributor have requested, or anticipate requesting, that the Agent sell Shares pursuant to an Offering, provide to the Agent such certificates and other documents, in any case, as the Agent may reasonably request upon reasonable notice
(but in no event upon notice of less than five business days) relating to authorization, capacity, enforceability and compliance matters.&nbsp;Any such certifications shall be made as of the end of the calendar quarter immediately preceding the
calendar quarter in which such request by the Agent is made. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;In connection with this Agreement and the Offerings, the Agent will
promptly notify the Distributor of any material <FONT STYLE="white-space:nowrap">non-confidential</FONT> claim or complaint, any material enforcement action or other material proceeding by a regulatory authority with respect to the Fund, the Shares
or the Offerings against or directed at or to the Agent or its principals, affiliates, officers, directors, employees or agents, or any person who controls the Agent, within the meaning of Section&nbsp;15 of the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;In connection with this Agreement and the Offerings, the Agent will promptly notify the Distributor of any examination by any
regulatory agency or self-regulatory organization that has resulted in a material compliance deficiency in connection with the Offerings. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION 2.&nbsp;<U>Representations and Warranties by the Distributor</U>.&nbsp;The Distributor represents, warrants to and agrees with the
Agent, as of the date hereof and as of each Offering Date and Settlement Date, that: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;Based upon the representations made by the
Fund to the Distributor in the Distribution Agreement, a registration statement on <FONT STYLE="white-space:nowrap">Form&nbsp;N-2</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-266318</FONT> and
<FONT STYLE="white-space:nowrap">811-21566)</FONT> (the &#147;<I>Registration Statement</I>&#148;) (i) has been prepared by the Fund in conformity with the requirements of the Securities Act and the Investment Company Act of 1940, as amended, and
the rules and regulations thereunder (collectively called the &#147;<I>1940 Act</I>&#148;) in all material respects, (ii)&nbsp;has been filed with the U.S. Securities and Exchange Commission (the &#147;<I>Commission</I>&#148;) under the Securities
Act and the 1940 Act, and (iii)&nbsp;heretofore became, and is, effective; the Registration Statement sets forth the terms of the offering, sale and plan of distribution of the Shares and contains additional information concerning the Fund and its
business; no stop order of the Commission preventing or suspending the use of the Prospectus (as defined below), or the effectiveness of the Registration Statement, has been issued, and no proceedings for such purpose have been instituted or, to the
Fund&#146;s knowledge, have been threatened by the Commission.&nbsp;Except where the context otherwise requires, &#147;<I>Registration Statement</I>,&#148; as used herein, means, collectively, the various parts of the Registration Statement at the
time of effectiveness for purposes of Section&nbsp;11 of the Securities Act (the &#147;<I>Effective Time</I>&#148;), as such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;3&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
section applies to the Distributor, including (1)&nbsp;all documents filed as a part thereof or incorporated or deemed to be incorporated by reference therein, (2)&nbsp;any information contained
or incorporated by reference in a prospectus filed with the Commission pursuant to Rule 425(b)(2) and/or Rule 424(b)(5) under the Securities Act, to the extent such information is deemed pursuant to Rule 430B or Rule 430C under the Securities Act to
be part of the Registration Statement at the Effective Time, and (3)&nbsp;any registration statement filed to register the offer and sale of Shares pursuant to Rule 462(b) under the Securities Act. &#147;<I>Prospectus</I>,&#148; as used herein,
means the final prospectus, including the related statement of additional information, relating to the Shares, filed by the Fund with the Commission pursuant to Rule 424(b)(2) and/or Rule 424(b)(5) under the Securities Act, in the form furnished by
the Fund to the Distributor in connection with the offering of the Shares, together with, if applicable, any final prospectus supplement relating to the Shares attached to or used with such final prospectus, filed by the Fund with the Commission
pursuant to Rule 424(b)(2) and/or Rule 424(b)(5) under the Securities Act, in the form furnished by the Fund to the Distributor in connection with the offering of the Shares (the &#147;<I>Prospectus Supplement</I>&#148;). Any reference herein to the
Registration Statement or the Prospectus shall be deemed to refer to and include the documents, if any, incorporated by reference, or deemed to be incorporated by reference, therein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;Based upon the representations made by the Fund to the Distributor in the Distribution Agreement, (i)&nbsp;the Fund is duly
registered under the 1940 Act as a <FONT STYLE="white-space:nowrap">closed-end</FONT> management investment company; (ii)&nbsp;a notification of registration of the Fund as an investment company under the 1940 Act on Form <FONT
STYLE="white-space:nowrap">N-8A</FONT> (the &#147;<I>1940 Act Notification</I>&#148;) has been prepared by the Fund in conformity with the 1940 Act and has been filed with the Commission and, at the time of filing thereof and at the time of filing
any amendment or supplement thereto, conformed in all material respects with all applicable provisions of the 1940 Act; (iii)&nbsp;the Fund has not received any notice in writing from the Commission pursuant to Section&nbsp;8(e) of the 1940 Act with
respect to the 1940 Act Notification or the Registration Statement (or any amendment or supplement to either of them); and (iv)&nbsp;no person is serving or acting as an officer, trustee or investment adviser of the Fund except in accordance with
the provisions of the 1940 Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;Based upon the representations made by the Fund to the Distributor in the Distribution
Agreement, the Registration Statement, the 1940 Act Notification and the Prospectus as from time to time amended or supplemented each complied when it became effective or was filed (as the case may be), complies as of the date hereof and, as amended
or supplemented, will comply, at each time of purchase of Shares in connection with each Offering, and at all times during which a prospectus is required by the Securities Act to be delivered in connection with any sale of Shares, in all material
respects, with the requirements of the Securities Act and the 1940 Act; the Registration Statement did not, as of the Effective Time, contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or
necessary to make the statements therein not misleading; at no time during the period that begins on the earlier of the date of the Prospectus and the date such Prospectus was filed with the Commission and ends at the later of each time of purchase
of Shares in connection with each Offering, and the end of the period during which a prospectus is required by the Securities Act to be delivered in connection with any sale of Shares, did or will the Prospectus, as from time to time amended or
supplemented, include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided, however, that
the Distributor does not make any representation or warranty with respect to any statement contained in the Registration Statement or the Prospectus in reliance </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;4&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
upon and in conformity with information furnished in writing by the Agent or on the Agent&#146;s behalf to the Distributor or the Fund expressly for use in the Registration Statement or the
Prospectus (the &#147;<I>Agent Provided Information</I>&#148;).&nbsp;The Agent confirms that (i)&nbsp;the Agent&#146;s name on the front cover of the Prospectus Supplement and (ii)&nbsp;the seventh paragraph under the heading &#147;Plan of
Distribution&#148; in the Prospectus Supplement was the only information furnished in writing to the Distributor or the Fund by or on behalf of the Agent expressly for use in the Registration Statement or Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;Based upon the representations made by the Fund to the Distributor in the Distribution Agreement, the financial statements
incorporated by reference in the Registration Statement or the Prospectus, together with the related notes and schedules, present fairly the financial position of the Fund as of the dates indicated and the results of operations, cash flows and
changes in shareholders&#146; equity of the Fund for the periods specified and have been prepared in compliance in all material respects with the requirements of the Securities Act, the 1940 Act and the Securities Exchange Act of 1934, as amended
(the &#147;<I>Exchange Act</I>&#148;), and in conformity in all material respects with U.S. generally accepted accounting principles applied on a consistent basis during the periods involved; the other financial and statistical data contained or
incorporated by reference in the Registration Statement or the Prospectus are accurately and fairly presented, in all material respects, and prepared on a basis consistent with the financial statements and books and records of the Fund in all
material respects; there are no financial statements that are required to be included or incorporated by reference in the Registration Statement or the Prospectus by the Securities Act, the 1940 Act or the Exchange Act that are not included or
incorporated by reference as required; and the Fund does not have any material liabilities or obligations, direct or contingent (including any <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet obligations), not described in the Registration
Statement (excluding the exhibits thereto). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;Based upon the representations made by the Fund to the Distributor in the
Distribution Agreement, as of the date of this Agreement, the Fund has an authorized and outstanding capitalization as set forth in the Registration Statement and the Prospectus and, with respect to any issuance and sale under this Agreement, the
Fund shall have as of the date of the most recent amendment or supplement to the Registration Statement or Prospectus, an authorized and outstanding capitalization as set forth in the Registration Statement and the Prospectus; all of the issued and
outstanding shares of capital stock, including the Common Shares, of the Fund have been duly authorized and validly issued and are fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> (except as described below and in the
Registration Statement), have been issued in material compliance with all applicable securities laws and were not issued in violation of any preemptive right, resale right, right of first refusal or similar right; the Shares will be duly listed, and
admitted and authorized for trading, subject to official notice of issuance, on the Stock Exchange. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;Based upon the
representations made by the Fund to the Distributor in the Distribution Agreement, (i)&nbsp;the Fund has been duly formed, is validly existing and is in good standing under the laws of Delaware, with full power and authority to own, lease and
operate and conduct its business as described in the Registration Statement and the Prospectus and to issue, sell and deliver the Shares as contemplated herein; and (ii)&nbsp;the Fund is duly qualified to do business as a foreign entity and is in
good standing in each jurisdiction where the conduct of its business requires such qualification, except where the failure to be so qualified and in good standing would not, individually or in the aggregate, have a material adverse effect on the
business, properties, financial condition or results of operations of the Fund. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;5&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;Based upon the representations made by the Fund to the Distributor in the Distribution
Agreement, (i)&nbsp;the Shares have been duly and validly authorized and, when issued and delivered against payment therefor as provided herein, will be duly and validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT>
(except as described below and in the Registration Statement) and free of statutory and contractual preemptive rights, resale rights, rights of first refusal and similar rights; (ii)&nbsp;the Shares, when issued and delivered against payment
therefor as provided herein, will be free of any restriction upon the voting or transfer thereof pursuant to the Fund&#146;s Agreement and Declaration of Trust, as amended or supplemented, Bylaws, as amended or supplemented, or any agreement or
other instrument to which the Fund is a party; (iii)&nbsp;the capital stock of the Fund, including the Shares, conforms in all material respects to each description thereof, if any, contained or incorporated by reference in the Registration
Statement or the Prospectus; (iv)&nbsp;the certificates for the Shares, if any, are in due and proper form; and (v)&nbsp;the Fund is in material compliance with the rules of the Stock Exchange, including, without limitation, the requirements for
continued listing of the Common Shares on the Stock Exchange and the Fund has not received any written notice from the Stock Exchange regarding the delisting of the Common Shares from the Stock Exchange. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;The Distributor has full corporate power and authority to enter into this Agreement and the transactions contemplated
hereby.&nbsp;This Agreement has been duly authorized, executed and delivered by the Distributor.&nbsp;Assuming due authorization, execution and delivery of this Agreement by the Agent, this Agreement constitutes a valid and binding agreement of the
Distributor and is enforceable against the Distributor in accordance with its terms, except as the enforceability hereof and thereof may be limited by applicable bankruptcy, insolvency, reorganization and similar laws affecting creditors&#146;
rights generally and moratorium laws in effect from time to time and by equitable principles restricting the availability of equitable remedies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;Based upon the representations made by the Fund to the Distributor in the Distribution Agreement, no approval, authorization, consent
or order of or filing with any federal, state, local or foreign governmental or regulatory commission, board, body, authority or agency, or of or with any self-regulatory organization or other <FONT STYLE="white-space:nowrap">non-governmental</FONT>
regulatory authority (including, without limitation, the Stock Exchange), or approval of the shareholders of the Fund that has not already been obtained, is required in connection with the issuance and sale of the Shares or the consummation by the
Fund of the transactions contemplated hereby, other than (i)&nbsp;the registration of the Shares under the Securities Act, which has been effected, (ii)&nbsp;the listing of the Shares with the Stock Exchange, upon official notice of issuance,
(iii)&nbsp;any necessary qualification under the securities or blue sky laws of the various jurisdictions in which the Shares are being offered by the Distributor or (iv)&nbsp;any necessary qualification pursuant to the rules of the Financial
Industry Regulatory Authority, Inc. (&#147;<I>FINRA</I>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION 3.&nbsp;<U>Representations and Warranties by the
Agent</U>.&nbsp;The Agent represents, warrants to and agrees with the Distributor, as of the date hereof and as of each Offering Date and Settlement Date, that: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;6&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;The Agent has full corporate power and authority to enter into this Agreement and the
transactions contemplated hereby.&nbsp;This Agreement has been duly authorized, executed and delivered by the Agent.&nbsp;Assuming due authorization, execution and delivery by the Distributor, this Agreement constitutes a valid and binding agreement
of the Agent and is enforceable against the Agent in accordance with its terms, except as the enforceability hereof and thereof may be limited by applicable bankruptcy, insolvency, reorganization and similar laws affecting creditors&#146; rights
generally and moratorium laws in effect from time to time and by equitable principles restricting the availability of equitable remedies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;The Agent Provided Information is or will be complete and accurate in all material respects and does not or will not, as from time to
time amended or supplemented, include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were
made, not misleading. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;The Agent has adopted and implemented written policies and procedures reasonably designed to prevent
violation of federal and state securities laws, including policies and procedures that provide oversight of compliance by each registered representative of the Agent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION 4.&nbsp;<U>Additional Covenants</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;The Agent hereby confirms that it is actually engaged in the investment banking and securities business and is a member in good
standing with FINRA and hereby agrees that it will undertake to comply with all applicable FINRA rules (as amended from time to time, including without limitation, any successor provision) in connection with acting as
<FONT STYLE="white-space:nowrap">sub-placement</FONT> agent for the sale of the Shares.&nbsp;The Agent further agrees that in acting as <FONT STYLE="white-space:nowrap">sub-placement</FONT> agent for the sale of the Shares, it will comply with all
applicable laws, rules and regulations, including the applicable provisions of the Securities Act and the Exchange Act, the applicable rules and regulations of the Commission thereunder, and the applicable rules and regulations of any state or any
securities exchange or self-regulatory organization having jurisdiction over the relevant Offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;The Agent hereby agrees that
in acting as <FONT STYLE="white-space:nowrap">sub-placement</FONT> agent for the sale of the Shares, it will not use, authorize use of, refer to, or participate in the planning for use of any &#147;written communication&#148; (as defined in Rule 405
under the Securities Act) concerning any Offering, other than the Prospectus.&nbsp;The Agent further agrees that in acting as <FONT STYLE="white-space:nowrap">sub-placement</FONT> agent for the sale of the Shares, it is not authorized by the
Distributor or the Fund or any other seller of the Shares offered pursuant to the Prospectus to give any information or to make any representation not contained in the Prospectus in connection with the sale of such Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;The Distributor shall not be under any obligation to the Agent except for obligations assumed hereunder or in writing by the
Distributor in connection with any Offering.&nbsp;Nothing contained herein or in any communication in writing from us shall constitute the Distributor and the Agent an association or partners with one another.&nbsp;If such parties should be deemed
to constitute a partnership for Federal income tax purposes, then the Agent elects to be excluded from the application of Subchapter K, Chapter 1, Subtitle A of the Internal Revenue Code of 1986, as amended, and agrees not to take any position
inconsistent with that election.&nbsp;The Agent </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;7&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
authorizes the Distributor, in its discretion, to execute and file on its behalf such evidence of that election as may be required by the Internal Revenue Service.&nbsp;In connection with any
Offering, each party shall be liable for its proportionate amount of any tax, claim, demand or liability that may be asserted against it alone, based upon the claim that either of them constitutes an association, an unincorporated business or other
entity, including, in each case, its proportionate amount of any expense incurred in defending against any such tax, claim, demand or liability. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;The parties acknowledge and agree that all share related numbers contained in this Agreement shall be adjusted to take into account
any stock split effected with respect to the Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;The Agent shall at all times comply with the offering requirements as set
forth herein and under the heading &#147;Plan of Distribution&#148; in the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION 5.&nbsp;<U>Indemnification and
Contribution</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;The Distributor agrees to indemnify, defend and hold harmless the Agent, its partners, directors and officers,
and any person who controls the Agent within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act, and the successors and assigns of all of the foregoing persons, from and against any reasonable loss, damage,
expense, liability or claim (including the reasonable cost of investigation) which the Agent or any such person may incur under the Securities Act, the 1940 Act, the Exchange Act, the common law or otherwise, insofar as such loss, damage, expense,
liability or claim (or any actions or proceedings in respect thereof) arises out of or is based upon (i)&nbsp;any material breach of any representation, warranty, covenant or agreement of the Distributor contained in this Agreement, (ii)&nbsp;any
material violation by the Distributor of any law, rule or regulation (including any rule of any self-regulatory organization) applicable to the Offerings, or (iii)&nbsp;any untrue statement or alleged untrue statement of a material fact appearing in
the Registration Statement or the Prospectus or omission or alleged omission to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances in which they were made, not
misleading, except to the extent such statements were included in the Registration Statement or the Prospectus in reliance upon and in conformity with the Agent Provided Information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;The Agent agrees to indemnify, defend and hold harmless the Distributor, the Fund, their partners, trustees, directors and officers,
and any person who controls the Distributor or the Fund within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act, and the successors and assigns of all of the foregoing persons, from and against any loss,
damage, expense, liability or claim (including the reasonable cost of investigation) which the Distributor, the Fund or any such other person may incur under the Securities Act, the 1940 Act, the Exchange Act, the common law or otherwise, insofar as
such loss, damage, expense, liability or claim (or any actions or proceedings in respect thereof) arises out of or is based upon (i)&nbsp;any material breach of any representation, warranty, covenant or agreement of the Agent contained in this
Agreement or (ii)&nbsp;any material violation by the Agent of any law, rule or regulation (including any rule of any self-regulatory organization), or (iii)&nbsp;any untrue statement or alleged untrue statement or omission or alleged omission made
in the Registration Statement or the Prospectus in reliance upon and in conformity with the Agent Provided Information. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;8&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;An indemnified person under Section&nbsp;5 of this Agreement (the &#147;<I>Indemnified
Party</I>&#148;) shall give written notice to the other party (the &#147;<I>Indemnifying Party</I>&#148;) of any loss, damage, expense, liability or claim in respect of which the Indemnifying Party has a duty to indemnify such Indemnified Party
under Section&nbsp;5(a) or (b)&nbsp;of this Agreement (a &#147;<I>Claim</I>&#148;), specifying in reasonable detail the nature of the loss, damage, expense, liability or claim for which indemnification is sought, except that any delay or failure so
to notify such Indemnifying Party shall only relieve such Indemnifying Party of its obligations hereunder to the extent, if at all, that such Indemnifying Party is actually prejudiced by reason of such delay or failure. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;If a Claim results from any action, suit or proceeding brought or asserted against an Indemnified Party, the Indemnifying Party shall
assume the defense thereof, including the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all fees and expenses. The Indemnified Party shall have the right to employ separate counsel in such action, suit or
proceeding and participate in such defense thereof, but the fees and expenses of such separate counsel shall be at the expense of the Indemnified Party unless (i)&nbsp;the Indemnifying Party has agreed in writing to pay such fees and expenses,
(ii)&nbsp;the Indemnifying Party has failed within a reasonable time to assume the defense and employ counsel or (iii)&nbsp;the named parties to any such action, suit or proceeding (including any impleaded parties) include both such Indemnified
Party and Indemnifying Party and such Indemnified Party shall have been advised by its counsel that representation of such Indemnified Party and Indemnifying Party by the same counsel would be inappropriate under applicable standards of professional
conduct (whether or not such representation by the same counsel has been proposed) due to actual or potential differing interests between the Indemnifying Party and the Indemnified Party (in which case the Indemnifying Party shall not have the right
to assume the defense of such action, suit or proceeding on behalf of such Indemnified Party). It is understood, however, that the Indemnifying Party shall, in connection with any one action, suit or proceeding or separate but substantially similar
or related actions, suits or proceedings in the same jurisdiction arising out of the same general allegations or circumstances be liable for the reasonable fees and expenses of only one separate firm of attorneys (in addition to any local counsel)
at any time for all such Indemnified Parties not having actual or potential differing interests with the Indemnifying Party or among themselves, which firm shall be designated in writing by an authorized representative of such parties and that all
such fees and expenses shall be reimbursed promptly as they are incurred. The Indemnifying Party shall not be liable for any settlement of any such action, suit or proceeding effected without its written consent, but if settled with such written
consent or if there be a final judgment for the plaintiff in any such action, suit or proceeding, the Indemnifying Party agrees to indemnify and hold harmless any Indemnified Party from and against any loss, liability, damage or expense by reason by
such settlement or judgment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;With respect to any Claim not within Paragraph (d)&nbsp;of Section&nbsp;5 hereof, the Indemnifying
Party shall have 20 days from receipt of notice from the Indemnified Party of such Claim within which to respond thereto. If the Indemnifying Party does not respond within such <FONT STYLE="white-space:nowrap">twenty-day</FONT> period, it shall be
deemed to have accepted responsibility to make payment and shall have no further right to contest the validity of such Claim. If the Indemnifying Party notifies the Indemnified Party within such <FONT STYLE="white-space:nowrap">twenty-day</FONT>
period that it rejects such Claim in whole or in part, the Indemnified Party shall be free to pursue such remedies as may be available to the Indemnified Party under applicable law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;9&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;If the indemnification provided for in this Section&nbsp;5 is unavailable to an
Indemnified Party or insufficient to hold an Indemnified Party harmless in respect of any losses, damages, expenses, liabilities or claims referred to therein, then each applicable Indemnifying Party shall contribute to the amount paid or payable by
such Indemnified Party as a result of such losses, damages, expenses, liabilities or claims in such proportion as is appropriate to reflect (i)&nbsp;the relative benefits received by the Indemnified Party, on the one hand, and the Indemnifying
Party, on the other hand, from the offering of the Shares; or (ii)&nbsp;if, but only if, the allocation provided for in clause (i)&nbsp;is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative
benefits referred to in clause (i)&nbsp;but also the relative fault of the Indemnified Party, on the one hand, and of the Indemnifying Party, on the other, in connection with any statements or omissions or other matters which resulted in such
losses, damages, expenses, liabilities or claims, as well as any other relevant equitable considerations. The relative benefits received by the Distributor, on the one hand, and the Agent, on the other, shall be deemed to be in the same respective
proportions as the total compensation received by the Distributor from sales of the Shares bears to the total compensation received by the Agent from sales of the Shares. The relative fault of the parties hereto shall be determined by reference to,
among other things, whether the untrue statement or alleged untrue statement of a material fact or omission or alleged omission relates to information supplied by such party, on one hand, or by the other party, on the other hand, and the
parties&#146; relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. The amount paid or payable by a party hereto as a result of the losses, damages, expenses, liabilities and claims
referred to in this subsection shall be deemed to include any legal or other fees or expenses reasonably incurred by such party in connection with investigating, preparing to defend or defending any proceeding. The parties hereto agree that it would
not be just and equitable if contribution pursuant to this Section&nbsp;5 were determined by pro rata allocation or by any other method of allocation that does not take account of the equitable considerations referred to in this subsection (f). No
person guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.&nbsp;Notwithstanding the
foregoing provisions of this subsection (f), the Agent shall not be required to contribute any amount in excess of the commissions received by it under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;The indemnity and contribution agreements contained in this Section&nbsp;5 and the covenants, warranties and representations of the
parties contained in this Agreement shall remain in full force and effect regardless of any investigation made by or on behalf of the Agent, its partners, directors or officers or any person (including each partner, officer or director of such
person) who controls the Agent within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act, or by or on behalf of the Distributor, its directors or officers or any person who controls the Distributor within the
meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act, and shall survive any termination of this Agreement or the issuance and delivery of the Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;IN NO EVENT WILL ANY PARTY TO THIS AGREEMENT BE LIABLE TO ANY OTHER PERSON OR ANY THIRD PARTY FOR ANY CONSEQUENTIAL, INCIDENTAL,
SPECIAL OR INDIRECT DAMAGES (INCLUDING BUT NOT LIMITED TO LOST PROFITS), EVEN IF SUCH PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSSES. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;10&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION 6.&nbsp;<U>Termination</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;This Agreement shall continue in full force and effect until terminated by either party by five days&#146; written notice to the
other party; provided, that if this Agreement has become effective with respect to any Offering pursuant to this Agreement, this Agreement may not be terminated by either party with respect to such Offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;This Agreement shall remain in full force and effect unless terminated pursuant to Section&nbsp;6(a) above or otherwise by mutual
agreement of the parties; provided that any such termination by mutual agreement shall in all cases be deemed to provide that Section&nbsp;5 shall remain in full force and effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;Any termination of this Agreement shall be effective on the date specified in such notice of termination; provided that in any event
such termination shall not be effective until any earlier than the close of business on the fifth day after receipt of such notice by the Distributor or the Agent, as the case may be.&nbsp;If such termination shall occur prior to the Settlement Date
for any sale of the Shares, such sale shall settle in accordance with the provisions of Section&nbsp;1 of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION
7.&nbsp;<U>Notices</U>.&nbsp;Except as otherwise herein provided, all statements, requests, notices and agreements under this Agreement shall be in writing and delivered by hand, overnight courier, mail or facsimile and, if to the Distributor, it
shall be sufficient in all respects if delivered or sent to: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">BlackRock Investments, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">55 East 52nd Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">New York,
New York 10055 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Attn: Jonathan Diorio </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">and
if to the Agent, it shall be sufficient in all respects if delivered or sent to: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">UBS Securities LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1285 Avenue of the Americas </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">New
York, New York 10019 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Attn: Saawan Pathange </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each party to this Agreement may change such address for notices by sending to the parties to this Agreement written notice of a new address for such purpose.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION 8.&nbsp;<U>Parties in Interest</U>.&nbsp;The Agreement herein set forth has been and is made solely for the benefit of the
Distributor, the Fund and the Agent and, to the extent provided in Section&nbsp;5 of this Agreement, the partners, trustees, directors, officers and controlling persons (within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20
of the Exchange Act) referred to in such section, and their respective successors and assigns.&nbsp;No other person, partnership, association or corporation (including a purchaser, as such purchaser, from the Distributor) shall acquire or have any
right under or by virtue of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;11&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION 9.&nbsp;<U>No Fiduciary Relationship</U>.&nbsp;The Distributor hereby acknowledges that
the Agent is acting solely as <FONT STYLE="white-space:nowrap">sub-placement</FONT> agent in connection with the sale of the Shares and that the Agent is acting pursuant to a contractual relationship created solely by this Agreement entered into on
an arm&#146;s length basis, and in no event do the parties intend that the Agent act or be responsible as a fiduciary to the Distributor or the Fund, their respective management, shareholders or creditors, or any other person in connection with any
activity that the Agent may undertake or have undertaken in furtherance of the sale of the Shares, either before or after the date hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION 10.&nbsp;<U>Entire Agreement</U>.&nbsp;This Agreement constitutes the entire agreement and supersedes all other prior and
contemporaneous agreements and undertakings, both written and oral, among the parties hereto with regard to the subject matter hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION 11.&nbsp;<U>Counterparts; Heading</U>.&nbsp;This Agreement may be signed by the parties in one or more counterparts which together
shall constitute one and the same agreement among the parties.&nbsp;The Section headings in this Agreement have been inserted as a matter of convenience of reference and are not a part of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION 12.&nbsp;<U>Law; Construction</U>.&nbsp;This Agreement and any claim, counterclaim or dispute of any kind or nature whatsoever arising
out of or in any way relating to this Agreement (&#147;<I>Dispute</I>&#148;), directly or indirectly, shall be governed by, and construed in accordance with, the internal laws of the State of New York. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION 13.&nbsp;<U>Submission to Jurisdiction</U>.&nbsp;Except as set forth below, no Dispute may be commenced, prosecuted or continued in
any court other than the courts of the State of New York located in the City and County of New York or in the United States District Court for the Southern District of New York, which courts shall have jurisdiction over the adjudication of such
matters, and each party hereto consents to the jurisdiction of such courts and personal service with respect thereto. Each party hereto hereby consents to personal jurisdiction, service and venue in any court in which any Dispute arising out of or
in any way relating to this Agreement is brought by any third party against any Indemnified Party. Each party hereto (on its behalf and, to the extent permitted by applicable law, on behalf of its stockholders and affiliates) waives all right to
trial by jury in any action, proceeding or counterclaim (whether based upon contract, tort or otherwise) in any way arising out of or relating to this Agreement. Each party hereto agrees that a final judgment in any such action, proceeding or
counterclaim brought in any such court shall be conclusive and binding upon such party and may be enforced in any other courts to the jurisdiction of which such party is or may be subject, by suit upon such judgment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION 14.&nbsp;<U>Successors and Assigns</U>.&nbsp;This Agreement shall be binding upon the Distributor and the Agent and their successors
and permitted assigns and any successor or permitted assign of any substantial portion of the Distributor&#146;s or the Agent&#146;s respective businesses and/or assets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Agreement may not be transferred or assigned without the consent of the <FONT STYLE="white-space:nowrap">non-transferring</FONT> or <FONT
STYLE="white-space:nowrap">non-assigning</FONT> party; provided, however, that no such consent shall be required to transfer or assign this Agreement to an entity controlling, controlled by or under common control with, the transferring or assigning
party. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;12&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION 15.&nbsp;<U>Severability</U>.&nbsp;Whenever possible, each provision of this Agreement
shall be interpreted in such manner as to be effective and valid under applicable law. If, however, any provision of this Agreement is held, under applicable law, to be invalid, illegal or unenforceable in any respect, such provision shall be
ineffective only to the extent of such invalidity, and the validity, legality and enforceability of the remaining provisions of this Agreement shall not be affected or impaired in any way and shall be interpreted to give effect to the intent of the
parties manifested thereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION 16.&nbsp;<U>Investigations and Proceedings</U>.&nbsp;The parties to this Agreement agree to cooperate
fully in any securities regulatory investigation or proceeding or any judicial proceeding with respect to each party&#146;s activities under this Agreement and promptly to notify the other party of any such investigation or proceeding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION 17.&nbsp;<U>Modification, Waiver and Amendment</U>.&nbsp;No modification, alteration or amendment of this Agreement will be valid or
binding unless in writing and signed by all parties.&nbsp;No waiver of any term or condition of this Agreement will be construed as a waiver of any other term or condition; nor will any waiver of any default or breach under this Agreement be
construed as a waiver of any other default or breach.&nbsp;No waiver will be binding unless in writing and signed by the party waiving the term, condition, default or breach.&nbsp;Any failure or delay by any party to enforce any of its rights under
this Agreement will not be deemed a continuing waiver or modification hereof and such party, within the time provided by law, may commence appropriate legal proceedings to enforce any or all of such right. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;13&nbsp;- </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the foregoing correctly sets forth the understanding between the Distributor and the Agent,
please so indicate in the space provided below for that purpose, whereupon this Agreement and your acceptance shall constitute a binding agreement between the Distributor and the Agent.&nbsp;Alternatively, the execution of this Agreement by the
Distributor and the acceptance by or on behalf of the Agent may be evidenced by an exchange of telegraphic or other written communications. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">BlackRock Investments, LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jonathan Diorio</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Name:&nbsp;&nbsp;&nbsp;Jonathan Diorio</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Title:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Managing Director</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ACCEPTED as of the date</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">first above
written</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">UBS SECURITIES LLC</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(as <FONT
STYLE="white-space:nowrap">sub-placement</FONT> agent)</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Saawan Pathange</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name:&nbsp;&nbsp;&nbsp;Saawan Pathange</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jonathan Reiser</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name:&nbsp;&nbsp;&nbsp;Jonathan Reiser</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Associate Director</TD></TR>
</TABLE>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ADDENDUM </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TO </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT
STYLE="white-space:nowrap">SUB-PLACEMENT</FONT> AGENT AGREEMENT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BETWEEN </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BLACKROCK INVESTMENTS, LLC </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AND </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>UBS SECURITIES LLC
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Compensation payable to the Agent for acting as a <FONT STYLE="white-space:nowrap">sub-placement</FONT> agent with respect to a
specified sale of Shares pursuant to this Agreement shall be determined by multiplying the Gross Sales Proceeds by the Applicable Selling Agent Commission as set forth below: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Applicable Selling </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Agent
Commission</U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">0.80% </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Where:
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Gross Sales Proceeds&#148; with respect to each sale of Shares shall be the Gross Sales Price multiplied by the number of Shares
sold; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Gross Sales Price&#148; with respect to each sale of Shares sold pursuant to this Agreement shall be the gross sales price
per share of such Shares. </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(K)(8)
<SEQUENCE>4
<FILENAME>d421862dex99k8.htm
<DESCRIPTION>FORM OF NINTH AMENDED AND RESTATED SECURITIES LENDING AGREEMENT
<TEXT>
<HTML><HEAD>
<TITLE>Form of Ninth Amended and Restated Securities Lending Agreement</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NINTH AMENDED AND RESTATED SECURITIES LENDING AGENCY AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Ninth Amended and Restated Agreement, dated as of January&nbsp;1, 2023, between each investment company, severally and not jointly,
identified on Schedule A, as such schedule may be amended from time to time (each a &#147;Client&#148;), acting on behalf of itself or the funds listed on Schedule A hereto and any future series of a Client (each, a &#147;Fund&#148;), by and through
BlackRock Advisors, LLC (&#147;BlackRock&#148;), not in its individual capacity but as agent and investment advisor, and BlackRock Investment Management, LLC (the &#147;Lending Agent&#148;), a Delaware limited liability company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS, </B>each Client is registered as an <FONT STYLE="white-space:nowrap">open-end</FONT> management investment company or closed end
management investment company under the Investment Company Act of 1940, as amended (the &#147;1940 Act&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS, </B>the
Lending Agent acts as the agent for each Client and its corresponding Funds, as applicable, for the purpose of lending securities pursuant to an Eighth Amended and Restated Securities Lending Agency Agreement dated January&nbsp;1, 2022; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS, </B>the parties to this Agreement desire to amend and restate such agreement on the terms set forth herein; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS, </B>the Directors or Trustees, as the case may be, of each Client have authorized each Client and its corresponding Funds, as
applicable, to lend securities to Approved Borrowers (as defined below); and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS, </B>the Directors or Trustees, as the case may
be, of each Client have approved the appointment of the Lending Agent as each Client&#146;s securities lending agent and coordinator of each Client&#146;s securities lending program, subject to the terms and conditions set forth herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>NOW, THEREFORE, </B>for and in consideration of the mutual promises contained herein, the parties hereto agree as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.&nbsp;&nbsp;&nbsp;&nbsp;<B>Appointment</B>. The Client, on behalf of its Funds, as applicable, appoints BlackRock Investment Management, LLC
as its lending agent to perform the duties and responsibilities set forth in this Agreement in its capacity as Lending Agent, and BlackRock Investment Management, LLC accepts such appointment. The Lending Agent will act solely as a directed agent of
the Client hereunder, and the Lending Agent shall have no duties or responsibilities in respect of securities lending transactions except those expressly set forth in this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.&nbsp;&nbsp;&nbsp;&nbsp;<B>Authorizations</B>. The Client authorizes the Lending Agent to act as agent as set forth in this Section. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Lending of Available Securities</B>. The Client authorizes the Lending Agent to lend, on the Client&#146;s
behalf, those securities (&#147;Available Securities&#148;) which are held in accounts maintained under the supervision of the Client&#146;s custodian (the &#147;Custodian&#148;) or any <FONT STYLE="white-space:nowrap">sub-custodian</FONT> (each a
&#147;Custody Account&#148;), other than </P></TD></TR></TABLE>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
securities which the Client&#146;s investment advisor (the &#147;Advisor&#148;), on behalf of the Client, specifically notifies the Lending Agent are not available for lending. The Client
warrants to the Lending Agent that it will give appropriate instructions to the Advisor and the Custodian sufficient to permit the Lending Agent to arrange and settle loan transactions on the Client&#146;s behalf as contemplated by this Agreement.
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Lending to Approved Borrowers. </B>The Client authorizes the lending of Available Securities to any one or
more of the institutions approved by the Client, the Client&#146;s Board of Directors/Trustees and/or the Client&#146;s Advisor, in accordance with the Funds&#146; Guidelines and Procedures for Lending of Securities (&#147;Securities Lending
Guidelines&#148;) (each, an &#147;Approved Borrower&#148;). The Client&#146;s Advisor, on behalf of the Client, may request that the Lending Agent change the Approved Borrowers by delivering an updated list to the Lending Agent, provided that the
Advisor shall report to the Board of Directors/Trustees at its next quarterly meeting any addition or removal of an Approved Borrower to or from the &#147;approved list&#148; made by the Advisor since the Board of Directors/Trustees prior quarterly
meeting. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Securities Loan Agreement. </B>The Lending Agent is authorized to execute securities loan agreements (each
an &#147;SLA&#148;) as the Client&#146;s agent on a disclosed basis with Approved Borrowers. The SLA will be in substantially a form or forms set forth in Schedule B hereto, as such form or forms may be materially amended from time to time with
prior written approval of the Client. The Client specifically approves such form of agreement and agrees, upon request of the Lending Agent, to cause the Advisor to promptly furnish to the Lending Agent the Client&#146;s financial statements or
other documents or information reasonably requested by the Lending Agent in order to enable the Lending Agent to satisfy reasonable credit and legal requests by Approved Borrowers in connection with any SLA or loan transaction.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Lending under Approved Terms. </B>All loans arranged by the Lending Agent on behalf of a Client shall comply
with applicable Securities and Exchange Commission (&#147;SEC&#148;) guidelines for securities lending, any applicable SEC exemptive orders, <FONT STYLE="white-space:nowrap">no-action</FONT> positions taken by the staff of the SEC with respect to
securities lending transactions, and the investment restrictions and/or guidelines for the Client, all of which shall be provided to the Lending Agent by the Client or the Advisor, and shall be subject to the terms of an SLA substantially similar to
Schedule B. The Client may, at the request of the Lending Agent, approve changes to the approved terms by delivering an amended Schedule B to the </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 2 - </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
Lending Agent. The Lending Agent shall negotiate on behalf of the Client with each Approved Borrower all terms of a securities loan, including the amounts or fees to be received or paid pursuant
to the applicable SLA. The Lending Agent may prepare a transactional confirmation in respect of each loan effected pursuant to an SLA, setting forth the securities borrowed and the material terms of the loan, and may transmit such confirmation to
the Approved Borrower in accordance with such SLA. The Client understands and agrees that the identity of the Client will be disclosed by the Lending Agent to the Approved Borrower in accordance with the SLA. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Authorizations by Client. </B>The Client authorizes and empowers the Lending Agent to execute in the
Client&#146;s name all agreements and documents as may be necessary or appropriate in the Lending Agent&#146;s judgment to carry out the purposes of this Agreement. It is understood and agreed that the Lending Agent is authorized to supply any
information regarding the Client that is required by an SLA or under applicable law, subject to Section&nbsp;10.1 hereof. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.&nbsp;&nbsp;&nbsp;&nbsp;<B>Loan of Securities. </B>During the term of any securities loan, the Client shall permit the loaned securities to
be transferred, pursuant to an SLA, into the name of an Approved Borrower. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Limits on Return of Loaned Securities. </B>The Client acknowledges that, under the applicable SLA, Approved
Borrowers will not be required to return loaned securities immediately upon receipt of notice from the Lending Agent terminating the applicable loan, but instead will be required to return such loaned securities within the earlier of (i)&nbsp;such
period of time following such notice which is the standard settlement period for trades of the loaned securities entered into on the date of such notice in the principal market therefor, or from the giving of such notice or (ii)&nbsp;the third
business day following such notice. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Recall of Loaned Securities. </B>Upon receiving a notice from the Advisor that Available Securities which
have been lent to an Approved Borrower should no longer be considered Available Securities (whether because of the sale of such securities or otherwise), the Lending Agent shall notify promptly thereafter the Approved Borrower which has borrowed
such securities that the loan of such securities is terminated and that such securities are to be returned within the time specified by the applicable SLA, provided that the Lending Agent may alternatively determine that it is in the best interests
of another lending client of the Lending Agent to renew and restate such loan transaction on behalf, and in the name, of such other lending client and cause to be delivered to the Client an equivalent amount of such security from the assets of such
other lending client (in which event such renewal and restatement of the loan shall constitute separate transactions between each lending client of the Lending Agent and the borrower and shall not be construed as a transaction between such lending
clients). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Notification of Sales of Loaned Securities. </B>The Client acknowledges its obligation to the Lending Agent,
as applicable, to cause and require the Advisor to provide notification of any sale of securities which are out on loan by the close of business, in the principal market therefor, on the trade date of such sale. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 3 - </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Termination. </B>The Lending Agent is authorized in its discretion to terminate any securities loan entered
into with an Approved Borrower without prior notice to the Client, subject to the conditions of the relevant SLA. The Advisor, on behalf of a Client, may instruct the Lending Agent to terminate any loan on any date, subject to the conditions of the
relevant SLA. The Lending Agent agrees to comply with any such instruction. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Lending Agent Subject to Supervision of Advisor. </B>The Lending Agent shall at all times be subject to the
supervision of the Advisor. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.6</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Compliance with Securities Lending Guidelines</B>. The Lending Agent hereby acknowledges receipt of the
current Securities Lending Guidelines. The Client shall promptly notify the Lending Agent of any changes to the Securities Lending Guidelines. The Lending Agent acknowledges and agrees that it shall only lend Securities on behalf of the Client and
its Funds in accordance with the conditions of the Securities Lending Guidelines applicable to the Lending Agent. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.&nbsp;&nbsp;&nbsp;&nbsp;<B>Loan Collateral. </B>For each loan of securities, the Approved Borrower shall pledge at all times during the term
of the loan collateral in the form of one or more of the following items: (a)&nbsp;cash in U.S. dollars or foreign currency (&#147;Cash Collateral&#148;), or (b)&nbsp;securities issued or fully guaranteed by the United States government or any
agencies or instrumentalities thereof or such other collateral as may be then permitted by applicable law, regulation and/or interpretation, and the Securities Lending Guidelines <FONT STYLE="white-space:nowrap">(&#147;Non-Cash</FONT>
Collateral&#148; and, collectively with Cash Collateral, &#147;Collateral&#148;) in the aggregate having a market value (as determined by the Lending Agent pursuant to the applicable SLA) at least equal to the market value of the loaned securities
(as determined by the Lending Agent pursuant to the applicable SLA). </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Receipt of Collateral. </B>At the commencement of any loan, the Lending Agent shall instruct the Approved
Borrower to transfer to the Lending Agent the required Collateral. Collateral will be received from an Approved Borrower prior to or simultaneous with delivery of the securities loaned. If the Approved Borrower does not provide Collateral to the
Lending Agent, as previously agreed, then the Lending Agent will cancel the corresponding loan instruction prior to delivery. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Holding and Administration of Collateral</B>. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Cash Collateral. </B>All Cash Collateral shall be received, held and administered by the Lending Agent for
the benefit of the Client in the applicable account maintained for the Lending Agent. The Lending Agent is hereby authorized and directed, without obtaining any further approval from the Client or the Advisor, to invest and reinvest all Cash
Collateral in accordance with the Securities Lending Guidelines (&#147;Permitted Investments&#148;). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 4 - </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><FONT STYLE="white-space:nowrap">Non-Cash</FONT> Collateral. </B>All
<FONT STYLE="white-space:nowrap">Non-Cash</FONT> Collateral shall be received, held and administered by the Lending Agent for the benefit of the Client in the applicable account established for the purpose of holding
<FONT STYLE="white-space:nowrap">Non-Cash</FONT> Collateral. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Perfection. </B>The Lending Agent acknowledges that it has control of the Cash Collateral and the security
entitlements relating to the <FONT STYLE="white-space:nowrap">Non-Cash</FONT> Collateral on behalf of the Fund. The Fund has a perfected security interest in the Cash Collateral pursuant to UCC
<FONT STYLE="white-space:nowrap">Section&nbsp;9-104(a)(5)</FONT> and the security entitlements relating to the <FONT STYLE="white-space:nowrap">Non-Cash</FONT> Collateral pursuant to UCC
<FONT STYLE="white-space:nowrap">Section&nbsp;8-106(d)(3).</FONT> &#147;UCC&#148; means the Uniform Commercial Code as in effect from time to time in the State of New York; <I>provided</I>, <I>however</I>, that, at any time, if by reason of
mandatory provisions of law any or all of the perfection or priority of the Lending Agent&#146;s security interest in any item or portion of the Collateral is governed by the Uniform Commercial Code as in effect in a jurisdiction other than the
State of New York, the term &#147;UCC&#148; shall mean the Uniform Commercial Code as in effect, at such time, in such other jurisdiction for purposes of the provisions relating to such perfection or priority and for purposes of definitions relating
to such provisions. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Maintenance of Collateral Margin. </B>In respect of loans of securities entered into on behalf of the
Client, the Lending Agent will value on a daily basis under policies consistent with the valuation policies of the Client, in accordance with the applicable SLA, the loaned securities and all Collateral and, where applicable, the Lending Agent
shall, in accordance with the provisions of the applicable SLA, request the Approved Borrower to deliver sufficient additional Collateral to the Client by 12:00 noon on the next business day to satisfy the applicable margin requirement. If, as a
result of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">marking-to-market,</FONT></FONT> Collateral is required to be returned to the Approved Borrower under the SLA, the Lending Agent will return such Collateral to the Approved
Borrower. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Substitution of Collateral. </B>To the extent the Client&#146;s Board of Directors/Trustees permits the use
of <FONT STYLE="white-space:nowrap">Non-Cash</FONT> Collateral, the Client acknowledges and agrees that, pursuant to any SLA, the Lending Agent may permit an Approved Borrower to substitute Collateral of any type specified in Section&nbsp;4 hereof
during the term of any loan so long as the required margin in respect of such loan continues to be satisfied at the time of such substitution. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Return of Collateral. </B>Upon termination of the loan, the Lending Agent shall instruct the Approved
Borrower to return the loaned securities to the applicable Custody Account. The Lending Agent will instruct any custodian or <FONT STYLE="white-space:nowrap">sub-custodian</FONT> of the Client to accept such return delivery of loaned securities. The
Lending Agent shall monitor the return of loaned securities. Once the Lending Agent has confirmed settlement of the return of the loaned securities, the Lending Agent shall effect, on behalf of the Client, the redemption of any Permitted Investment,
if applicable, and effect the return of Collateral due the Approved Borrower in accordance with the Approved Borrower&#146;s transfer instructions with respect thereto, without obtaining any further approval from the Client. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 5 - </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.&nbsp;&nbsp;&nbsp;&nbsp;<B>Investment of Cash Collateral. </B>Pursuant to the SLA, the Client
shall have the right to invest Cash Collateral received in respect of any loan, subject to an obligation, upon the termination of the loan, to return to the Approved Borrower the amount of cash initially pledged (as adjusted for any interim <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">marks-to-market).</FONT></FONT> </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Cash Collateral Investment Direction. </B>The Client authorizes and directs the Lending Agent, subject to
oversight by the Advisor, to cause to be invested, on the Client&#146;s behalf and at the Client&#146;s sole risk, all Cash Collateral by effecting purchases and sales and/or subscriptions and redemptions of such Collateral in accordance with the
Securities Lending Guidelines. The Lending Agent shall, where applicable, send timely instructions to the transfer agent of the Permitted Investment with respect to any cash transfers required to be completed in conjunction with any subscription or
redemption in a Permitted Investment, and cause the Advisor and the Custodian to be notified of such investment. To facilitate the Lending Agent&#146;s ability to effect investments of Cash Collateral authorized by this Agreement, the Client
appoints the Lending Agent as its true and lawful <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorney-in-fact,</FONT></FONT> with full power of substitution and revocation, in its name, place and stead to take action in the
Client&#146;s name to the extent necessary or desirable to fulfill the purposes of this Agreement, including, without limitation, (i)&nbsp;to establish trading accounts in a Client&#146;s name, (ii)&nbsp;to execute and deliver such contracts and
other documents on a Client&#146;s behalf as the Lending Agent, in its discretion, deems necessary or desirable to establish such trading accounts or otherwise to effect investments on the Client&#146;s behalf that are authorized by this Agreement,
and (iii)&nbsp;to act, in the Lending Agent&#146;s discretion, in the Client&#146;s name to enforce the Client&#146;s rights and remedies under such contracts or documents. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Cash Collateral Investment Risk. </B>Any investment of Cash Collateral shall be at the sole risk of the
Client. Any income or gains and losses from investing and reinvesting any Cash Collateral delivered by an Approved Borrower pursuant to an SLA shall be at the Client&#146;s risk, and the Client agrees that to the extent any such losses reduce the
amount of cash below the amount required to be returned to the Approved Borrower upon the termination of any loan (including any Cash Collateral Fee as defined in the SLA), the Client will, on demand of the Lending Agent, immediately pay or cause to
be paid to such Approved Borrower an equivalent amount in cash. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.&nbsp;&nbsp;&nbsp;&nbsp;<B>Borrower Default. </B>In
the event of default by a Borrower with respect to any loan entered into pursuant to an SLA, the Lending Agent will take such actions as agent for the Client as are set forth in the applicable SLA. In addition, the following provisions shall apply.
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">6.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Replacement of Loaned Securities. </B>If the Lending Agent declares an event of default pursuant to the SLA
with a Borrower (a &#147;Default Event&#148;), then the Lending Agent shall use the Collateral or the proceeds of the liquidation of </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 6 - </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
Collateral to purchase for the affected Client&#146;s account, for settlement in the normal course, replacement securities of the same issue, type, class and series as that of the loaned
securities <FONT STYLE="white-space:nowrap">(&#147;Buy-In&#148;).</FONT> The Lending Agent shall purchase an amount of replacement securities having a value equal to the value of the securities on loan for which a Default Event has been declared. If
the cost of fully replacing the loaned securities is greater than the value of the Collateral (or liquidated damages calculated under Section&nbsp;6.2), the Lending Agent shall be responsible for using its funds, at its expense, to satisfy the
shortfall, but only to the extent that such shortfall is not due to any diminution in the value of the Collateral due to reinvestment risk that is borne by the Client pursuant to Section&nbsp;5 of this Agreement. For purposes of this Section, value
of the Collateral shall be calculated as follows: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Value of Cash Collateral. </B>In the case of loans collateralized solely by Cash Collateral, the value of
the Collateral shall be the market value of such Cash Collateral. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.1.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Value of Securities Collateral. </B>In the case of loans collateralized solely by securities Collateral, the
value of the Collateral shall be the market value of such Collateral. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.1.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Valuation Date. </B>The value of the Collateral shall be determined on the date of the <FONT
STYLE="white-space:nowrap">Buy-In</FONT> (or the payment made pursuant to Section&nbsp;6.2 below). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.1.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Market Value. </B>Market value shall be determined by the Lending Agent, where applicable, based upon the
valuation policies adopted by the Client&#146;s Board of Directors/Trustees. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.1.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Multiple Forms of Collateral. </B>Where a loan is collateralized by more than one type of Collateral, the
aggregate market value of Collateral securing such loan (for the purpose of computing the indemnity) shall be the sum of the market values for each relevant type of Collateral. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">6.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Impossibility of Replacement/Liquidated Damages. </B>If the Lending Agent determines that a <FONT
STYLE="white-space:nowrap">Buy-In</FONT> is commercially impracticable (for any reason other than price), the Lending Agent shall, in lieu of effecting a <FONT STYLE="white-space:nowrap">Buy-In,</FONT> pay to the affected Client an amount equal to
the market value of the loaned securities determined at the close of business on the date of the Default Event to be reduced by any shortfall diminution in the value of the Collateral due to reinvestment risk that is borne by the Client pursuant to
Section&nbsp;5. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">6.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Replacement of Distributions. </B>In addition to making the purchases or payments required above, the
Lending Agent shall pay from the proceeds of Collateral to the Client the value of all distributions on the Loaned Securities, the record dates for which occur before the date that the Lending Agent executes a
<FONT STYLE="white-space:nowrap">Buy-In</FONT> or makes the payments to the Client required pursuant to Section&nbsp;6.2 and that have not otherwise been credited to the Client&#146;s applicable account. For purposes of
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 7 - </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
this Section, the value of such distributions shall be calculated net of taxes, expenses or other deductions that would normally accrue to such distributions. The Lending Agent shall use
Collateral or the proceeds of such Collateral to the extent available to make such payments of distributions. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">6.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Collateral not in Possession or Control of the Lending Agent. </B>If, on the date of the Default Event, by
reason of the Client&#146;s request or actions, the Lending Agent is not in possession or control of the Collateral allocated to the defaulted Loan, the Client shall promptly cause such Collateral to be transferred to the Lending Agent for
application against the cost of any <FONT STYLE="white-space:nowrap">Buy-In.</FONT> In such event, the replacement provisions of this Section&nbsp;6 shall not apply, and the compensation of the Client shall be limited to the value of the Collateral
on the date that <FONT STYLE="white-space:nowrap">Buy-In</FONT> or replacement payment may be affected. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">6.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Subrogation and Assignment of Rights in Collateral. </B>In the event that the Lending Agent is required to
perform or make any payment under this Section, the Client agrees that, to the extent of such performance or payment, the Lending Agent shall be subrogated to the Client, and the Client shall assign, and be deemed to have assigned, to the Lending
Agent all of such Client&#146;s rights in, to and against the Borrower in respect of the related loan, any Collateral pledged by such Borrower in respect of such loan and all proceeds of such Collateral to the extent permitted by applicable law. In
the event that the Client receives or is credited with any payment, benefit or value from or on behalf of the Borrower in respect of rights to which the Lending Agent is subrogated as provided herein, the Client shall promptly remit or pay to the
Lending Agent the same (or, where applicable, its United States dollar equivalent). </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.&nbsp;&nbsp;&nbsp;&nbsp;<B>Income, Corporate Actions and Substitute Payments. </B>Income, corporate actions and Substitute Payments (as
defined in Sections 7.1 and 7.2) shall be dealt with as provided in this Section&nbsp;7. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">7.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Income and Related Payments to Borrower. </B>Payments to an Approved Borrower shall be made in accordance
with the terms of the applicable SLA. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">7.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Income and Related Payments to Client. </B>The Lending Agent shall instruct each Approved Borrower which is
a party to an SLA to remit any payment <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">in-lieu-of</FONT></FONT> the interest or other distribution on loaned securities (&#147;Loan Substitute Payment&#148;) for the account of the
Client. The Lending Agent shall also instruct each Approved Borrower which is a party to an SLA to remit any other fees payable on loaned securities to the Lending Agent for the account of the Client, and the Lending Agent shall receive, hold and
administer the same for the account of the Client. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">7.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Corporate Actions and Proxy Rights. </B>The Client acknowledges that, with respect to securities which are
out on loan over the applicable record date for such action, unless otherwise agreed hereto, it will not be entitled to participate in any dividend reinvestment program or vote any proxies; provided, however, that the </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Client may recall such securities upon sufficient notice to exercise proxy rights. Corporate actions will otherwise be processed in accordance with the SLA. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 8 - </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.&nbsp;&nbsp;&nbsp;&nbsp;<B>Reports and Statements. </B>The Lending Agent shall furnish the
Client with the reports and statements set forth in the Securities Lending Guidelines or as otherwise agreed from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.&nbsp;&nbsp;&nbsp;&nbsp;<B>SIPC Coverage. </B>THE PARTIES ACKNOWLEDGE THAT THE PROVISIONS OF THE SECURITIES INVESTOR PROTECTION ACT OF 1970
(&#147;SIPA&#148;) OR THE DODD-FRANK ACT OF 2010 (&#147;DFA&#148;) MAY NOT PROTECT THE FUND WITH RESPECT TO THE SECURITIES LOAN TRANSACTION AND THAT, THEREFORE, THE COLLATERAL DELIVERED BY AN APPROVED BORROWER TO THE FUND MAY CONSTITUTE THE ONLY
SOURCE OF SATISFACTION OF THE OBLIGATION OF THE APPROVED BORROWER IN THE EVENT THE APPROVED BORROWER (OR ITS AGENT) FAILS TO RETURN THE SECURITIES. THE LENDING AGENT SHALL NOT BE RESPONSIBLE FOR ANY LOSSES INCURRED OR LIABILITIES WHICH ARISE SOLELY
DUE TO THE APPLICATION OF SIPA OR DFA TO THE SECURITIES LENDING TRANSACTIONS DESCRIBED HEREIN. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.&nbsp;&nbsp;&nbsp;&nbsp;<B>Client
Information. </B>The Client covenants and agrees to promptly furnish to the Lending Agent any information regarding the Client which is necessary to effect transactions on behalf of the Client, including, but not limited to, any limitations imposed
pursuant to any applicable law, regulation, authority, charter, <FONT STYLE="white-space:nowrap">by-law,</FONT> statute or other instrument. The Lending Agent agrees to comply with such restrictions and limitations. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">10.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Lending Agent may not disclose or supply any information regarding the Client or Fund unless required by
any law or governmental regulation now or hereafter in effect or requested to do so by the Client; provided that the Lending Agent may disclose or supply information regarding the Client and/or Fund and any transactions authorized by this Agreement
as necessary in the sole discretion of the Lending Agent in order to facilitate, effect or continue any securities loans hereunder or to assist in the analysis of the performance of the securities lending program. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.&nbsp;&nbsp;&nbsp;&nbsp;<B>Tax Treatment. </B>The Client acknowledges that the tax treatment of Substitute Payments may differ from the tax
treatment of the interest or dividend to which such payment relates and that the Client has made its own determination as to the tax treatment of any securities loan transactions undertaken pursuant to this Agreement and of any dividends,
distributions, remuneration or other funds received hereunder. The Client also acknowledges that, to the extent that either the Client or the Approved Borrower is a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> resident, the Lending Agent may be
required to withhold tax on amounts payable to or by the Client pursuant to a securities loan and may at any time claim from the Client any shortfall in the amount so withheld. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.&nbsp;&nbsp;&nbsp;&nbsp;<B>Responsibility of the Lending Agent. </B>Except as otherwise set forth herein, and subject to the requirements
of applicable law, the Lending Agent shall not be liable with respect to any losses incurred by the Client in connection with this securities lending program or under </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 9 - </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any provision hereof, except to the extent that such losses result from the Lending Agent&#146;s willful misfeasance, bad faith, negligence or reckless disregard in the performance of its duties
under this Agreement. The Lending Agent shall not be liable for losses, costs, expenses or liabilities caused by or resulting from the acts or omissions of the Client or of any agent or third party custodian of the Client. The Lending Agent shall
not be responsible for any special, punitive, indirect or consequential damages, whether or not the Lending Agent has been apprised of the likelihood of such damages. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">13.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Standard of Care: Indemnification</B>. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">13.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to Section&nbsp;6, the Client shall indemnify and hold harmless the Lending Agent (which, for purposes
of this paragraph shall include its respective officers, directors, partners, managers, employees and agents) from and against any and all claims, damages, liabilities, losses, costs or expenses, including the reasonable fees and expenses of counsel
(each, a &#147;Loss&#148;) incurred, suffered or sustained by the Lending Agent, which arise from the Lending Agent&#146;s actions or failure to act, in either case taken in good faith in performance of this Agreement, except to the extent that such
claims, damages, liabilities, losses, costs or expenses were caused by the willful misfeasance, bad faith, negligence or reckless disregard of the Lending Agent, provided that the Client&#146;s indemnification obligation with respect to the acts or
omissions of the Lending Agent shall not exceed the indemnification provided by such Lending Agent to the Client. This indemnity shall survive the termination of this Agreement and the resignation or removal of the Lending Agent as agent.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">13.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Lending Agent shall indemnify and hold harmless the Client and each Fund, its Board of Directors/Trustees
and the Advisor (which for purposes of this paragraph shall include its officers, directors, partners, managers, employees and agents) and any other investment advisor for the Clients and Funds from any and all Losses to the extent that any such
Loss arises out of the material breach of this Agreement by or the willful misfeasance, bad faith, negligence or reckless disregard of the Lending Agent, its officers, directors or employees in connection with the securities lending activities
undertaken pursuant to this Agreement, provided that the Lending Agent&#146;s indemnification obligation with respect to the acts or omissions of its subcustodians shall not exceed the indemnification provided by the applicable subcustodian to the
Lending Agent. This indemnity shall survive the termination of this Agreement and the resignation or removal of the Lending Agent. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">13.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Representations and Warranties. </B>Each party represents and warrants to the other that (i)&nbsp;it has due
authority to enter into and perform this Agreement and any transactions contemplated thereby; (ii)&nbsp;the execution and performance of this Agreement and any transaction contemplated thereby has been duly authorized by all necessary action,
corporate or otherwise, and does not violate any law, regulation, charter, <FONT STYLE="white-space:nowrap">by-law</FONT> or other instrument, restriction or provision applicable to it; and (iii)&nbsp;this Agreement constitutes such party&#146;s
legal, valid and binding obligation enforceable in accordance with its terms. In addition, the Client </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 10 - </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
represents that: (a)&nbsp;any loan authorized hereunder and the performance of this Agreement in respect of such loan is authorized by the prospectus and other constitutive documents of the
Client (including any limits as to the aggregate amount of authorized lending under such documents); and (b)&nbsp;as to any securities lent at any time and from time to time on behalf of the Client, the Client shall be the owner thereof with clear
title thereto and no lien, charge or encumbrance upon such securities shall exist. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">13.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><FONT STYLE="white-space:nowrap">Non-Exclusivity</FONT> of Agency Service and Similar Matters. </B>The
Client acknowledges that the Lending Agent, acting on behalf of other lending clients, may effect transactions with or for the same Approved Borrowers to which loans of securities may be made hereunder, which transactions may give rise to potential
conflict of interest situations. Lending opportunities among Approved Borrowers shall be allocated at the discretion of the Lending Agent in an equitable manner. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.&nbsp;&nbsp;&nbsp;&nbsp;<B>Force Majeure. </B>The Lending Agent shall not be responsible or liable for any failure or delay in the
performance of its obligations under this Agreement arising out of, or caused directly or indirectly by, circumstances beyond its control, including without limitation, acts of God; earthquakes; fires; floods; wars; civil or military disturbances;
sabotage; epidemics; riots; interruptions, loss or malfunctions of utilities, transportation, computer (hardware or software) or communications service; accidents; labor disputes; acts of civil or military authority; governmental actions; or
inability to obtain labor, material, equipment or transportation. Without limiting the foregoing, but subject to Section&nbsp;6, the Lending Agent shall not be responsible for economic, political or investment risks incurred through the
Client&#146;s participation in this securities lending program. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.&nbsp;&nbsp;&nbsp;&nbsp;<B>Reliance on Client Communications. </B>The
Lending Agent shall be entitled to conclusively rely upon any certification, notice or other communication (including by facsimile or email) reasonably believed by it to be genuine and correct and to have been signed or sent by or on behalf of an
approved person of the party sending such certification, notice or other communication. The Lending Agent reserves the right to notify the Client of any restrictions (self-imposed or otherwise) concerning its activities worldwide. The Lending Agent
and the Client shall each have the right to consult with counsel with respect to their respective rights and duties hereunder and shall not be liable for actions taken or not taken in reliance on such advice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16.&nbsp;&nbsp;&nbsp;&nbsp;<B>Compensation. </B>In connection with the lending of Available Securities, a Fund shall pay to the Lending Agent
a percentage (the &#147;Lending Agent Fee Percentage&#148;) of the net amount earned from securities lending activities, consisting of income earned on the investment and reinvestment of Cash Collateral plus any Securities Loan Fees otherwise paid
by the Authorized Borrowers. For purposes of this Agreement, &#147;Securities Loan Fees&#148; shall mean the amount payable by an Authorized Borrower to the Lending Agent, as agent to the Fund, pursuant to the applicable SLA in connection with the
loan of Available Securities, if any, collateralized by collateral other than Cash Collateral. The net amount to be paid to the Lending Agent shall be computed after deducting (a)&nbsp;any applicable rebate due to the Authorized Borrowers under the
applicable SLA and (b)&nbsp;Cash Management Costs. &#147;Cash Management Costs&#148; shall mean the expenses incurred in connection with the management and investment of a Fund&#146;s Cash </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 11 - </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Collateral in accordance with Section&nbsp;5 of this Agreement, including any fees payable to the Lending Agent, the Advisor or any other affiliate of the Lending Agent as a result of the
investment of Cash Collateral in any joint account, fund or similar vehicle. The Lending Agent, upon mutual agreement with the Client, may determine to cap the Cash Management Costs. Any such cap on the Cash Management Costs shall be set forth in
Appendix A or Appendix B hereto, as applicable, as each such Appendix may be amended from time to time. The Lending Agent Fee Percentage shall be such percentage as may from time to time be agreed upon by the Board of Directors/Trustees of the
Client and the Lending Agent and shall be set forth in writing. The Lending Agent Fee Percentage for each Fund is set forth in Appendix A or Appendix B hereto, as applicable, as each such Appendix may be amended from time to time. The Client
authorizes and directs the Lending Agent to deduct amounts equal to such compensation from the Custody Account and to retain such amounts as compensation. The Lending Agent shall notify the Client, on or about the 10th (tenth) day of each month, of
the amount of fees due the Lending Agent hereunder and, promptly upon receipt of such notice, the Client shall effect the requisite payment to the Lending Agent in immediately available funds of U.S. dollars. The Lending Agent shall be responsible
for all transaction fees and all other operational costs relating to securities lending activities, other than Cash Management Costs as described above and extraordinary expenses <I>(e.g., </I>litigation and indemnification expenses), each to be
borne by the respective Fund. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17.&nbsp;&nbsp;&nbsp;&nbsp;<B>Termination. </B>This Agreement may be terminated at any time upon mutual
written agreement of the Lending Agent and the Client or upon sixty (60)&nbsp;days&#146; prior written notice to the other party; provided that the indemnification obligations in Section&nbsp;13 shall survive any such termination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.&nbsp;&nbsp;&nbsp;&nbsp;<B>Action on Termination. </B>It is agreed that (a)&nbsp;upon receipt of notice of termination, no further loans
shall be made hereunder by the Lending Agent and (b)&nbsp;the Lending Agent shall, as promptly as possible after termination of this Agreement, terminate any and all outstanding loans but continue to administer to any outstanding loans as necessary
to effect their termination and remit and deliver to the Custody Account all securities, earnings and other items due to the Client. The provisions hereof shall continue in full force and effect in all other respects until all loans have been
terminated and all obligations satisfied as herein provided. Both parties shall take all commercially reasonable steps to cooperate to provide a smooth transition in the event of a termination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19.&nbsp;&nbsp;&nbsp;&nbsp;<B>Notices. </B>All notices, demands and other communications hereunder shall be in writing and delivered or
transmitted (as the case may be) by registered mail, facsimile, email, courier, or be effected by telephone promptly confirmed in writing and delivered or transmitted as aforesaid, to the intended recipient as provided below. Notices shall be
effective upon receipt. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">19.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any notice or other instrument in writing, authorized or required by this Agreement to be given to the Lending
Agent, shall be sufficiently given if addressed to BlackRock Investment Management, LLC and received by it at its offices at 1 University Square Drive, Princeton, NJ 08540, Attention: Securities Lending Department, with a copy to BlackRock
Investment Management, LLC, 400 Howard Street, San Francisco, CA 94105, Attention: Securities Lending Department, or at such other place as the Lending Agent may from time to time designate in writing. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 12 - </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">19.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any notice or other instrument in writing, authorized or required by this Agreement to be given to the Client
shall be sufficiently given if addressed to the Client and received by it at: Mutual Fund Administration, c/o BlackRock Advisors, LLC, 100 Bellevue Parkway, Wilmington, Delaware 19809, with a copy to: Legal Department, or at such other place as the
Client may from time to time designate in writing. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20.&nbsp;&nbsp;&nbsp;&nbsp;<B>Governing Law and Jurisdiction.
</B>This agreement shall be governed by and construed in accordance with the laws of the State of New York without reference to conflict of law provisions thereof. The parties hereto hereby irrevocably consent to the exclusive jurisdiction of (and
waive dispute of venue in) the courts of the State of New York and the federal courts located in New York City in the Borough of Manhattan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21.&nbsp;&nbsp;&nbsp;&nbsp;<B>Entire Agreement. </B>This Agreement supersedes any other agreement between the parties hereto concerning loans
of securities owned by the Client. This Agreement constitutes the entire understanding of the parties hereto with respect to the subject matter hereof. This Agreement together with any other written agreements between the parties entered into in
connection with this Agreement contain the entire agreement between the parties with respect to the transactions contemplated hereby and supersede all previous oral or written negotiations, commitments and understandings related thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">22.&nbsp;&nbsp;&nbsp;&nbsp;<B>Assignment. </B>This Agreement shall not be assigned by any party without the prior written consent of the other
party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">23.&nbsp;&nbsp;&nbsp;&nbsp;<B>Capitalized Terms. </B>Capitalized terms not otherwise defined herein shall have the meanings
provided in the SLA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">24.&nbsp;&nbsp;&nbsp;&nbsp;<B>Amendment. </B>This Agreement may not be amended or modified in any respect, without
the written agreement of both parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">25.&nbsp;&nbsp;&nbsp;&nbsp;<B>Waiver. </B>No provision of this Agreement may be waived, without
the written agreement of both parties. No waiver by one party of any obligation of the other hereunder shall be considered a waiver of any other obligation of such party. The failure of a party to this Agreement to insist upon strict adherence to
any term of this Agreement on any occasion shall not be considered a waiver or deprive that party of the right thereafter to insist upon strict adherence to that term or any other term of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">26.&nbsp;&nbsp;&nbsp;&nbsp;<B>Remedies. </B>All remedies hereunder shall survive the termination of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">27.&nbsp;&nbsp;&nbsp;&nbsp;<B>Severability. </B>In the event any provision of this Agreement is adjudicated to be void, illegal, invalid, or
unenforceable, the remaining terms and provisions of this Agreement shall not be affected thereby, and each of such remaining terms and provisions shall be valid and enforceable to the fullest extent permitted by law, unless a party demonstrates by
a preponderance of the evidence that the invalidated provision was an essential economic term of the Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 13 - </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">28.&nbsp;&nbsp;&nbsp;&nbsp;<B>Further Assurances. </B>Each party hereto shall execute and deliver
such other documents or agreements as may be necessary or desirable for the implementation of this Agreement and the consummation of the transactions contemplated hereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">29.&nbsp;&nbsp;&nbsp;&nbsp;<B>Counterparts. </B>This Agreement may be executed in one or more counterparts, each of which shall be deemed an
original and all of which taken together shall be deemed one and the same instrument. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">30.&nbsp;&nbsp;&nbsp;&nbsp;<B>Headings. </B>The
headings of sections herein are included solely for convenience and shall have no effect on the meaning of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">31.&nbsp;&nbsp;&nbsp;&nbsp;<B>Separate Agreement. </B>Execution of this Agreement by more than one Client or on behalf of itself and more than
one Fund shall not create any contractual or other obligation between or among such Clients or Funds, and this Agreement shall constitute a separate agreement between the Lending Agent and each Client on behalf of itself and each respective Fund.
Every reference to Client or Fund shall be construed to be a reference solely to the particular Client or Fund that is a party to the relevant transaction. Each of the parties agrees that under no circumstances shall any rights, obligations,
remedies or liabilities of a particular Client or Fund, or with respect to transactions to which a particular Client or Fund is a party, be deemed to constitute rights, obligations, remedies or liabilities applicable to any other Client or Fund or
to transactions to which other Clients or Funds are parties, and the Lending Agent shall have no right to set off claims of any Client or Fund against property or liabilities of any other Client or Fund. All transactions are entered into in reliance
on the fact that this Agreement constitutes a separate agreement between the Lending Agent and the Client or Fund. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">32.&nbsp;&nbsp;&nbsp;&nbsp;<B>Additional Parties. </B>The Lending Agent agrees that additional Clients may be added as parties to this
Agreement from time to time upon written notice to the Lending Agent and upon written consent of the Lending Agent to the addition of any such additional Client. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">33.&nbsp;&nbsp;&nbsp;&nbsp;<B>Business Trust. </B>With respect to a Client which is a business trust, the Lending Agent acknowledges and
agrees that this Agreement is executed by such Client on behalf of the trustees of such Client as trustees and not individually; and no trustee, shareholder, officer, employee or agent of such business trust shall be held to any personal liability,
nor shall resort be had to their property (other than the applicable trust property) for the satisfaction of the Client&#146;s obligations under this Agreement, and such obligations are binding only upon the applicable trust property held by such
trustee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">34.&nbsp;&nbsp;&nbsp;&nbsp;<B>Series Trusts. </B>The parties acknowledge that the Client is an investment company, whose assets
may be allocated to two or more series. In such case, the Lending Agent agrees to seek satisfaction of all obligations of such Client hereunder solely out of the assets of the series on whose behalf the Transaction(s) giving to the obligations was
entered into. If the Client establishes two or more series, the Client shall so indicate on Schedule A or otherwise give notice thereof and identify such series, and from such time the liability of such series shall be limited as set forth above, as
though and to the same extent as if such series was a separate and distinct Client hereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 14 - </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed in its name and
behalf as of the day and year first set forth above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BLACKROCK ADVISORS, LLC,</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">on
behalf of each investment company indicated on Schedule A</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Name: John Perlowski</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Title: Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BLACKROCK INVESTMENT MANAGEMENT, LLC,</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>as Lending Agent</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Name: Roland Villacorta</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Title: Managing Director</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 15 - </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Schedule A: Clients and Funds </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Multi-Asset Complex <FONT STYLE="white-space:nowrap">Open-End</FONT> Funds &#150; Group A </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock Advantage Global Fund, Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock
Advantage SMID Cap Fund, Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock Capital Appreciation Fund, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock Emerging Markets Fund, Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock Equity
Dividend Fund </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock EuroFund </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock
Financial Institutions Series Trust </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Summit Cash Reserves Fund </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock Funds<SUP STYLE="font-size:75%; vertical-align:top">SM</SUP></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Advantage Emerging Markets Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Advantage International Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Advantage Large Cap Growth Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Advantage Small Cap Core Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Advantage Small Cap Growth Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock China A Opportunities Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Commodity Strategies Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Defensive Advantage Emerging Markets Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Defensive Advantage International Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Defensive Advantage U.S. Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Energy Opportunities Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Exchange Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Global Equity Absolute Return Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Global Equity Market Neutral Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Global Impact Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Health Sciences Opportunities Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock High Equity Income Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Infrastructure Sustainable Opportunities Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock International Dividend Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock International Impact Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Liquid Environmentally Aware Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock <FONT STYLE="white-space:nowrap">Mid-Cap</FONT> Growth Equity Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Real Estate Securities Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Short Obligations Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock <FONT STYLE="white-space:nowrap">SMID-Cap</FONT> Growth Equity Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Sustainable Advantage Emerging Markets Equity Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Sustainable Advantage International Equity Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Sustainable Advantage Large Cap Core Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Tactical Opportunities Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Technology Opportunities Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Total Factor Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock U.S. Impact Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Wealth Liquid Environmentally Aware Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Circle Reserve Fund </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Sch. A-1 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock Funds II </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock 20/80 Target Allocation Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock 40/60 Target Allocation Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock 60/40 Target Allocation Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock 80/20 Target Allocation Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Dynamic High Income Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Global Dividend Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Managed Income Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Multi-Asset Income Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Retirement Income 2030 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Retirement Income 2040 Fund </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock Funds VII, Inc. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock
Sustainable Emerging Markets Equity Fund </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Sustainable International Equity Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Sustainable U.S. Growth Equity Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Sustainable U.S. Value Equity Fund </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock Global Allocation Fund, Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock
Large Cap Focus Growth Fund, Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock Large Cap Focus Value Fund, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock Large Cap Series Funds, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Advantage Large Cap Core Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Advantage Large Cap Value Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Event Driven Equity Fund </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock
Liquidity Funds </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">California Money Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Liquid Federal Trust Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">FedFund </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">MuniCash </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">New York Money Fund </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">TempCash
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">TempFund <FONT STYLE="white-space:nowrap">T-Fund</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Treasury Trust Fund </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock <FONT
STYLE="white-space:nowrap">Mid-Cap</FONT> Value Series, Inc. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock <FONT STYLE="white-space:nowrap">Mid-Cap</FONT> Value Fund <B>
</B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock Natural Resources Trust BlackRock Series Fund, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Advantage Large Cap Core Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Capital Appreciation Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Global Allocation Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Government Money Market Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Sustainable Balanced Portfolio </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock Series, Inc. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock
International Fund </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock Sustainable Balanced Fund, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock Unconstrained Equity Fund </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock Variable
Series Funds, Inc. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Sch. A-2 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock 60/40 Target Allocation ETF V.I. Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Advantage Large Cap Core V.I. Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Advantage Large Cap Value V.I. Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Advantage SMID Cap V.I. Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Basic Value V.I. Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Capital Appreciation V.I. Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Equity Dividend V.I. Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Global Allocation V.I. Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Government Money Market V.I. Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock International Index V.I. Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock International V.I. Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Large Cap Focus Growth V.I. Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Managed Volatility V.I. Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock S&amp;P 500 Index V.I. Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Small Cap Index V.I. Fund </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Managed
Account Series </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock GA Disciplined Volatility Equity Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock GA Dynamic Equity Fund </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Master
Large Cap Series LLC </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Master Advantage Large Cap Core Portfolio </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Fixed-Income Complex <FONT STYLE="white-space:nowrap">Open-End</FONT> Funds &#150; Group B </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock Allocation Target Shares </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BATS:
Series A Portfolio </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BATS: Series C Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BATS: Series E Portfolio </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BATS:
Series M Portfolio </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BATS: Series P Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BATS: Series S Portfolio </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BATS:
Series V Portfolio </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock Bond Fund, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Sustainable Total Return Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Total Return Fund </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock
California Municipal Series Trust </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock California Municipal Opportunities Fund </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock Funds IV </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Global
Long/Short Credit Fund </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Sustainable Advantage CoreAlpha Bond Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Systematic Multi-Strategy Fund </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock Funds V </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Core Bond
Portfolio </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Floating Rate Income Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock GNMA Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock High Yield Bond Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Impact Mortgage Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Income Fund </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock
Inflation Protected Bond Portfolio </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Low Duration Bond Portfolio </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Sch. A-3 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
BlackRock Strategic Income Opportunities Portfolio </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Sustainable Emerging
Markets Bond Fund </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Sustainable Emerging Markets Flexible Bond Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Sustainable High Yield Bond Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Sustainable Low Duration Bond Fund </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock Multi-State Municipal Series Trust </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock New Jersey Municipal Bond Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock New York Municipal Opportunities Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Pennsylvania Municipal Bond Fund </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock Municipal Bond Fund, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock High Yield Municipal Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Impact Municipal Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock National Municipal Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Short-Term Municipal Fund </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock Municipal Series Trust </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Strategic Municipal Opportunities Fund </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock Series Fund II, Inc. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock
High Yield Portfolio </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock U.S. Government Bond Portfolio <B> </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock Strategic Global Bond Fund, Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock
Variable Series Funds II, Inc. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock High Yield V.I. Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Total Return V.I. Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock U.S. Government Bond V.I. Fund </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Managed Account Series II </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock U.S.
Mortgage Portfolio </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Master Bond LLC </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Master Total Return Portfolio </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Fixed-Income Complex <FONT STYLE="white-space:nowrap">Closed-End</FONT> Funds &#150; Group B </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock 2037 Municipal Target Term Trust </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock California
Municipal Income Trust </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Capital Allocation Trust </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Core Bond Trust </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Corporate High Yield Fund,
Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Credit Allocation Income Trust </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock
Credit Strategies Fund </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Debt Strategies Fund, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Energy and Resources Trust </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Enhanced Capital
and Income Fund, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Enhanced Equity Dividend Trust </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Enhanced Global Dividend Trust </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Enhanced
Government Fund, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Enhanced International Dividend Trust </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock ESG Capital Allocation Trust </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Floating Rate
Income Strategies Fund, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Floating Rate Income Trust </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Sch. A-4 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Health Sciences Trust </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Health Sciences Trust II </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Hedge Fund Guided
Portfolio Solution </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Income Trust, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock
Innovation and Growth Trust </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Investment Quality Municipal Trust, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Limited Duration Income Trust </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Long-Term
Municipal Advantage Trust </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Multi-Sector Income Trust </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Multi-Sector Opportunities Trust </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock
Multi-Sector Opportunities Trust II </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock MuniAssets Fund, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Municipal 2030 Target Term Trust </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Municipal
Income Fund, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Municipal Income Quality Trust </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Municipal Income Trust </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Municipal Income
Trust II </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock MuniHoldings California Quality Fund, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock MuniHoldings Fund, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock MuniHoldings New
Jersey Quality Fund, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock MuniHoldings New York Quality Fund, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock MuniHoldings Quality Fund II, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock MuniVest
Fund II, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock MuniVest Fund, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock
MuniYield Fund, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock MuniYield Michigan Quality Fund, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock MuniYield New York Quality Fund, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock
MuniYield Pennsylvania Quality Fund </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock MuniYield Quality Fund II, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock MuniYield Quality Fund III, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock MuniYield
Quality Fund, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock New York Municipal Income Trust </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Private Investments Fund </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock
Resources&nbsp;&amp; Commodities Strategy Trust </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Science and Technology Trust </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Science and Technology Trust II </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Taxable
Municipal Bond Trust </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Utilities, Infrastructure&nbsp;&amp; Power Opportunities Trust </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Virginia Municipal Bond Trust </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Sch. A-5 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Schedule B: Forms of Securities Loan Agreement </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Sch. B-1 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Appendix A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Group A Funds </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">For the Funds in the Multi-Asset Complex identified on Schedule A as Multi-Asset Complex <FONT
STYLE="white-space:nowrap">Open-End</FONT> Funds &#150; Group A (the &#147;Group A Funds&#148;), the Lending Agent Fee Percentage shall be as set forth below: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">With respect to a Group A Fund that is identified as a &#147;U.S. Equity Fund&#148; in accordance with a
methodology agreed to between the Lending Agent and the Client, the Lending Agent Fee Percentage is nineteen percent (19%). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">With respect to a Group A Fund that is identified as an &#147;International Equity Fund&#148; in accordance
with a methodology agreed to between the Lending Agent and the Client, the Lending Agent Fee Percentage is eighteen percent (18%). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">With respect to a Group A Fund that is identified as a &#147;Fund of Funds&#148; in accordance with a
methodology agreed to between the Lending Agent and the Client, the Lending Agent Fee Percentage is eighteen percent (18%). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">d.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">With respect to a Group A Fund that is identified as a &#147;Fixed Income Fund&#148; in accordance with a
methodology agreed to between the Lending Agent and the Client, the Lending Agent Fee Percentage is eighteen percent (18%). </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The &#147;Multi-Asset Complex&#148; refers to all of the Funds currently or in the future overseen by a board of directors/trustees consisting
of the same individuals who comprise the members of the boards of directors/trustees of the Group A Funds listed on Schedule A and the funds listed on Appendix C hereto. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notwithstanding the foregoing, if at any point during a calendar year, the aggregate gross revenues earned by
the funds in the Multi-Asset Complex prior to payment of compensation to the applicable lending agent exceed $29,780,000 (the &#147;Multi-Asset Complex Breakpoint&#148;), the Lending Agent Fee Percentage shall be equal to or reduced to, as
applicable, the following in allocating net income after the gross revenues for the calendar year equal the Multi-Asset Complex Breakpoint: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">With respect to a Group A Fund that is identified as a &#147;U.S. Equity Fund&#148; in accordance with a
methodology agreed to between the Lending Agent and the Client, the Lending Agent Fee Percentage shall be nineteen percent (19%). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">With respect to a Group A Fund that is identified as an &#147;International Equity Fund&#148; in accordance
with a methodology agreed to between the Lending Agent and the Client, the Lending Agent Fee Percentage shall be fifteen percent (15%). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">With respect to a Group A Fund that is identified as a &#147;Fund of Funds&#148; in accordance with a
methodology agreed to between the Lending Agent and the Client, the Lending Agent Fee Percentage shall be fifteen percent (15%). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">App. A-1 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">d.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">With respect to a Group A Fund that is identified as a &#147;Fixed Income Fund&#148; in accordance with a
methodology agreed to between the Lending Agent and the Client, the Lending Agent Fee Percentage shall be fifteen percent (15%). </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The adjusted allocation shall become effective on incremental gross income starting on the next business day after the Multi-Asset Complex
Breakpoint is reached. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Client and the Lending Agent agree and acknowledge that no advisory fee is payable with respect to
management and investment of a Group A Fund&#146;s Cash Collateral in any joint account, fund or similar vehicle. The Lending Agent has agreed to cap the Cash Management Costs in respect of the investment of Cash Collateral in Money Market Series on
an annualized basis at 0.04% of the daily net asset value of Money Market Series. The cap on the Cash Management Costs may be raised or reduced upon mutual agreement between the Lending Agent and the Client. In the event that a Group A Fund directly
or indirectly bears any Cash Management Costs, as computed at least monthly by the Lending Agent or its designee, in excess of such cap, then such excess shall, without limitation, be deemed a transaction fee or other operational cost for which the
Lending Agent shall be responsible. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notwithstanding any of the foregoing, if the fee calculated pursuant to paragraphs 1, 2 and 3 of this Appendix
A would result in an effective fee split for a Group A Fund of less than seventy percent (70%) of the sum of such Group A Fund&#146;s securities lending income (after deducting the rebate to the Approved Borrowers) and Cash Management Costs for any
day (the &#147;Group A Funds Effective Fee Split Floor&#148;), then the Lending Agent&#146;s fees for such day shall be reduced to the extent necessary to provide such Group A Fund with the Group A Funds Effective Fee Split Floor.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">App. A-2 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Appendix B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Group B Funds </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">For the Funds in the Fixed-Income Complex identified on Schedule A as Fixed-Income Complex <FONT
STYLE="white-space:nowrap">Open-End</FONT> Funds &#150; Group B or Fixed-Income Complex <FONT STYLE="white-space:nowrap">Closed-End</FONT> Funds &#150; Group B (collectively, the &#147;Group B Funds&#148;), the Lending Agent Fee Percentage shall be
as set forth below: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">With respect to a Group B Fund that is identified as a &#147;U.S. Equity Fund&#148; in accordance with a
methodology agreed to between the Lending Agent and the Client, the Lending Agent Fee Percentage is nineteen percent (19%). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">With respect to a Group B Fund that is identified as an &#147;International Equity Fund&#148; in accordance
with a methodology agreed to between the Lending Agent and the Client, the Lending Agent Fee Percentage is eighteen percent (18%). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">With respect to a Group B Fund that is identified as a &#147;Fund of Funds&#148; in accordance with a
methodology agreed to between the Lending Agent and the Client, the Lending Agent Fee Percentage is eighteen percent (18%). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">d.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">With respect to a Group B Fund that is identified as a &#147;Fixed Income Fund&#148; in accordance with a
methodology agreed to between the Lending Agent and the Client, the Lending Agent Fee Percentage is eighteen percent (18%). </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The &#147;Fixed-Income Complex&#148; refers to all of the Funds currently or in the future overseen by a board of directors/trustees consisting
of the same individuals (or a subset thereof) who comprise the members of the boards of directors/trustees of the Group B Funds listed on Schedule A and the funds listed on Appendix D hereto. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notwithstanding the foregoing, if at any point during a calendar year, the aggregate gross revenues earned by
the funds in the Fixed-Income Complex prior to payment of compensation to the applicable lending agent exceed $3,700,000 (the &#147;Fixed-Income Complex Breakpoint&#148;), the Lending Agent Fee Percentage shall be equal to or reduced to, as
applicable, the following in allocating net income after the gross revenues for the calendar year equal the Fixed-Income Complex Breakpoint: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">With respect to a Group B Fund that is identified as a &#147;U.S. Equity Fund&#148; in accordance with a
methodology agreed to between the Lending Agent and the Client, the Lending Agent Fee Percentage shall be nineteen percent (19%). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">With respect to a Group B Fund that is identified as an &#147;International Equity Fund&#148; in accordance
with a methodology agreed to between the Lending Agent and the Client, the Lending Agent Fee Percentage shall be fifteen percent (15%). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">App. B-1 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">With respect to a Group B Fund that is identified as a &#147;Fund of Funds&#148; in accordance with a
methodology agreed to between the Lending Agent and the Client, the Lending Agent Fee Percentage shall be fifteen percent (15%). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">d.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">With respect to a Group B Fund that is identified as a &#147;Fixed Income Fund&#148; in accordance with a
methodology agreed to between the Lending Agent and the Client, the Lending Agent Fee Percentage shall be fifteen percent (15%). </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The adjusted allocation shall become effective on incremental gross income starting on the next business day after the Fixed-Income Complex
Breakpoint is reached. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Client and the Lending Agent agree and acknowledge that no advisory fee is payable with respect to
management and investment of a Group B Fund&#146;s Cash Collateral in any joint account, fund or similar vehicle. The Lending Agent has agreed to cap the Cash Management Costs in respect of the investment of Cash Collateral in Money Market Series on
an annualized basis at 0.04% of the daily net asset value of Money Market Series. The cap on the Cash Management Costs may be raised or reduced upon mutual agreement between the Lending Agent and the Client. In the event that a Group B Fund directly
or indirectly bears any Cash Management Costs, as computed at least monthly by the Lending Agent or its designee, in excess of such cap, then such excess shall, without limitation, be deemed a transaction fee or other operational cost for which the
Lending Agent shall be responsible. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notwithstanding any of the foregoing, if the fee calculated pursuant to paragraphs 1, 2 and 3 of this Appendix
B would result in an effective fee split for a Group B Fund of less than seventy percent (70%) of the sum of such Group B Fund&#146;s securities lending income (after deducting the rebate to the Approved Borrowers) and Cash Management Costs for any
day (the &#147;Group B Funds Effective Fee Split Floor&#148;), then the Lending Agent&#146;s fees for such day shall be reduced to the extent necessary to provide such Group B Fund with the Group B Funds Effective Fee Split Floor.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">App. B-2 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Appendix C </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Multi-Asset Complex <FONT STYLE="white-space:nowrap">Open-End</FONT> Funds* </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock ETF Trust </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Future
Climate and Sustainable Economy ETF </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Future Financial&nbsp;&amp; Technology ETF </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Future Health ETF </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Future Innovators ETF </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Future Tech ETF </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Future U.S. Themes ETF </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock U.S. Carbon Transition Readiness ETF </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock U.S. Equity Factor Rotation ETF </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock World ex U.S. Carbon Transition Readiness ETF </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock Funds<SUP STYLE="font-size:75%; vertical-align:top">SM</SUP></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">iShares Developed Real Estate Index Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">iShares Municipal Bond Index Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">iShares Russell <FONT STYLE="white-space:nowrap">Mid-Cap</FONT> Index Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">iShares Russell <FONT STYLE="white-space:nowrap">Small/Mid-Cap</FONT> Index Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">iShares Short-Term TIPS Bond Index Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">iShares Total U.S. Stock Market Index Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">iShares U.S. Long Credit Bond Index Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">iShares U.S. Intermediate Credit Bond Index Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">iShares U.S. Long Government Bond Index Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">iShares U.S. Intermediate Government Bond Index Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">iShares U.S. Securitized Bond Index Fund </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock Funds III </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Cash
Funds: Institutional </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Cash Funds: Treasury </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Dynamic Retirement Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Dynamic 2025 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Dynamic 2030 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Dynamic 2035 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Dynamic 2040 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Dynamic 2045 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Dynamic 2050 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Dynamic 2055 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Dynamic 2060 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Dynamic 2065 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> ESG Index Retirement Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> ESG Index 2025 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> ESG Index 2030 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> ESG Index 2035 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> ESG Index 2040 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> ESG Index 2045 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> ESG Index 2050 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> ESG Index 2055 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> ESG Index 2060 Fund
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">App. C-1 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> ESG Index 2065 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Index Retirement Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Index 2025 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Index 2030 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Index 2035 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Index 2040 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Index 2045 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Index 2050 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Index 2055 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Index 2060 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock LifePath<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Index 2065 Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">iShares MSCI Total International Index Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">iShares Russell 1000 <FONT STYLE="white-space:nowrap">Large-Cap</FONT> Index Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">iShares S&amp;P 500 Index Fund </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">iShares U.S. Aggregate Bond Index Fund </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock Index Funds, Inc. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">iShares MSCI
EAFE International Index Fund </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">iShares Russell 2000 <FONT STYLE="white-space:nowrap">Small-Cap</FONT> Index Fund </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Master Investment Portfolio </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Diversified
Equity Master Portfolio </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">International Tilts Master Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Large Cap Index Master Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Money Market Master Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">S&amp;P 500 Index Master Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Total International ex U.S. Index Master Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Treasury Money Market Master Portfolio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">U.S. Total Bond Index Master Portfolio </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Quantitative Master Series LLC </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Master
Small Cap Index Series </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><I>*</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Funds have alternative securities lending agency arrangement. </I></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">App. C-2 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Appendix D </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Fixed-Income Complex <FONT STYLE="white-space:nowrap">Open-End</FONT> Funds* </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock ETF Trust II </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock AAA CLO
ETF </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Floating Rate Loan ETF </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock High Yield Muni Income Bond ETF </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Intermediate Muni Income Bond ETF </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock Funds VI </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">BlackRock Advantage
CoreAlpha Bond Fund </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Master Investment Portfolio II </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Advantage CoreAlpha Bond Master Portfolio </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><I>*</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Funds have alternative securities lending agency arrangement. </I></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">App. D-1 </P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(L)(2)
<SEQUENCE>5
<FILENAME>d421862dex99l2.htm
<DESCRIPTION>OPINION AND CONSENT OF COUNSEL TO THE REGISTRANT
<TEXT>
<HTML><HEAD>
<TITLE>Opinion and Consent of Counsel to the Registrant</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Exhibit (l)(2) </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>M<SMALL>ORRIS</SMALL>, N<SMALL>ICHOLS</SMALL>, A<SMALL>RSHT</SMALL>&nbsp;&amp; T<SMALL>UNNELL</SMALL> <SMALL>LLP</SMALL> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1201 N<SMALL>ORTH</SMALL> M<SMALL>ARKET</SMALL> S<SMALL>TREET</SMALL> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">P.O. B<SMALL>OX</SMALL> 1347 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">W<SMALL>ILMINGTON</SMALL>, D<SMALL>ELAWARE</SMALL> 19899-1347 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(302) <FONT
STYLE="white-space:nowrap">658-9200</FONT> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(302) <FONT STYLE="white-space:nowrap">658-3989</FONT> FAX </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">January&nbsp;9, 2023 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Floating Rate
Income Trust </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">100 Bellevue Parkway </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Wilmington, Delaware
19809 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Re:&nbsp;&nbsp;&nbsp;&nbsp;<U>BlackRock Floating Rate Income Trust</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">We have acted as special
Delaware counsel to BlackRock Floating Rate Income Trust, a Delaware statutory trust (the &#147;Trust&#148;), in connection with certain matters of Delaware law relating to the issuance of up to 11,000,000 shares (the &#147;Offered Shares&#148;) of
the Trust&#146;s common shares of beneficial interest, par value $0.001 per share pursuant to the Registration Statement (as defined below). Capitalized terms used herein and not otherwise herein defined are used as defined in the Amended and
Restated Agreement and Declaration of Trust of the Trust dated as of May&nbsp;27, 2004 (the &#147;Governing Instrument&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
rendering this opinion, we have examined and relied on copies of the following documents in the forms provided to us: the Trust&#146;s Registration Statement on Form <FONT STYLE="white-space:nowrap">N-2</FONT> (Registration Nos. <FONT
STYLE="white-space:nowrap">333-266318</FONT> and <FONT STYLE="white-space:nowrap">811-21566)</FONT> as filed on July&nbsp;25, 2022 with the Securities and Exchange Commission (the &#147;Commission&#148;) under the Securities Act of 1933, as amended
(the &#147;Securities Act&#148;), and under the Investment Company Act of 1940, as amended (the &#147;Investment Company Act&#148;), as amended by <FONT STYLE="white-space:nowrap">Pre-Effective</FONT> Amendment No.&nbsp;1 under the Securities Act
and Amendment No.&nbsp;8 under the Investment Company Act on Form <FONT STYLE="white-space:nowrap">N-2/A</FONT> of the Trust as filed with the Commission on December&nbsp;28, 2022 (as so amended, the &#147;Registration Statement&#148;), including
the Prospectus of the Trust included in the Registration Statement (the &#147;Prospectus&#148;); the Prospectus Supplement of the Trust (the &#147;Prospectus Supplement&#148;), relating to the offering of the Offered Shares, in the form filed with
the Commission pursuant to Rule 424(b)(2) of the Securities Act Rules and Regulations on or about the date hereof; the <FONT STYLE="white-space:nowrap">Sub-Placement</FONT> Agent Agreement (the
<FONT STYLE="white-space:nowrap">&#147;Sub-Placement</FONT> Agent Agreement&#148;) dated on or about the date hereof between BlackRock Investments, LLC and UBS Securities LLC; the Distribution Agreement (the &#147;Distribution Agreement&#148; and
together with the <FONT STYLE="white-space:nowrap">Sub-Placement</FONT> Agent Agreement, the &#147;Agreements&#148; and each, individually, an &#147;Agreement&#148;) dated on or about the date hereof between the Trust and BlackRock Investments, LLC;
the Certificate of Trust of the Trust (then named &#147;BlackRock Variable Rate and Inflation Protected Securities Trust&#148;) as filed in the Office of the Secretary of State of the State of Delaware (the &#147;State Office&#148;) on
April&nbsp;20, 2004, as </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Floating Rate Income Trust </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">January 9, 2023 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 2
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
amended by the Certificate of Amendment thereto as filed in the State Office on May&nbsp;27, 2004, changing the name of the Trust from &#147;BlackRock Variable Rate and Inflation Protected
Securities Trust&#148; to &#147;BlackRock Global Floating Rate Income Trust&#148;, as further amended by the Certificate of Amendment thereto as filed in the State Office on March&nbsp;9, 2009, changing the name of the Trust from &#147;BlackRock
Global Floating Rate Income Trust&#148; to &#147;BlackRock Floating Rate Income Trust&#148; (as so amended, the &#147;Trust Certificate&#148;); resolutions of the Board of Trustees of the Trust prepared for adoption at a meeting held on February <FONT
STYLE="white-space:nowrap">17-18,</FONT> 2022 (the &#147;Resolutions&#148;); the Governing Instrument; the Agreement and Declaration of Trust of the Trust dated as of April&nbsp;20, 2004 (the &#147;Initial Governing Instrument&#148;); the Amended
and Restated Bylaws of the Trust effective as of October&nbsp;28, 2016, as amended by Amendment No.&nbsp;1 thereto dated as of November&nbsp;19, 2020 (as so amended, the &#147;Bylaws&#148; and, together with the Governing Instrument, the
Registration Statement (including the Prospectus), the Prospectus Supplement, the <FONT STYLE="white-space:nowrap">Sub-Placement</FONT> Agent Agreement, the Distribution Agreement, the Trust Certificate and the Resolutions, the &#147;Governing
Documents&#148;); an Officer&#146;s Certificate of the Trust dated on or about the date hereof; and a certification of good standing of the Trust obtained as of a recent date from the State Office. In such examinations, we have assumed the
genuineness of all signatures, the conformity to original documents of all documents submitted to us as drafts or copies or forms of documents to be executed and the legal capacity of natural persons to complete the execution of documents. We have
further assumed for purposes of this opinion: (i)&nbsp;except to the extent set forth in our opinion in paragraph 1 below, the due formation or organization, valid existence and good standing of each entity that is a party to any of the documents
reviewed by us under the laws of the jurisdiction of its respective formation or organization; (ii)&nbsp;the due authorization, adoption, execution and delivery by, or on behalf of, each of the parties thereto (other than the Trust) of the
above-referenced documents; (iii)&nbsp;that the Trust has and will comply with all Fundamental Policies in connection with conducting its business as described in the Governing Documents; (iv)&nbsp;that the appropriate notation of the names and
addresses of, the number of Shares held by, and the consideration paid by, Shareholders will be maintained in the appropriate registers and other books and records of the Trust in connection with the issuance or transfer of Shares; (v)&nbsp;the
taking of all appropriate action by the Trustees to designate the series and classes of the Shares and the rights and preferences attributable thereto as contemplated by the Governing Instrument; (vi)&nbsp;that the required consideration for the
Shares (including the Offered Shares) has been or will be paid, and the Shares (including the Offered Shares) have been or will be issued, in accordance with the terms, conditions, requirements and procedures of the Initial Governing Instrument and
the Governing Documents, as applicable; (vii)&nbsp;that the activities of the Trust have been and will be conducted in accordance with the terms of the Governing Instrument and the Delaware Statutory Trust Act, 12 <U>Del.</U> <U>C.</U>
&#167;&nbsp;3801 <U>et</U> <U>seq.</U> (the &#147;Delaware Act&#148;); and (viii)&nbsp;that each of the documents examined by us is in full force and effect, expresses the entire understanding of the parties thereto with respect to the subject
matter thereof and has not been amended, supplemented or otherwise modified, except as herein referenced. We have not reviewed any documents other than those identified above in connection with this opinion, and we have assumed that there are no
documents, facts or circumstances that are contrary to or inconsistent with the opinions expressed herein. No opinion is expressed with respect to the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;2&nbsp;- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Floating Rate Income Trust </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">January 9, 2023 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 3
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
requirements of, or compliance with, federal or state securities or blue sky laws. In addition, we express no opinion with respect to the Registration Statement (including the Prospectus), or any
other offering materials relating to any Shares. As to any fact material to our opinions, other than those assumed, we have relied without independent investigation on the above-referenced documents and on the accuracy, as of the date hereof, of the
matters therein contained. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Based on and subject to the foregoing, and limited in all respects to matters of Delaware law, it is our
opinion that: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.&nbsp;&nbsp;&nbsp;&nbsp;The Trust is a duly formed Delaware statutory trust, validly existing and in good standing under
the laws of the State of Delaware with requisite statutory trust power and authority to own, lease and operate its properties and to conduct its business as described in the Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.&nbsp;&nbsp;&nbsp;&nbsp;The Offered Shares have been duly authorized by the Trust for issuance and, when duly entered into the stock record
books of the Trust and issued and delivered by the Trust in accordance with the terms, conditions, requirements and procedures set forth in the Governing Documents against payment therefor of the consideration set forth in the Agreements, will be
validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> Shares (except to the extent that under Section&nbsp;3.8 of the Governing Instrument, the Trustees have the power to cause each Shareholder to pay directly, in
advance or arrears, for charges of distribution, of the custodian, transfer, Shareholder servicing or similar agent, a pro rata amount as defined from time to time by the Trustees, by setting off such charges due from such Shareholder from declared
but unpaid dividends or distributions owed such Shareholder and/or by reducing the number of Shares in the account of such Shareholder by that number of full and/or fractional Shares which represents the outstanding amount of such charges due from
such Shareholder). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.&nbsp;&nbsp;&nbsp;&nbsp;Under the Governing Instrument and the Delaware Act, the issuance of the Offered Shares is
not subject to any preemptive rights or any other similar rights of the Shareholders to subscribe to any additional Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">We hereby
consent to being named in the Prospectus Supplement, to the discussion of this opinion in the Prospectus Supplement and to the filing of a copy of this opinion with the Commission as an exhibit to the Registration Statement. In giving this consent,
we do not hereby admit that we come within the category of persons whose consent is required under Section&nbsp;7 of the Securities Act or the rules and regulations of the Commission thereunder. This opinion speaks only as of the date hereof and is
based on our understandings and assumptions as to present facts, and on the application of Delaware law as the same exist on the date hereof, and we undertake no obligation to update or supplement this opinion after the date hereof for the benefit
of any person or entity (including any Shareholder or any person or entity granted reliance in the following sentence) with respect to any facts or circumstances that may hereafter come to our attention or any changes in facts or law that may
hereafter occur or take effect. This opinion is intended solely for the benefit of the Trust and the Shareholders in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;3&nbsp;- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BlackRock Floating Rate Income Trust </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">January 9, 2023 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 4
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
connection with the matters contemplated hereby and may not be relied upon by any other person or entity, or for any other purpose, without our prior written consent; provided, that in the event
that Willkie Farr&nbsp;&amp; Gallagher LLP delivers its opinion to the Trust on or about the date hereof, which opinion addresses any matters of Delaware law addressed herein, it may rely on this opinion in connection therewith. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">MORRIS, NICHOLS, ARSHT&nbsp;&amp; TUNNELL LLP</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Louis G. Hering</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Louis G. Hering</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-&nbsp;4&nbsp;- </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(R)
<SEQUENCE>6
<FILENAME>d421862dex99r.htm
<DESCRIPTION>CODE OF ETHICS OF THE REGISTRANT
<TEXT>
<HTML><HEAD>
<TITLE>Code of Ethics of the Registrant</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Code of Ethics for Fund Access Persons </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>April&nbsp;1, 2021 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BlackRock </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Code of Ethics for Fund Access Persons </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Effective
Date: April&nbsp;1, 2021 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Applies to the following types of Funds registered under the 1940 Act: </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">Open-End</FONT> Mutual Funds (excluding money-market funds)
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Money Market Funds </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">ETFs </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">Closed-End</FONT> Funds </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Business Development Companies </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Objective and Scope </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The purpose of this Code of Ethics
(the &#147;Code&#148;) is to prevent Access Persons (as defined below) of BlackRock open- and <FONT STYLE="white-space:nowrap">closed-end</FONT> funds, exchange traded funds and business development companies (each a &#147;Fund&#148; and
collectively, the &#147;Funds&#148;) from engaging in any act, practice or course of business prohibited by paragraph (b)&nbsp;of Rule <FONT STYLE="white-space:nowrap">17j-1</FONT> (the &#147;Rule&#148;) under the Investment Company Act of 1940, as
amended (the &#147;1940 Act&#148;). This Code is required by paragraph (c)&nbsp;of the Rule. A copy of the Rule is attached to this Code as Appendix A. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Summary </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Access Persons (as defined below) of
the Funds, in conducting their personal securities transactions, owe a fiduciary duty to the Funds. The fundamental standard to be followed in personal securities transactions is that Access Persons may not take inappropriate advantage of their
positions. All personal securities transactions by Access Persons must be conducted in such a manner as to avoid any actual or potential conflict of interest between the Access Person&#146;s interest and the interests of the Funds, or any abuse of
an Access Person&#146;s position of trust and responsibility. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Policy / Document Requirements and Statements </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Introduction </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Potential conflicts arising from personal investment activities could include buying or selling securities based on knowledge of a Fund&#146;s trading position
or plans (sometimes referred to as front-running), and acceptance of personal favors that could influence trading judgments on behalf of the Fund. While this Code is designed to address identified conflicts and potential conflicts, it cannot
possibly be written broadly enough to cover all potential situations and, in this regard, Access Persons are expected to adhere not only to the letter, but also the spirit, of the policies contained herein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>BlackRock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Public</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">1</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Confidential Information </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In order to understand how this Code applies to particular persons and transactions, familiarity with the key terms and concepts used in this Code is
necessary. Those key terms and concepts are: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>2.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;Access Person&#148; with respect to a Fund means any Advisory Person of the Fund, BlackRock or a
Subadviser. Those persons who may be considered Access Persons of the Funds include those listed on attached Appendix B to this Code and will be updated from time to time. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>2.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;Advisory Person&#148; means: (a)&nbsp;any director or advisory board<SUP
STYLE="font-size:75%; vertical-align:top">1</SUP> member, officer, general partner or employee of a Fund, BlackRock or a Subadviser or of any company in a control relationship to the Fund, BlackRock or a Subadviser, who, in connection with his or
her regular functions or duties, makes, participates in, or obtains information regarding, the purchase or sale of a Covered Security by the Fund, or whose functions relate to the making of any recommendations with respect to such purchases or
sales; and (b)&nbsp;any natural person in a control relationship to the Fund, BlackRock or a Subadviser who obtains information concerning recommendations made to the Fund with regard to the purchase or sale of Covered Securities by the Fund.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>2.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;Automatic Investment Plan&#148; means a program in which regular periodic purchases (or withdrawals) are
made automatically in (or from) investment accounts in accordance with a predetermined schedule and allocation. An Automatic Investment Plan includes a dividend reinvestment plan. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>2.4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;Beneficial ownership&#148; has the meaning set forth in Rule
<FONT STYLE="white-space:nowrap">16a-1(a)(2)</FONT> under the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), a copy of which is included as Appendix C. The determination of direct or indirect beneficial ownership shall
apply to all securities which an Access Person has or acquires. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>2.5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;BRIL&#148; means BlackRock Investments, LLC, each <FONT STYLE="white-space:nowrap">open-end</FONT>
Fund&#146;s principal underwriter and the principal underwriter of certain <FONT STYLE="white-space:nowrap">closed-end</FONT> Funds. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>2.6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;BlackRock&#148; means persons controlling, controlled by or under common control with BlackRock, Inc.
that act as investment adviser or subadviser to the Funds. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>2.7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;Board&#148; means, collectively, the boards of directors or trustees of the Funds. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>2.8.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;PTP&#148; means the Personal Trading Policy adopted by BlackRock and BRIL and approved by the Board.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>2.9.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;control&#148; has the meaning set forth in Section&nbsp;2(a)(9) of the 1940 Act. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>2.10.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;Covered Security&#148; has the meaning set forth in Section&nbsp;2(a)(36) of the 1940 Act, except that it
shall not include: direct obligations of the U.S. Government; bankers&#146; acceptances, </P></TD></TR></TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As defined in Section&nbsp;2(a)(1) of the 1940 Act
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>BlackRock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Public</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">2</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
bank certificates of deposit, commercial paper, and high-quality short-term debt instruments, including repurchase agreements; and shares issued by registered
<FONT STYLE="white-space:nowrap">open-end</FONT> investment companies. A high-quality short-term debt instrument is one with a maturity at issuance of less than 366 days and that is rated in one of the two highest rating categories by a nationally
recognized statistical rating organization. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>2.11.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;Independent Director&#148; means a director or trustee of a Fund who is not an &#147;interested
person&#148; of the Fund within the meaning of<BR> Section&nbsp;2(a)(19) of the 1940 Act. All provisions of this Code applicable to Independent Directors will also be applicable to advisory board members. </P></TD>
<TD WIDTH="2%">&nbsp;</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>2.12.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;Investment Personnel&#148; of a Fund, BlackRock or a Subadviser means: (a)&nbsp;any employee of the Fund,
BlackRock, or a Subadviser (or of any company in a control relationship to the Fund, BlackRock, or a Subadviser) who, in connection with his or her regular functions or duties, makes or participates in making recommendations regarding the purchase
or sale of securities by the Fund and (b)&nbsp;any natural person who controls the Fund, BlackRock, or a Subadviser and who obtains information concerning recommendations made to the Fund regarding the purchase or sale of securities by the Fund.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>2.13.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;IPO&#148; means an offering of securities registered under the Securities Act of 1933, as amended (the
&#147;1933 Act&#148;) the issuer of which, immediately before the registration, was not subject to the reporting requirements of Section&nbsp;13 or 15(d) of the Exchange Act. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>2.14.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;Limited Offering&#148; means an offering exempt from registration under the 1933 Act pursuant to
Section&nbsp;4(a)(2) or 4(a)(5) or Rule 504, 505, or 506 under the 1933 Act. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>2.15.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;Purchase or sale of a Covered Security&#148; includes, among other things, the writing of an option to
purchase or sell a Covered Security. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>2.16.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;Subadviser&#148; means any investment adviser to a Fund that does not control, is not controlled by, and
is not under common control with, BlackRock and to whom BlackRock delegates certain investment management responsibilities. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Restrictions Applicable to Directors, Officers and Employees of BlackRock and BRIL
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>3.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">All Access Persons of BlackRock&#146;s investment advisory companies and BRIL shall be subject to the
restrictions, limitations and reporting responsibilities set forth in the PTP, as if fully set forth herein. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>3.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Persons subject to this Section&nbsp;3 shall not be subject to the restrictions, limitations and reporting
responsibilities set forth in Sections 4 and 5 below. In particular, an Access Person of BlackRock&#146;s investment advisory companies need not make a separate report under this Code to the extent the information would duplicate information
required to be recorded under Rule <FONT STYLE="white-space:nowrap">204-2(a)(13)</FONT> under the Investment Advisers Act of 1940, as amended. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>3.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any Access Person of a Subadviser shall not be subject to this Code, so long as such Access Person is subject
to a code of ethics duly adopted by the Subadviser relating to personal securities transactions by such Access Person, provided that such code of ethics complies with the requirements of the Rule and has been approved by the Board.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>BlackRock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Public</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">3</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><FONT STYLE="white-space:nowrap">Pre-Approval</FONT> of Investments in Initial Public Offerings or Limited
Offerings </B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With respect to purchases of securities (including, but not limited to, any Covered Security) issued in an IPO or a
Limited Offering, all Access Persons of BlackRock&#146;s investment advisory companies are subject to the restrictions, limitations, and reporting responsibilities set forth in the PTP and in addition, with respect to Limited Offerings, the Global
Employee Private Investment Policy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No Investment Personnel shall purchase any security (including, but not limited to, any Covered Security) issued in
an IPO or a Limited Offering unless permitted by Legal&nbsp;&amp; Compliance in advance. The Chief Compliance Officer (&#147;CCO&#148;) of the Funds shall maintain a written record of any decisions to permit these transactions, along with the
reasons supporting the decision. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Reporting </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>5.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Initial Holdings Reports </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No later than ten days after a person becomes an Access Person, he or she must report to Legal&nbsp;&amp; Compliance the following information (which
information must be current as of a date no more than 45 days prior to the date the person becomes an Access Person): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the title, number of shares and principal amount of each Covered Security in which the Access Person had any
direct or indirect beneficial ownership when the person became an Access Person; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the name of any broker, dealer or bank with whom the Access Person maintained an account in which any
securities were held for the direct or indirect benefit of the Access Person as of the date the person became an Access Person; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the date that the report is submitted by the Access Person. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>5.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Quarterly Reporting </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">5.2.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Every Access Person shall either report to Legal&nbsp;&amp; Compliance the information described in paragraphs
5.2.2 and 5.2.3 below with respect to transactions in any Covered Security in which the Access Person has, or by reason of the transaction acquires, any direct or indirect beneficial ownership or, in the alternative, make the representation in
Section&nbsp;5.2.4 below. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">5.2.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Every report shall be made not later than 30 days after the end of the calendar quarter in which the
transaction to which the report relates was effected and shall contain the following information: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the date of the transaction, the title, the interest rate and maturity date (if applicable), the number of
units, and the principal amount of each Covered Security involved; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>BlackRock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Public</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">4</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the nature of the transaction (i.e., purchase, sale or any other type of acquisition or disposition);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the price at which the transaction was effected; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">d.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the name of the broker, dealer, or bank with or through whom the transaction was effected;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">e.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the date that the report is submitted by the Access Person; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">f.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a description of any factors potentially relevant to an analysis of whether the Access Person may have a
conflict of interest with respect to the transaction, including the existence of any substantial economic relationship between the transaction and securities held or to be acquired by a Fund. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">5.2.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Upon establishing any account in which any securities are held for the direct or indirect benefit of the Access
Person, an Access Person shall provide a report to Legal&nbsp;&amp; Compliance containing the following information: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the name of the broker, dealer or bank with whom the Access Person established the account;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the date the account was established; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the date that the report is submitted by the Access Person. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">5.2.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If no transactions were conducted by an Access Person during a calendar quarter that are subject to the
reporting requirements described above, such Access Person shall, not later than 30 days after the end of that calendar quarter, provide a written representation to that effect to the Funds. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>5.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Annual Reporting </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">5.3.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Every Access Person shall report to each Fund the information described in Section&nbsp;5.3.2 below with
respect to transactions in any Covered Security in which the Access Person has, or by reason of the transaction acquires, any direct or indirect beneficial ownership in the security. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">5.3.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Annually, an Access Person shall provide a report to each Fund containing the following information (which
information must be current as of a date no more than 45 days before the report is submitted): </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the title, number of shares and principal amount of each Covered Security in which the Access Person had any
direct or indirect beneficial ownership; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the name of any broker, dealer or bank with whom the Access Person maintains an account in which any securities
are held for the direct or indirect benefit of the Access Person; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the date that the report is submitted by the Access Person. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>5.4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Exceptions to Reporting Requirements </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">5.4.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">An Access Person is not required to make a report otherwise required under Sections 5.1, 5.2 and 5.3 above with
respect to any transaction effected for any </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>BlackRock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Public</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">5</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
account over which the Access Person does not have any direct or indirect influence or control; provided, however, that if the Access Person is relying upon the provisions of this
Section&nbsp;5.4.1 to avoid making such a report, the Access Person shall, not later than 30 days after the end of each calendar quarter, identify any such account in writing and certify in writing that he or she had no direct or indirect influence
over any such account. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">5.4.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">An Access Person is not required to make a report otherwise required under Section&nbsp;5.2 above with respect
to transactions effected pursuant to an Automatic Investment Plan. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">5.4.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">An Independent Director of a Fund (which for purposes of this Section shall include an advisory board member)
who would be required to make a report pursuant to Sections 5.1, 5.2 and 5.3 above, solely by reason of being a board member of the Fund, is not required to make an initial holdings report under Section&nbsp;5.1 above and an annual report under
Section&nbsp;5.3 above, and is only required to make a quarterly report under Section&nbsp;5.2 above, with respect to a transaction in a Covered Security, if the Independent Director knew or, in the ordinary course of fulfilling the Independent
Director&#146;s official duties as a board member of the Fund, should have known that: (a)&nbsp;the Fund has engaged in a transaction in the same security within the last 15 days of such Independent Director&#146;s transaction in such Covered
Security or is engaging or going to engage in a transaction in the same security within the next 15 days of such Independent Director&#146;s transaction in such Covered Security; or (b)&nbsp;the Fund or BlackRock has within the last 15 days of such
Independent Director&#146;s transaction in such Covered Security considered a transaction in the same security or is considering a transaction in the same security or within the next 15 days of such Independent Director&#146;s transaction in such
Covered Security is going to consider a transaction in the same security. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>5.5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Annual Certification </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">5.5.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">All Access Persons are required to certify that they have read and understand this Code and recognize that they
are subject to the provisions hereof and will comply with the policy and procedures stated herein. Further, all Access Persons are required to certify annually that they have complied with the requirements of this Code and that they have reported
all personal securities transactions required to be disclosed or reported pursuant to the requirements of such policies. A copy of the certification form to be used in complying with this Section&nbsp;5.5.1 is attached to this Code as Appendix D.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">5.5.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Each Fund, BlackRock and BRIL shall prepare an annual report to the Board to be presented to the Board each
year and which shall: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">summarize existing procedures concerning personal investing, including preclearance policies and the monitoring
of personal investment activity after preclearance has been granted, and any material changes in the procedures during the past year; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>BlackRock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Public</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">6</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">describe any issues arising under this Code or procedures since the last report to the Board including, but not
limited to, information about any material violations of this Code or procedures and the sanctions imposed during the past year; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">identify any recommended changes in existing restrictions or procedures based upon experience under this Code,
evolving industry practice or developments in applicable laws and regulations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">d.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">contain such other information, observations and recommendations as deemed relevant by such Fund, BlackRock or
BRIL; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">e.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">certify that such Fund, BlackRock and BRIL have adopted this Code with procedures reasonably necessary to
prevent Access Persons from violating the provisions of Rule <FONT STYLE="white-space:nowrap">17j-1(b)</FONT> or this Code. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>5.6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Notification of Reporting Obligation and Review of Reports </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each Access Person shall receive a copy of this Code and be notified of his or her reporting obligations. All reports shall be promptly submitted upon
completion to the Funds&#146; CCO who shall review such reports. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>5.7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Miscellaneous </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any report under this Code may contain a statement that the report shall not be construed as an admission by the person making the report that the person has
any direct or indirect beneficial ownership in the securities to which the report relates. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Recordkeeping Requirements </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each Fund shall maintain, at its principal place of business, records in the manner and to the extent set out below, which records shall be available for
examination by representatives of the Securities and Exchange Commission (the &#147;SEC&#148;). </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>6.1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As long as this Code is in effect, a copy of it (and any version thereof that was in effect within the past
five years) shall be preserved in an easily accessible place. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>6.2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The following records must be maintained in an easily accessible place for five years after the end of the
fiscal year in which the event took place: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a record of any violation of this Code, and of any action taken as a result of the violation;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a record of all persons, currently or within the past five years, who are or were required to make reports
under Section&nbsp;5, or who are or were responsible for reviewing these reports; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a record of any decision, and the reasons supporting the decision, to approve the acquisition by Investment
Personnel of securities under Section&nbsp;4. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>BlackRock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Public</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">7</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>6.3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The following records must be maintained for five years after the end of the fiscal year in which the event
took place, the first two years in an easily accessible place: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a copy of each report made by an Access Person pursuant to this Code, including any information required by
Section&nbsp;5.4.1 in lieu of such reports; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a copy of each annual report submitted by each Fund, BlackRock and BRIL to the Board. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Confidentiality </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No Access Person shall reveal to any other person (except in the normal course of his or her duties on behalf of a Fund) any information regarding securities
transactions by a Fund or consideration by a Fund or BlackRock of any such securities transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All information obtained from any Access Person
hereunder shall be kept in strict confidence, except that reports of securities transactions hereunder will be made available to the SEC or any other regulatory or self-regulatory organization to the extent required by law or regulation. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>8.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Sanctions </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon discovering a violation of this Code, Legal&nbsp;&amp; Compliance reviews the violation and imposes appropriate sanctions. In addition, the Board may
impose any sanctions it deems appropriate, including a letter of censure, the suspension or termination of any officer or employee of a Fund or BlackRock, or the recommendation to the employer of the violator of the suspension or termination of the
employment of the violator. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>BlackRock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Public</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">8</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>DEFINITIONS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of this section: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Access Person means: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any Advisory Person of a Fund or of a Fund&#146;s investment adviser. If an investment adviser&#146;s primary
business is advising Funds or other advisory clients, all of the investment adviser&#146;s directors, officers, and general partners are presumed to be Access Persons of any Fund advised by the investment adviser. All of a Fund&#146;s directors,
officers, and general partners are presumed to be Access Persons of the Fund. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">B.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any director, officer or general partner of a principal underwriter who, in the ordinary course of business,
makes, participates in or obtains information regarding, the purchase or sale of Covered Securities by the Fund for which the principal underwriter acts, or whose functions or duties in the ordinary course of business relate to the making of any
recommendation to the Fund regarding the purchase or sale of Covered Securities. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Advisory Person of a Fund or of a Fund&#146;s investment adviser means: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any director, officer, general partner or employee of the Fund or investment adviser (or of any company in a
control relationship to the Fund or investment adviser) who, in connection with his or her regular functions or duties, makes, participates in, or obtains information regarding, the purchase or sale of Covered Securities by a Fund, or whose
functions relate to the making of any recommendations with respect to such purchases or sales; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">B.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any natural person in a control relationship to the Fund or investment adviser who obtains information
concerning recommendations made to the Fund with regard to the purchase or sale of Covered Securities by the Fund. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Control has the same meaning as in section 2(a)(9) of the Act. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Covered Security means a security as defined in section 2(a)(36) of the Act, except that it does not include:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Direct obligations of the Government of the United States; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">B.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Bankers&#146; acceptances, bank certificates of deposit, commercial paper and high quality short-term debt
instruments, including repurchase agreements; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">C.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Shares issued by <FONT STYLE="white-space:nowrap">open-end</FONT> Funds. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>BlackRock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Public</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">9</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fund means an investment company registered under the Investment Company Act. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">An Initial Public Offering means an offering of securities registered under the Securities Act of 1933, the
issuer of which, immediately before the registration, was not subject to the reporting requirements of sections 13 or 15(d) of the Securities Exchange Act of 1934. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Investment Personnel of a Fund or of a Fund&#146;s investment adviser means: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any employee of the Fund or investment adviser (or of any company in a control relationship to the Fund or
investment adviser) who, in connection with his or her regular functions or duties, makes or participates in making recommendations regarding the purchase or sale of securities by the Fund. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">B.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any natural person who controls the Fund or investment adviser and who obtains information concerning
recommendations made to the Fund regarding the purchase or sale of securities by the Fund. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A Limited Offering means an offering that is exempt from registration under the Securities Act of 1933 pursuant
to section 4(a)(2) or section 4(a)(5) or pursuant to rule 504, or rule 506 under the Securities Act of 1933. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Purchase or sale of a Covered Security includes, among other things, the writing of an option to purchase or
sell a Covered Security. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Security Held or to be Acquired by a Fund means: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any Covered Security which, within the most recent 15 days: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Is or has been held by the Fund; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Is being or has been considered by the Fund or its investment adviser for purchase by the Fund; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">B.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any option to purchase or sell, and any security convertible into or exchangeable for, a Covered Security
described in paragraph (1)(10)(A) of this section. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">11.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Automatic Investment Plan means a program in which regular periodic purchases (or withdrawals) are made
automatically in (or from) investment accounts in accordance with a predetermined schedule and allocation. An Automatic Investment Plan includes a dividend reinvestment plan. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>BlackRock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Public</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">10</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>UNLAWFUL ACTIONS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">It is unlawful for any affiliated person of or principal underwriter for a Fund, or any affiliated person of an investment adviser of or principal underwriter
for a Fund, in connection with the purchase or sale, directly or indirectly, by the person of a Security Held or to be Acquired by the Fund: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To employ any device, scheme or artifice to defraud the Fund; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To make any untrue statement of a material fact to the Fund or omit to state a material fact necessary in order
to make the statements made to the Fund, in light of the circumstances under which they are made, not misleading; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To engage in any act, practice or course of business that operates or would operate as a fraud or deceit on the
Fund; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To engage in any manipulative practice with respect to the Fund. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>CODE OF ETHICS </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Adoption and Approval of Code of Ethics. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Every Fund (other than a money market fund or a Fund that does not invest in Covered Securities) and each
investment adviser of and principal underwriter for the Fund, must adopt a written code of ethics containing provisions reasonably necessary to prevent its Access Persons from engaging in any conduct prohibited by paragraph (II)&nbsp;of this
section. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">B.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The board of directors of a Fund, including a majority of directors who are not interested persons, must
approve the code of ethics of the Fund, the code of ethics of each investment adviser and principal underwriter of the Fund, and any material changes to these codes. The board must base its approval of a code and any material changes to the code on
a determination that the code contains provisions reasonably necessary to prevent Access Persons from engaging in any conduct prohibited by paragraph (II)&nbsp;of this section. Before approving a code of a Fund, investment adviser or principal
underwriter or any amendment to the code, the board of directors must receive a certification from the Fund, investment adviser or principal underwriter that it has adopted procedures reasonably necessary to prevent Access Persons from violating the
Funds, investment adviser&#146;s, or principal underwriter&#146;s code of ethics. The Fund&#146;s board must approve the code of an investment adviser or principal underwriter before initially retaining the services of the investment adviser or
principal underwriter. The Fund&#146;s board must approve a material change to a code no later than six months after adoption of the material change. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">C.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If a Fund is a unit investment trust, the Fund&#146;s principal underwriter or depositor must approve the
Fund&#146;s code of ethics, as required by paragraph (III)(1)(B) of this section. If the Fund has more than one principal underwriter or depositor, the principal underwriters and depositors may designate, in writing, which principal underwriter or
depositor must conduct the approval required by paragraph<BR> (III)(1)(B) of this section, if they obtain written consent from the designated principal underwriter or depositor. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>BlackRock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Public</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">11</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Administration of Code of Ethics. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Fund, investment adviser and principal underwriter must use reasonable diligence and institute procedures
reasonably necessary to prevent violations of its code of ethics. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">B.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No less frequently than annually, every Fund (other than a unit investment trust) and its investment advisers
and principal underwriters must furnish to the Fund&#146;s board of directors, and the board of directors must consider, a written report that: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Describes any issues arising under the code of ethics or procedures since the last report to the board of
directors, including, but not limited to, information about material violations of the code or procedures and sanctions imposed in response to the material violations; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Certifies that the Fund, investment adviser or principal underwriter, as applicable, has adopted procedures
reasonably necessary to prevent Access Persons from violating the code. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Exception for Principal Underwriters. The requirements of paragraphs (III)(1) and (III)(2) of this section
do not apply to any principal underwriter unless: </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The principal underwriter is an affiliated person of the Fund or of the Fund&#146;s investment adviser; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">B.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">An officer, director or general partner of the principal underwriter serves as an officer, director or general
partner of the Fund or of the Fund&#146;s investment adviser. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>REPORTING REQUIREMENTS OF ACCESS PERSONS </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Reports Required. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless excepted by paragraph (IV)(2) of this section, every Access Person of a Fund (other than a money market fund or a Fund that does not invest in Covered
Securities) and every Access Person of an investment adviser of or principal underwriter for the Fund, must report to that Fund, investment adviser or principal underwriter: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Initial Holdings Reports. No later than 10 days after the person becomes an Access Person (which information
must be current as of a date no more than 45 days prior to the date the person becomes an Access Person): </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The title, number of shares and principal amount of each Covered Security in which the Access Person had any
direct or indirect beneficial ownership when the person became an Access Person; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The name of any broker, dealer or bank with whom the Access Person maintained an account in which any
securities were held for the direct or indirect benefit of the Access Person as of the date the person became an Access Person; and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>BlackRock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Public</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">12</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The date that the report is submitted by the Access Person. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Quarterly Transaction Reports. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">No later than 30 days after the end of a calendar quarter, the following information: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">With respect to any transaction during the quarter in a Covered Security in which the Access Person had any
direct or indirect beneficial ownership: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The date of the transaction, the title, the interest rate and maturity date (if applicable), the number of
shares and the principal amount of each Covered Security involved; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The nature of the transaction (i.e., purchase, sale or any other type of acquisition or disposition);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The price of the Covered Security at which the transaction was effected; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The name of the broker, dealer or bank with or through which the transaction was effected; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The date that the report is submitted by the Access Person. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">B.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">With respect to any account established by the Access Person in which any securities were held during the
quarter for the direct or indirect benefit of the Access Person: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The name of the broker, dealer or bank with whom the Access Person established the account;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The date the account was established; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The date that the report is submitted by the Access Person. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Annual Holdings Reports. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Annually, the following information (which information must be current as of a date no more than 45 days before
the report is submitted): </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The title, number of shares and principal amount of each Covered Security in which the Access Person had any
direct or indirect beneficial ownership; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The name of any broker, dealer or bank with whom the Access Person maintains an account in which any securities
are held for the direct or indirect benefit of the Access Person; and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>BlackRock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Public</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">13</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The date that the report is submitted by the Access Person. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Exceptions from Reporting Requirements. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A person need not make a report under paragraph (IV)(1) of this section with respect to transactions effected
for, and Covered Securities held in, any account over which the person has no direct or indirect influence or control. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">B.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A director of a Fund who is not an &#147;interested person&#148; of the Fund within the meaning of section
2(a)(19) of the Act, and who would be required to make a report solely by reason of being a Fund director, need not make: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">An initial holdings report under paragraph (IV)(1)(A) of this section and an annual holdings report under
paragraph (IV)(1)(C) of this section; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A quarterly transaction report under paragraph (IV)(1)(B) of this section, unless the director knew or, in the
ordinary course of fulfilling his or her official duties as a Fund director, should have known that during the <FONT STYLE="white-space:nowrap">15-day</FONT> period immediately before or after the director&#146;s transaction in a Covered Security,
the Fund purchased or sold the Covered Security, or the Fund or its investment adviser considered purchasing or selling the Covered Security. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">C.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">An Access Person to a Fund&#146;s principal underwriter need not make a report to the principal underwriter
under paragraph (IV)(1) of this section if: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The principal underwriter is not an affiliated person of the Fund (unless the Fund is a unit investment trust)
or any investment adviser of the Fund; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The principal underwriter has no officer, director or general partner who serves as an officer, director or
general partner of the Fund or of any investment adviser of the Fund. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">D.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">An Access Person to an investment adviser need not make a separate report to the investment adviser under
paragraph (IV)(1) of this section to the extent the information in the report would duplicate information required to be recorded under &#167; <FONT STYLE="white-space:nowrap">275.204-2(a)(13)</FONT> of this chapter. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">E.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">An Access Person need not make a quarterly transaction report under paragraph (IV)(1)(B) of this section if the
report would duplicate information contained in broker trade confirmations or account statements received by the Fund, investment adviser or principal underwriter with respect to the Access Person in the time period required by paragraph (IV)(1)(B),
if all of the information required by that paragraph is contained in the broker trade confirmations or account statements, or in the records of the Fund, investment adviser or principal underwriter. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>BlackRock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Public</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">14</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">F.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">An Access Person need not make a quarterly transaction report under paragraph (IV)(1)(B) of this section with
respect to transactions effected pursuant to an Automatic Investment Plan. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Review of Reports. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">Each Fund, investment adviser and principal underwriter to which reports are required to be made by paragraph (IV)(1) of this section must
institute procedures by which appropriate management or compliance personnel review these reports. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Notification of Reporting Obligation. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">Each Fund, investment adviser and principal underwriter to which reports are required to be made by paragraph (IV)(1) of this section must
identify all Access Persons who are required to make these reports and must inform those Access Persons of their reporting obligation. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Beneficial Ownership. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">For purposes of this section, beneficial ownership is interpreted in the same manner as it would be under Rule
<FONT STYLE="white-space:nowrap">16a-</FONT> 1(a)(2) of this chapter in determining whether a person is the beneficial owner of a security for purposes of section 16 of the Securities Exchange Act of 1934 and the rules and regulations thereunder.
Any report required by paragraph (IV)&nbsp;of this section may contain a statement that the report will not be construed as an admission that the person making the report has any direct or indirect beneficial ownership in the Covered Security to
which the report relates. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">PRE-APPROVAL</FONT> OF INVESTMENTS IN IPOS AND LIMITED OFFERINGS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investment Personnel of a Fund or its investment adviser must obtain approval from the Fund or the Fund&#146;s investment adviser before directly or indirectly
acquiring beneficial ownership in any securities in an Initial Public Offering or in a Limited Offering. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>RECORDKEEPING REQUIREMENTS </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>Each Fund, investment adviser and principal underwriter that is required to adopt a code of ethics or to
which reports are required to be made by Access Persons must, at its principal place of business, maintain records in the manner and to the extent set out in this paragraph (VI), and must make these records available to the Commission or any
representative of the Commission at any time and from time to time for reasonable periodic, special or other examination: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A copy of each code of ethics for the organization that is in effect, or at any time within the past five years
was in effect, must be maintained in an easily accessible place; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>BlackRock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Public</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">15</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">B.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A record of any violation of the code of ethics, and of any action taken as a result of the violation, must be
maintained in an easily accessible place for at least five years after the end of the fiscal year in which the violation occurs; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">C.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A copy of each report made by an Access Person as required by this section, including any information provided
in lieu of the reports under paragraph (IV)(2)(E) of this section, must be maintained for at least five years after the end of the fiscal year in which the report is made or the information is provided, the first two years in an easily accessible
place; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">D.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A record of all persons, currently or within the past five years, who are or were required to make reports
under paragraph (IV)&nbsp;of this section, or who are or were responsible for reviewing these reports, must be maintained in an easily accessible place; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">E.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A copy of each report required by paragraph (III)(2)(B) of this section must be maintained for at least five
years after the end of the fiscal year in which it is made, the first two years in an easily accessible place. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>A Fund or investment adviser must maintain a record of any decision, and the reasons supporting the
decision, to approve the acquisition by investment personnel of securities under paragraph (V), for at least five years after the end of the fiscal year in which the approval is granted. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">The following are &#147;Access Persons&#148; for purposes of the foregoing Code of Ethics: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Each Director/Trustee of the Funds </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Any advisory board member of the Funds </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Each Officer of the Funds </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Portfolio Managers of the Funds </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">All employees of BlackRock, Inc. and its subsidiaries </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other than for purposes of determining whether a person is a beneficial owner of more than ten percent of any class of equity securities registered under
Section&nbsp;12 of the Act, the term beneficial owner shall mean any person who, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, has or shares a direct or indirect pecuniary interest in the equity
securities, subject to the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The term pecuniary interest in any class of equity securities shall mean the opportunity, directly or
indirectly, to profit or share in any profit derived from a transaction in the subject securities. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>BlackRock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Public</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">16</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The term indirect pecuniary interest in any class of equity securities shall include, but not be limited to:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Securities held by members of a person&#146;s immediate family sharing the same household; provided, however,
that the presumption of such beneficial ownership may be rebutted; see also Rule <FONT STYLE="white-space:nowrap">16a-1(a)(4);</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">B.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A general partner&#146;s proportionate interest in the portfolio securities held by a general or limited
partnership. The general partner&#146;s proportionate interest, as evidenced by the partnership agreement in effect at the time of the transaction and the partnership&#146;s most recent financial statements, shall be the greater of:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The general partner&#146;s share of the partnership&#146;s profits, including profits attributed to any limited
partnership interests held by the general partner and any other interests in profits that arise from the purchase and sale of the partnership&#146;s portfolio securities; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The general partner&#146;s share of the partnership capital account, including the share attributable to any
limited partnership interest held by the general partner. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">C.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A performance-related fee, other than an asset-based fee, received by any broker, dealer, bank, insurance
company, investment company, investment adviser, investment manager, trustee or person or entity performing a similar function; provided, however, that no pecuniary interest shall be present where: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The performance-related fee, regardless of when payable, is calculated based upon net capital gains and/or net
capital appreciation generated from the portfolio or from the fiduciary&#146;s overall performance over a period of one year or more; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Equity securities of the issuer do not account for more than ten percent of the market value of the portfolio.
A right to a nonperformance-related fee alone shall not represent a pecuniary interest in the securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">D.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A person&#146;s right to dividends that is separated or separable from the underlying securities. Otherwise, a
right to dividends alone shall not represent a pecuniary interest in the securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">E.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A person&#146;s interest in securities held by a trust, as specified in Rule
<FONT STYLE="white-space:nowrap">16a-8(b);</FONT> and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">F.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A person&#146;s right to acquire equity securities through the exercise or conversion of any derivative
security, whether or not presently exercisable. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A shareholder shall not be deemed to have a pecuniary interest in the portfolio securities held by a
corporation or similar entity in which the person owns securities if the shareholder is not a controlling shareholder of the entity and does not have or share investment control over the entity&#146;s portfolio. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>BlackRock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Public</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">17</TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Code of Ethics for the Funds </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This is to certify that I have read and understand the Code of Ethics of the Funds and that I recognize that I am subject to the provisions thereof and will
comply with the policy and procedures stated therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This is to further certify that I have complied with the requirements of such Code of Ethics and
that I have reported all personal securities transactions and accounts required to be disclosed or reported pursuant to the requirements of such Code of Ethics. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Please sign your name here:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Please print your name here:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Please date here:</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please sign two copies of this Certification Form, return one copy to Mr.&nbsp;Charles Park, c/o BlackRock, 40 East 52nd
Street, New York, NY 10022, and retain the other copy, together with a copy of the Code of Ethics, for your records. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>BlackRock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Public</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">18</TD></TR></TABLE>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(S)(3)
<SEQUENCE>7
<FILENAME>d421862dex99s3.htm
<DESCRIPTION>CALCULATION OF FILING FEE TABLES (FINAL PROSPECTUS DATED JANUARY 9, 2023)
<TEXT>
<HTML><HEAD>
<TITLE>Calculation of Filing Fee Tables (Final Prospectus Dated January 9, 2023)</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Exhibit (s)(3) </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Calculation of Filing Fee Tables </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT STYLE="white-space:nowrap">N-2</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Form Type) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BLACKROCK FLOATING
RATE INCOME TRUST </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Exact Name of Registrant as Specified in its Charter) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The maximum aggregate amount of common shares of beneficial interest being offered pursuant to the Prospectus Supplement dated January&nbsp;9, 2023 (the
&#147;Prospectus Supplement&#148;) and the accompanying Base Prospectus dated December&nbsp;28, 2022 is 11,000,000 common shares of beneficial interest (the &#147;Offering&#148;). The Base Prospectus and Prospectus Supplement, in the forms filed
with the Securities and Exchange Commission pursuant to Rule 424(b)(2) under the Securities Act of 1933, as amended, on January&nbsp;3, 2023 and January&nbsp;9, 2023, respectively, are the final prospectus relating to the Offering. </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>cik0001287480-20230109.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 06-January-2023 [10:37:48] {PM}-->
<schema targetNamespace="http://www.blackrockfloatingrateincometrust.com/20230109" elementFormDefault="qualified" xmlns:cik0001287480="http://www.blackrockfloatingrateincometrust.com/20230109" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:cef="http://xbrl.sec.gov/cef/2022">
<annotation>
<appinfo>
<link:linkbaseRef xlink:type="simple" xlink:href="cik0001287480-20230109_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="cik0001287480-20230109_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="cik0001287480-20230109_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
</appinfo>
</annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
<import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
<import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
<import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
<import namespace="http://xbrl.sec.gov/cef/2022" schemaLocation="https://xbrl.sec.gov/cef/2022/cef-2022.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>cik0001287480-20230109_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 06-January-2023 [10:37:48] {PM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
<roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2022/cef-2022.xsd#SecurityOnly" roleURI="http://xbrl.sec.gov/cef/role/SecurityOnly" />
<roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2022/cef-2022.xsd#RiskOnly" roleURI="http://xbrl.sec.gov/cef/role/RiskOnly" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
<definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2022/cef-2022.xsd#cef_AllSecuritiesMember" xlink:label="loc_cef_AllSecuritiesMember_74" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/RiskOnly">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2022/cef-2022.xsd#cef_AllRisksMember" xlink:label="loc_cef_AllRisksMember_76" />
</definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>cik0001287480-20230109_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 06-January-2023 [10:37:48] {PM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
<labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link" />
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>cik0001287480-20230109_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 06-January-2023 [10:37:48] {PM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2022/cef-2022.xsd#N2" roleURI="http://xbrl.sec.gov/cef/role/N2" />
<presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2022/cef-2022.xsd#cef_AllSecuritiesMember" xlink:label="loc_cef_AllSecuritiesMember_74" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2022/cef-2022.xsd#cef_AllRisksMember" xlink:label="loc_cef_AllRisksMember_76" />
</presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139680414693664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>N-2<br></strong></div></th>
<th class="th"><div>Jan. 09, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001287480<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Securities Act File Number</a></td>
<td class="text">333-266318<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_InvestmentCompanyActFileNumber', window );">Investment Company Act File Number</a></td>
<td class="text">811-21566<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">N-2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreEffectiveAmendment', window );">Pre-Effective Amendment</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PostEffectiveAmendment', window );">Post-Effective Amendment</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PostEffectiveAmendmentNumber', window );">Post-Effective Amendment Number</a></td>
<td class="text">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_InvestmentCompanyActRegistration', window );">Investment Company Act Registration</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_InvestmentCompanyRegistrationAmendment', window );">Investment Company Registration Amendment</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_InvestmentCompanyRegistrationAmendmentNumber', window );">Investment Company Registration Amendment Number</a></td>
<td class="text">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BlackRock Floating Rate Income Trust<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">100 Bellevue Parkway<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Wilmington<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">19809<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">882-0052<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ApproximateDateOfCommencementOfProposedSaleToThePublic', window );">Approximate Date of Commencement of Proposed Sale to Public</a></td>
<td class="text">From time to time after the effective date of this Registration Statement.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DividendOrInterestReinvestmentPlanOnly', window );">Dividend or Interest Reinvestment Plan Only</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DelayedOrContinuousOffering', window );">Delayed or Continuous Offering</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_PrimaryShelfFlag', window );">Primary Shelf [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EffectiveUponFiling462e', window );">Effective Upon Filing, 462(e)</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AdditionalSecuritiesEffective413b', window );">Additional Securities Effective, 413(b)</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EffectiveWhenDeclaredSection8c', window );">Effective when Declared, Section 8(c)</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_NewEffectiveDateForPreviousFiling', window );">New Effective Date for Previous Filing</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AdditionalSecurities462b', window );">Additional Securities. 462(b)</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_NoSubstantiveChanges462c', window );">No Substantive Changes, 462(c)</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ExhibitsOnly462d', window );">Exhibits Only, 462(d)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ExhibitsOnly462dFileNumber', window );">Exhibits Only, 462(d), File Number</a></td>
<td class="text">333-266318<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RegisteredClosedEndFundFlag', window );">Registered Closed-End Fund [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_BusinessDevelopmentCompanyFlag', window );">Business Development Company [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_IntervalFundFlag', window );">Interval Fund [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_PrimaryShelfQualifiedFlag', window );">Primary Shelf Qualified [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_NewCefOrBdcRegistrantFlag', window );">New CEF or BDC Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">55 East 52nd Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10055<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">John M. Perlowski, President<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_BusinessDevelopmentCompanyFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_BusinessDevelopmentCompanyFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_IntervalFundFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_IntervalFundFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_NewCefOrBdcRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_NewCefOrBdcRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_PrimaryShelfFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_PrimaryShelfFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_PrimaryShelfQualifiedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_PrimaryShelfQualifiedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RegisteredClosedEndFundFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RegisteredClosedEndFundFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AdditionalSecurities462b">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AdditionalSecurities462b</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AdditionalSecuritiesEffective413b">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 413<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AdditionalSecuritiesEffective413b</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ApproximateDateOfCommencementOfProposedSaleToThePublic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ApproximateDateOfCommencementOfProposedSaleToThePublic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:dateOrAsapItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DelayedOrContinuousOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form S-3<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form F-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DelayedOrContinuousOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DividendOrInterestReinvestmentPlanOnly">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form S-3<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form F-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DividendOrInterestReinvestmentPlanOnly</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EffectiveUponFiling462e">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection e<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EffectiveUponFiling462e</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EffectiveWhenDeclaredSection8c">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Section 8<br> -Subsection c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EffectiveWhenDeclaredSection8c</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ExhibitsOnly462d">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection d<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ExhibitsOnly462d</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ExhibitsOnly462dFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection d<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ExhibitsOnly462dFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyActFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-3<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-4<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyActFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyActRegistration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Investment Company Act<br> -Number 270<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyActRegistration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyRegistrationAmendment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Investment Company Act<br> -Number 270<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyRegistrationAmendment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyRegistrationAmendmentNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Investment Company Act<br> -Number 270<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyRegistrationAmendmentNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:sequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_NewEffectiveDateForPreviousFiling">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-3<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-4<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_NewEffectiveDateForPreviousFiling</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_NoSubstantiveChanges462c">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_NoSubstantiveChanges462c</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PostEffectiveAmendment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PostEffectiveAmendment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PostEffectiveAmendmentNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PostEffectiveAmendmentNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:sequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreEffectiveAmendment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreEffectiveAmendment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>d421862dposex_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cef="http://xbrl.sec.gov/cef/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cik0001287480-20230109.xsd" xlink:type="simple"/>
    <context id="P01_09_2023To01_09_2023">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001287480</identifier>
        </entity>
        <period>
            <startDate>2023-01-09</startDate>
            <endDate>2023-01-09</endDate>
        </period>
    </context>
    <context id="P01_09_2023To01_09_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001287480</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-09</startDate>
            <endDate>2023-01-09</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="P01_09_2023To01_09_2023">0001287480</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="P01_09_2023To01_09_2023">false</dei:AmendmentFlag>
    <dei:EntityFileNumber contextRef="P01_09_2023To01_09_2023">333-266318</dei:EntityFileNumber>
    <dei:InvestmentCompanyActFileNumber contextRef="P01_09_2023To01_09_2023">811-21566</dei:InvestmentCompanyActFileNumber>
    <dei:DocumentType contextRef="P01_09_2023To01_09_2023">N-2</dei:DocumentType>
    <dei:DocumentRegistrationStatement contextRef="P01_09_2023To01_09_2023">true</dei:DocumentRegistrationStatement>
    <dei:PreEffectiveAmendment contextRef="P01_09_2023To01_09_2023">false</dei:PreEffectiveAmendment>
    <dei:PostEffectiveAmendmentNumber contextRef="P01_09_2023To01_09_2023">1</dei:PostEffectiveAmendmentNumber>
    <dei:PostEffectiveAmendment contextRef="P01_09_2023To01_09_2023">true</dei:PostEffectiveAmendment>
    <dei:InvestmentCompanyActRegistration contextRef="P01_09_2023To01_09_2023">true</dei:InvestmentCompanyActRegistration>
    <dei:InvestmentCompanyRegistrationAmendmentNumber contextRef="P01_09_2023To01_09_2023">9</dei:InvestmentCompanyRegistrationAmendmentNumber>
    <dei:InvestmentCompanyRegistrationAmendment contextRef="P01_09_2023To01_09_2023">true</dei:InvestmentCompanyRegistrationAmendment>
    <dei:EntityRegistrantName contextRef="P01_09_2023To01_09_2023">BlackRock Floating Rate Income Trust</dei:EntityRegistrantName>
    <dei:EntityAddressAddressLine1 contextRef="P01_09_2023To01_09_2023">100 Bellevue Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="P01_09_2023To01_09_2023">Wilmington</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="P01_09_2023To01_09_2023">DE</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="P01_09_2023To01_09_2023">19809</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="P01_09_2023To01_09_2023">800</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="P01_09_2023To01_09_2023">882-0052</dei:LocalPhoneNumber>
    <dei:ContactPersonnelName contextRef="P01_09_2023To01_09_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">John M. Perlowski, President</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1 contextRef="P01_09_2023To01_09_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">55 East 52nd Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="P01_09_2023To01_09_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="P01_09_2023To01_09_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="P01_09_2023To01_09_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">10055</dei:EntityAddressPostalZipCode>
    <dei:ApproximateDateOfCommencementOfProposedSaleToThePublic contextRef="P01_09_2023To01_09_2023">From time to time after the effective date of this Registration Statement.</dei:ApproximateDateOfCommencementOfProposedSaleToThePublic>
    <dei:DividendOrInterestReinvestmentPlanOnly contextRef="P01_09_2023To01_09_2023">false</dei:DividendOrInterestReinvestmentPlanOnly>
    <dei:DelayedOrContinuousOffering contextRef="P01_09_2023To01_09_2023">true</dei:DelayedOrContinuousOffering>
    <cef:PrimaryShelfFlag contextRef="P01_09_2023To01_09_2023">true</cef:PrimaryShelfFlag>
    <dei:EffectiveUponFiling462e contextRef="P01_09_2023To01_09_2023">false</dei:EffectiveUponFiling462e>
    <dei:AdditionalSecuritiesEffective413b contextRef="P01_09_2023To01_09_2023">false</dei:AdditionalSecuritiesEffective413b>
    <dei:EffectiveWhenDeclaredSection8c contextRef="P01_09_2023To01_09_2023">false</dei:EffectiveWhenDeclaredSection8c>
    <dei:NewEffectiveDateForPreviousFiling contextRef="P01_09_2023To01_09_2023">false</dei:NewEffectiveDateForPreviousFiling>
    <dei:AdditionalSecurities462b contextRef="P01_09_2023To01_09_2023">false</dei:AdditionalSecurities462b>
    <dei:NoSubstantiveChanges462c contextRef="P01_09_2023To01_09_2023">false</dei:NoSubstantiveChanges462c>
    <dei:ExhibitsOnly462d contextRef="P01_09_2023To01_09_2023">true</dei:ExhibitsOnly462d>
    <dei:ExhibitsOnly462dFileNumber contextRef="P01_09_2023To01_09_2023">333-266318</dei:ExhibitsOnly462dFileNumber>
    <cef:RegisteredClosedEndFundFlag contextRef="P01_09_2023To01_09_2023">true</cef:RegisteredClosedEndFundFlag>
    <cef:BusinessDevelopmentCompanyFlag contextRef="P01_09_2023To01_09_2023">false</cef:BusinessDevelopmentCompanyFlag>
    <cef:IntervalFundFlag contextRef="P01_09_2023To01_09_2023">false</cef:IntervalFundFlag>
    <cef:PrimaryShelfQualifiedFlag contextRef="P01_09_2023To01_09_2023">true</cef:PrimaryShelfQualifiedFlag>
    <dei:EntityWellKnownSeasonedIssuer contextRef="P01_09_2023To01_09_2023">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityEmergingGrowthCompany contextRef="P01_09_2023To01_09_2023">false</dei:EntityEmergingGrowthCompany>
    <cef:NewCefOrBdcRegistrantFlag contextRef="P01_09_2023To01_09_2023">false</cef:NewCefOrBdcRegistrantFlag>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>39</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d421862dposex.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995470 - Disclosure - N-2</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cef/role/N2</Role>
      <ShortName>N-2</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="N-2" original="d421862dposex.htm">d421862dposex.htm</File>
    <File>cik0001287480-20230109.xsd</File>
    <File>cik0001287480-20230109_def.xml</File>
    <File>cik0001287480-20230109_lab.xml</File>
    <File>cik0001287480-20230109_pre.xml</File>
    <File>d421862dex99h1.htm</File>
    <File>d421862dex99h2.htm</File>
    <File>d421862dex99k8.htm</File>
    <File>d421862dex99l2.htm</File>
    <File>d421862dex99r.htm</File>
    <File>d421862dex99s3.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="6">http://xbrl.sec.gov/cef/2022</BaseTaxonomy>
    <BaseTaxonomy items="37">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d421862dposex.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/cef/2022": 6,
    "http://xbrl.sec.gov/dei/2022": 37
   },
   "contextCount": 2,
   "dts": {
    "definitionLink": {
     "local": [
      "cik0001287480-20230109_def.xml"
     ]
    },
    "inline": {
     "local": [
      "d421862dposex.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cik0001287480-20230109_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cik0001287480-20230109_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cik0001287480-20230109.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/2006/xbrldi-2006.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/cef/2022/cef-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022_lab.xsd"
     ]
    }
   },
   "elementCount": 189,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 39,
   "memberCustom": 0,
   "memberStandard": 1,
   "nsprefix": "cik0001287480",
   "nsuri": "http://www.blackrockfloatingrateincometrust.com/20230109",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d421862dposex.htm",
      "contextRef": "P01_09_2023To01_09_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityFileNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "true",
     "longName": "995470 - Disclosure - N-2",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://xbrl.sec.gov/cef/role/N2",
     "shortName": "N-2",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d421862dposex.htm",
      "contextRef": "P01_09_2023To01_09_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityFileNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 1,
   "tag": {
    "cef_AcquiredFundFeesAndExpensesNoteTextBlock": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses, Note [Text Block]"
       }
      }
     },
     "localname": "AcquiredFundFeesAndExpensesNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_AcquiredFundFeesAndExpensesPercent": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses [Percent]"
       }
      }
     },
     "localname": "AcquiredFundFeesAndExpensesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_AcquiredFundFeesEstimatedNoteTextBlock": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees Estimated, Note [Text Block]"
       }
      }
     },
     "localname": "AcquiredFundFeesEstimatedNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_AcquiredFundIncentiveAllocationNoteTextBlock": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Incentive Allocation, Note [Text Block]"
       }
      }
     },
     "localname": "AcquiredFundIncentiveAllocationNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_AcquiredFundTotalAnnualExpensesNoteTextBlock": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Total Annual Expenses, Note [Text Block]"
       }
      }
     },
     "localname": "AcquiredFundTotalAnnualExpensesNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_AllRisksMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Risks:"
       }
      }
     },
     "localname": "AllRisksMember",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "domainItemType"
    },
    "cef_AllSecuritiesMember": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Securities:"
       }
      }
     },
     "localname": "AllSecuritiesMember",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "domainItemType"
    },
    "cef_AnnualCoverageReturnRatePercent": {
     "auth_ref": [
      "r62"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Coverage Return Rate [Percent]"
       }
      }
     },
     "localname": "AnnualCoverageReturnRatePercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_AnnualDividendPayment": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment"
       }
      }
     },
     "localname": "AnnualDividendPayment",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_AnnualDividendPaymentCurrent": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Current"
       }
      }
     },
     "localname": "AnnualDividendPaymentCurrent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_AnnualDividendPaymentInitial": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Initial"
       }
      }
     },
     "localname": "AnnualDividendPaymentInitial",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_AnnualExpensesTableTextBlock": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Expenses [Table Text Block]"
       }
      }
     },
     "localname": "AnnualExpensesTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_AnnualInterestRateCurrentPercent": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Current [Percent]"
       }
      }
     },
     "localname": "AnnualInterestRateCurrentPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_AnnualInterestRateInitialPercent": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Initial [Percent]"
       }
      }
     },
     "localname": "AnnualInterestRateInitialPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_AnnualInterestRatePercent": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate [Percent]"
       }
      }
     },
     "localname": "AnnualInterestRatePercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_BasisOfTransactionFeesNoteTextBlock": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Transaction Fees, Note [Text Block]"
       }
      }
     },
     "localname": "BasisOfTransactionFeesNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_BdcFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "BDC File Number"
       }
      }
     },
     "localname": "BdcFileNumber",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "cef_BusinessDevelopmentCompanyFlag": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Development Company [Flag]"
       }
      }
     },
     "localname": "BusinessDevelopmentCompanyFlag",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock, Long-Term Debt, and Other Securities [Abstract]"
       }
      }
     },
     "localname": "CapitalStockLongTermDebtAndOtherSecuritiesAbstract",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_CapitalStockTableTextBlock": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock [Table Text Block]"
       }
      }
     },
     "localname": "CapitalStockTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_DistributionServicingFeesPercent": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distribution/Servicing Fees [Percent]"
       }
      }
     },
     "localname": "DistributionServicingFeesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_DistributionsMayReducePrincipalTextBlock": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distributions May Reduce Principal [Text Block]"
       }
      }
     },
     "localname": "DistributionsMayReducePrincipalTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_DividendAndInterestExpensesOnShortSalesPercent": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend and Interest Expenses on Short Sales [Percent]"
       }
      }
     },
     "localname": "DividendAndInterestExpensesOnShortSalesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_DividendExpenseOnPreferredSharesPercent": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Expenses on Preferred Shares [Percent]"
       }
      }
     },
     "localname": "DividendExpenseOnPreferredSharesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_DividendReinvestmentAndCashPurchaseFees": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Reinvestment and Cash Purchase Fees"
       }
      }
     },
     "localname": "DividendReinvestmentAndCashPurchaseFees",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_EffectsOfLeveragePurposeTextBlock": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage, Purpose [Text Block]"
       }
      }
     },
     "localname": "EffectsOfLeveragePurposeTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_EffectsOfLeverageTableTextBlock": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Table Text Block]"
       }
      }
     },
     "localname": "EffectsOfLeverageTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_EffectsOfLeverageTextBlock": {
     "auth_ref": [
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Text Block]"
       }
      }
     },
     "localname": "EffectsOfLeverageTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_ExpenseExampleTableTextBlock": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example [Table Text Block]"
       }
      }
     },
     "localname": "ExpenseExampleTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_ExpenseExampleYear01": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Year 01"
       }
      }
     },
     "localname": "ExpenseExampleYear01",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_ExpenseExampleYears1to10": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 10"
       }
      }
     },
     "localname": "ExpenseExampleYears1to10",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_ExpenseExampleYears1to3": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 3"
       }
      }
     },
     "localname": "ExpenseExampleYears1to3",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_ExpenseExampleYears1to5": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 5"
       }
      }
     },
     "localname": "ExpenseExampleYears1to5",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_FeeTableAbstract": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Table [Abstract]"
       }
      }
     },
     "localname": "FeeTableAbstract",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_FinancialHighlightsAbstract": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Highlights [Abstract]"
       }
      }
     },
     "localname": "FinancialHighlightsAbstract",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_GeneralDescriptionOfRegistrantAbstract": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Description of Registrant [Abstract]"
       }
      }
     },
     "localname": "GeneralDescriptionOfRegistrantAbstract",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_HighestPriceOrBid": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid"
       }
      }
     },
     "localname": "HighestPriceOrBid",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_HighestPriceOrBidNav": {
     "auth_ref": [
      "r68"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, NAV"
       }
      }
     },
     "localname": "HighestPriceOrBidNav",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_HighestPriceOrBidPremiumDiscountToNavPercent": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "localname": "HighestPriceOrBidPremiumDiscountToNavPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_IncentiveAllocationMaximumPercent": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Maximum [Percent]"
       }
      }
     },
     "localname": "IncentiveAllocationMaximumPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_IncentiveAllocationMinimumPercent": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Minimum [Percent]"
       }
      }
     },
     "localname": "IncentiveAllocationMinimumPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_IncentiveAllocationPercent": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation [Percent]"
       }
      }
     },
     "localname": "IncentiveAllocationPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_IncentiveFeesPercent": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Fees [Percent]"
       }
      }
     },
     "localname": "IncentiveFeesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_InterestExpensesOnBorrowingsPercent": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Expenses on Borrowings [Percent]"
       }
      }
     },
     "localname": "InterestExpensesOnBorrowingsPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_IntervalFundFlag": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interval Fund [Flag]"
       }
      }
     },
     "localname": "IntervalFundFlag",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "cef_InvestmentObjectivesAndPracticesTextBlock": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Objectives and Practices [Text Block]"
       }
      }
     },
     "localname": "InvestmentObjectivesAndPracticesTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LatestNav": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest NAV"
       }
      }
     },
     "localname": "LatestNav",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_LatestPremiumDiscountToNavPercent": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "localname": "LatestPremiumDiscountToNavPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_LatestSharePrice": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest Share Price"
       }
      }
     },
     "localname": "LatestSharePrice",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_LoanServicingFeesPercent": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan Servicing Fees [Percent]"
       }
      }
     },
     "localname": "LoanServicingFeesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_LongTermDebtDividendsAndCovenantsTextBlock": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Dividends and Covenants [Text Block]"
       }
      }
     },
     "localname": "LongTermDebtDividendsAndCovenantsTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LongTermDebtIssuanceAndSubstitutionTextBlock": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Issuance and Substitution [Text Block]"
       }
      }
     },
     "localname": "LongTermDebtIssuanceAndSubstitutionTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LongTermDebtPrincipal": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Principal"
       }
      }
     },
     "localname": "LongTermDebtPrincipal",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_LongTermDebtRightsLimitedByOtherSecuritiesTextBlock": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "localname": "LongTermDebtRightsLimitedByOtherSecuritiesTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LongTermDebtStructuringTextBlock": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Structuring [Text Block]"
       }
      }
     },
     "localname": "LongTermDebtStructuringTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LongTermDebtTableTextBlock": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt [Table Text Block]"
       }
      }
     },
     "localname": "LongTermDebtTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LongTermDebtTitleTextBlock": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Title [Text Block]"
       }
      }
     },
     "localname": "LongTermDebtTitleTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LowestPriceOrBid": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid"
       }
      }
     },
     "localname": "LowestPriceOrBid",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_LowestPriceOrBidNav": {
     "auth_ref": [
      "r68"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, NAV"
       }
      }
     },
     "localname": "LowestPriceOrBidNav",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_LowestPriceOrBidPremiumDiscountToNavPercent": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "localname": "LowestPriceOrBidPremiumDiscountToNavPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_ManagementFeeNotBasedOnNetAssetsNoteTextBlock": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fee not based on Net Assets, Note [Text Block]"
       }
      }
     },
     "localname": "ManagementFeeNotBasedOnNetAssetsNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_ManagementFeesPercent": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fees [Percent]"
       }
      }
     },
     "localname": "ManagementFeesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_NetExpenseOverAssetsPercent": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Expense over Assets [Percent]"
       }
      }
     },
     "localname": "NetExpenseOverAssetsPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_NewCefOrBdcRegistrantFlag": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New CEF or BDC Registrant [Flag]"
       }
      }
     },
     "localname": "NewCefOrBdcRegistrantFlag",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "cef_NoPublicTradingTextBlock": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Public Trading [Text Block]"
       }
      }
     },
     "localname": "NoPublicTradingTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_NoTradingHistoryTextBlock": {
     "auth_ref": [
      "r71"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading History [Text Block]"
       }
      }
     },
     "localname": "NoTradingHistoryTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OtherAnnualExpense1Percent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "order": 1.0,
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 1 [Percent]"
       }
      }
     },
     "localname": "OtherAnnualExpense1Percent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherAnnualExpense2Percent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "order": 2.0,
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 2 [Percent]"
       }
      }
     },
     "localname": "OtherAnnualExpense2Percent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherAnnualExpense3Percent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "order": 3.0,
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 3 [Percent]"
       }
      }
     },
     "localname": "OtherAnnualExpense3Percent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherAnnualExpensesAbstract": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Abstract]"
       }
      }
     },
     "localname": "OtherAnnualExpensesAbstract",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_OtherAnnualExpensesPercent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Percent]"
       }
      }
     },
     "localname": "OtherAnnualExpensesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherExpensesNoteTextBlock": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Expenses, Note [Text Block]"
       }
      }
     },
     "localname": "OtherExpensesNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OtherFeederFundExpensesPercent": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Feeder Fund Expenses [Percent]"
       }
      }
     },
     "localname": "OtherFeederFundExpensesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherMasterFundExpensesPercent": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Master Fund Expenses [Percent]"
       }
      }
     },
     "localname": "OtherMasterFundExpensesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherSecuritiesTableTextBlock": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Securities [Table Text Block]"
       }
      }
     },
     "localname": "OtherSecuritiesTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OtherSecurityDescriptionTextBlock": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Description [Text Block]"
       }
      }
     },
     "localname": "OtherSecurityDescriptionTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OtherSecurityTitleTextBlock": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Title [Text Block]"
       }
      }
     },
     "localname": "OtherSecurityTitleTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OtherTransactionExpense1Percent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "order": 1.0,
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 1 [Percent]"
       }
      }
     },
     "localname": "OtherTransactionExpense1Percent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherTransactionExpense2Percent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "order": 2.0,
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 2 [Percent]"
       }
      }
     },
     "localname": "OtherTransactionExpense2Percent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherTransactionExpense3Percent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "order": 3.0,
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 3 [Percent]"
       }
      }
     },
     "localname": "OtherTransactionExpense3Percent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherTransactionExpensesAbstract": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Abstract]"
       }
      }
     },
     "localname": "OtherTransactionExpensesAbstract",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_OtherTransactionExpensesPercent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Percent]"
       }
      }
     },
     "localname": "OtherTransactionExpensesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherTransactionFeesBasisMaximum": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum"
       }
      }
     },
     "localname": "OtherTransactionFeesBasisMaximum",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_OtherTransactionFeesBasisMaximumPercent": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum [Percent]"
       }
      }
     },
     "localname": "OtherTransactionFeesBasisMaximumPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherTransactionFeesBasisNoteTextBlock": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Note [Text Block]"
       }
      }
     },
     "localname": "OtherTransactionFeesBasisNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OtherTransactionFeesNoteTextBlock": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees, Note [Text Block]"
       }
      }
     },
     "localname": "OtherTransactionFeesNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OutstandingSecuritiesTableTextBlock": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Securities [Table Text Block]"
       }
      }
     },
     "localname": "OutstandingSecuritiesTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OutstandingSecurityAuthorizedShares": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Authorized [Shares]"
       }
      }
     },
     "localname": "OutstandingSecurityAuthorizedShares",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "sharesItemType"
    },
    "cef_OutstandingSecurityHeldShares": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Held [Shares]"
       }
      }
     },
     "localname": "OutstandingSecurityHeldShares",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "sharesItemType"
    },
    "cef_OutstandingSecurityNotHeldShares": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Not Held [Shares]"
       }
      }
     },
     "localname": "OutstandingSecurityNotHeldShares",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "sharesItemType"
    },
    "cef_OutstandingSecurityTitleTextBlock": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Title [Text Block]"
       }
      }
     },
     "localname": "OutstandingSecurityTitleTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_PreferredStockRestrictionsArrearageTextBlock": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Arrearage [Text Block]"
       }
      }
     },
     "localname": "PreferredStockRestrictionsArrearageTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_PreferredStockRestrictionsOtherTextBlock": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Other [Text Block]"
       }
      }
     },
     "localname": "PreferredStockRestrictionsOtherTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_PrimaryShelfFlag": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf [Flag]"
       }
      }
     },
     "localname": "PrimaryShelfFlag",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "cef_PrimaryShelfQualifiedFlag": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf Qualified [Flag]"
       }
      }
     },
     "localname": "PrimaryShelfQualifiedFlag",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "cef_ProspectusLineItems": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus [Line Items]"
       }
      }
     },
     "localname": "ProspectusLineItems",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "xbrltype": "stringItemType"
    },
    "cef_ProspectusTable": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus:"
       }
      }
     },
     "localname": "ProspectusTable",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_PurposeOfFeeTableNoteTextBlock": {
     "auth_ref": [
      "r31"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purpose of Fee Table , Note [Text Block]"
       }
      }
     },
     "localname": "PurposeOfFeeTableNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_RegisteredClosedEndFundFlag": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registered Closed-End Fund [Flag]"
       }
      }
     },
     "localname": "RegisteredClosedEndFundFlag",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "cef_ReturnAtMinusFivePercent": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Five [Percent]"
       }
      }
     },
     "localname": "ReturnAtMinusFivePercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_ReturnAtMinusTenPercent": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Ten [Percent]"
       }
      }
     },
     "localname": "ReturnAtMinusTenPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_ReturnAtPlusFivePercent": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Five [Percent]"
       }
      }
     },
     "localname": "ReturnAtPlusFivePercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_ReturnAtPlusTenPercent": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Ten [Percent]"
       }
      }
     },
     "localname": "ReturnAtPlusTenPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_ReturnAtZeroPercent": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Zero [Percent]"
       }
      }
     },
     "localname": "ReturnAtZeroPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_RightsLimitedByOtherSecuritiesTextBlock": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "localname": "RightsLimitedByOtherSecuritiesTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_RightsSubjectToOtherThanMajorityVoteTextBlock": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Subject to Other than Majority Vote [Text Block]"
       }
      }
     },
     "localname": "RightsSubjectToOtherThanMajorityVoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_RiskAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Axis]"
       }
      }
     },
     "localname": "RiskAxis",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_RiskFactorsTableTextBlock": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk Factors [Table Text Block]"
       }
      }
     },
     "localname": "RiskFactorsTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_RiskTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Text Block]"
       }
      }
     },
     "localname": "RiskTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SalesLoadPercent": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales Load [Percent]"
       }
      }
     },
     "localname": "SalesLoadPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_SecurityAxis": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security [Axis]"
       }
      }
     },
     "localname": "SecurityAxis",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_SecurityDividendsTextBlock": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Dividends [Text Block]"
       }
      }
     },
     "localname": "SecurityDividendsTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SecurityLiabilitiesTextBlock": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liabilities [Text Block]"
       }
      }
     },
     "localname": "SecurityLiabilitiesTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SecurityLiquidationRightsTextBlock": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liquidation Rights [Text Block]"
       }
      }
     },
     "localname": "SecurityLiquidationRightsTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SecurityObligationsOfOwnershipTextBlock": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Obligations of Ownership [Text Block]"
       }
      }
     },
     "localname": "SecurityObligationsOfOwnershipTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SecurityPreemptiveAndOtherRightsTextBlock": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Preemptive and Other Rights [Text Block]"
       }
      }
     },
     "localname": "SecurityPreemptiveAndOtherRightsTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SecurityTitleTextBlock": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Title [Text Block]"
       }
      }
     },
     "localname": "SecurityTitleTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SecurityVotingRightsTextBlock": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Voting Rights [Text Block]"
       }
      }
     },
     "localname": "SecurityVotingRightsTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SeniorSecuritiesAmount": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Amount"
       }
      }
     },
     "localname": "SeniorSecuritiesAmount",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_SeniorSecuritiesAverageMarketValuePerUnit": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Average Market Value per Unit"
       }
      }
     },
     "localname": "SeniorSecuritiesAverageMarketValuePerUnit",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_SeniorSecuritiesAveragingMethodNoteTextBlock": {
     "auth_ref": [
      "r55"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Averaging Method, Note [Text Block]"
       }
      }
     },
     "localname": "SeniorSecuritiesAveragingMethodNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SeniorSecuritiesCoveragePerUnit": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Coverage per Unit"
       }
      }
     },
     "localname": "SeniorSecuritiesCoveragePerUnit",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_SeniorSecuritiesHeadingsNoteTextBlock": {
     "auth_ref": [
      "r56"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Headings, Note [Text Block]"
       }
      }
     },
     "localname": "SeniorSecuritiesHeadingsNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SeniorSecuritiesHighlightsAnnualizedNoteTextBlock": {
     "auth_ref": [
      "r47",
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Annualized, Note [Text Block]"
       }
      }
     },
     "localname": "SeniorSecuritiesHighlightsAnnualizedNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SeniorSecuritiesHighlightsAuditedNoteTextBlock": {
     "auth_ref": [
      "r48",
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Audited, Note [Text Block]"
       }
      }
     },
     "localname": "SeniorSecuritiesHighlightsAuditedNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit": {
     "auth_ref": [
      "r52"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Involuntary Liquidating Preference per Unit"
       }
      }
     },
     "localname": "SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_SeniorSecuritiesNoteTextBlock": {
     "auth_ref": [
      "r46",
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities, Note [Text Block]"
       }
      }
     },
     "localname": "SeniorSecuritiesNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SeniorSecuritiesTableTextBlock": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities [Table Text Block]"
       }
      }
     },
     "localname": "SeniorSecuritiesTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SharePriceTableTextBlock": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price [Table Text Block]"
       }
      }
     },
     "localname": "SharePriceTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SharePricesNotActualTransactionsTextBlock": {
     "auth_ref": [
      "r66"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Prices Not Actual Transactions [Text Block]"
       }
      }
     },
     "localname": "SharePricesNotActualTransactionsTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_ShareholderTransactionExpensesTableTextBlock": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder Transaction Expenses [Table Text Block]"
       }
      }
     },
     "localname": "ShareholderTransactionExpensesTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_TotalAnnualExpensesPercent": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Annual Expenses [Percent]"
       }
      }
     },
     "localname": "TotalAnnualExpensesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_UnderwritersCompensationPercent": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriters Compensation [Percent]"
       }
      }
     },
     "localname": "UnderwritersCompensationPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_WaiversAndReimbursementsOfFeesPercent": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Waivers and Reimbursements of Fees [Percent]"
       }
      }
     },
     "localname": "WaiversAndReimbursementsOfFeesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_WarrantsOrRightsCalledAmount": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Amount"
       }
      }
     },
     "localname": "WarrantsOrRightsCalledAmount",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_WarrantsOrRightsCalledPeriodDate": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Period [Date]"
       }
      }
     },
     "localname": "WarrantsOrRightsCalledPeriodDate",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "dateItemType"
    },
    "cef_WarrantsOrRightsCalledTitleTextBlock": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Title"
       }
      }
     },
     "localname": "WarrantsOrRightsCalledTitleTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_WarrantsOrRightsExercisePrice": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Exercise Price"
       }
      }
     },
     "localname": "WarrantsOrRightsExercisePrice",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "dei_AdditionalSecurities462b": {
     "auth_ref": [
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "localname": "AdditionalSecurities462b",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "auth_ref": [
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "localname": "AdditionalSecurities462bFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "localname": "AdditionalSecuritiesEffective413b",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AddressTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.",
        "label": "Address Type [Domain]"
       }
      }
     },
     "localname": "AddressTypeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings.",
        "label": "Approximate Date of Commencement of Proposed Sale to Public"
       }
      }
     },
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "dateOrAsapItemType"
    },
    "dei_BusinessContactMember": {
     "auth_ref": [
      "r2",
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business contact for the entity",
        "label": "Business Contact [Member]"
       }
      }
     },
     "localname": "BusinessContactMember",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of contact personnel",
        "label": "Contact Personnel Name"
       }
      }
     },
     "localname": "ContactPersonnelName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DelayedOrContinuousOffering": {
     "auth_ref": [
      "r4",
      "r5",
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "localname": "DelayedOrContinuousOffering",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "auth_ref": [
      "r4",
      "r5",
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EffectiveAfter60Days486a": {
     "auth_ref": [
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "localname": "EffectiveAfter60Days486a",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveOnDate486a": {
     "auth_ref": [
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "localname": "EffectiveOnDate486a",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_EffectiveOnDate486b": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "localname": "EffectiveOnDate486b",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_EffectiveOnSetDate486a": {
     "auth_ref": [
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "localname": "EffectiveOnSetDate486a",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveOnSetDate486b": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "localname": "EffectiveOnSetDate486b",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveUponFiling462e": {
     "auth_ref": [
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "localname": "EffectiveUponFiling462e",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveUponFiling486b": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "localname": "EffectiveUponFiling486b",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "auth_ref": [
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "localname": "EffectiveWhenDeclaredSection8c",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Addresses, Address Type [Axis]"
       }
      }
     },
     "localname": "EntityAddressesAddressTypeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Securities Act File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityInvCompanyType": {
     "auth_ref": [
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product).",
        "label": "Entity Inv Company Type"
       }
      }
     },
     "localname": "EntityInvCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "invCompanyType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_ExhibitsOnly462d": {
     "auth_ref": [
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "localname": "ExhibitsOnly462d",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "auth_ref": [
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "localname": "ExhibitsOnly462dFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_InvestmentCompanyActFileNumber": {
     "auth_ref": [
      "r5",
      "r72",
      "r73",
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "localname": "InvestmentCompanyActFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_InvestmentCompanyActRegistration": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "localname": "InvestmentCompanyActRegistration",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "localname": "InvestmentCompanyRegistrationAmendment",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "sequenceNumberItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "auth_ref": [
      "r5",
      "r72",
      "r73",
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "localname": "NewEffectiveDateForPreviousFiling",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_NoSubstantiveChanges462c": {
     "auth_ref": [
      "r81"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "localname": "NoSubstantiveChanges462c",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "auth_ref": [
      "r81"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "localname": "NoSubstantiveChanges462cFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_PostEffectiveAmendment": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "localname": "PostEffectiveAmendment",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PostEffectiveAmendmentNumber": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective.",
        "label": "Post-Effective Amendment Number"
       }
      }
     },
     "localname": "PostEffectiveAmendmentNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "sequenceNumberItemType"
    },
    "dei_PreEffectiveAmendment": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "localname": "PreEffectiveAmendment",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreEffectiveAmendmentNumber": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective.",
        "label": "Pre-Effective Amendment Number"
       }
      }
     },
     "localname": "PreEffectiveAmendmentNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "sequenceNumberItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Form N-2",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subparagraph": "3",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form N-2",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subparagraph": "4",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form N-2",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subparagraph": "5",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form N-2",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subparagraph": "6",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form N-2",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subparagraph": "Instruction 2",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subparagraph": "1",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subparagraph": "2",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Form N-2",
   "Paragraph": "c",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Form N-2",
   "Paragraph": "d",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Form N-2",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r20": {
   "Name": "Form N-2",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r21": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r22": {
   "Name": "Form N-2",
   "Paragraph": "c",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r23": {
   "Name": "Form N-2",
   "Paragraph": "e",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r24": {
   "Name": "Form N-2",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r25": {
   "Name": "Form N-2",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "5",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r26": {
   "Name": "Form N-2",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "5",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r27": {
   "Name": "Form N-2",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "5",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r28": {
   "Name": "Form N-2",
   "Paragraph": "3",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "5",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r29": {
   "Name": "Form N-2",
   "Paragraph": "4",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "5",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r30": {
   "Name": "Form N-2",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r31": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 1",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r32": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 10",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subparagraph": "a",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r33": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 10",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subparagraph": "a, g, h",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r34": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 10",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subparagraph": "f",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r35": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 10",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subparagraph": "g",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r36": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 10",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subparagraph": "i",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r37": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 11",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r38": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 4",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r39": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 5",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Form F-3",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r40": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 6",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r41": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 7",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subparagraph": "a",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r42": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 7",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subparagraph": "b",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r43": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 8",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r44": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 9",
   "Publisher": "SEC",
   "Section": "Item 3",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r45": {
   "Name": "Form N-2",
   "Publisher": "SEC",
   "Section": "Item 4",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r46": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 2",
   "Publisher": "SEC",
   "Section": "Item 4",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r47": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 3",
   "Publisher": "SEC",
   "Section": "Item 4",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r48": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 8",
   "Publisher": "SEC",
   "Section": "Item 4",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r49": {
   "Name": "Form N-2",
   "Publisher": "SEC",
   "Section": "Item 4",
   "Subsection": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Form N-2",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r50": {
   "Name": "Form N-2",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "Item 4",
   "Subsection": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r51": {
   "Name": "Form N-2",
   "Paragraph": "3",
   "Publisher": "SEC",
   "Section": "Item 4",
   "Subparagraph": "Instruction 2",
   "Subsection": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r52": {
   "Name": "Form N-2",
   "Paragraph": "4",
   "Publisher": "SEC",
   "Section": "Item 4",
   "Subparagraph": "Instruction 3",
   "Subsection": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r53": {
   "Name": "Form N-2",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "Item 4",
   "Subsection": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r54": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 1",
   "Publisher": "SEC",
   "Section": "Item 4",
   "Subsection": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r55": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 4",
   "Publisher": "SEC",
   "Section": "Item 4",
   "Subsection": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r56": {
   "Name": "Form N-2",
   "Paragraph": "Instruction 5",
   "Publisher": "SEC",
   "Section": "Item 4",
   "Subsection": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r57": {
   "Name": "Form N-2",
   "Publisher": "SEC",
   "Section": "Item 8",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r58": {
   "Name": "Form N-2",
   "Paragraph": "b, d",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r59": {
   "Name": "Form N-2",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subsection": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Form N-2",
   "Publisher": "SEC",
   "Section": "Item 10",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r60": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subsection": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r61": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subparagraph": "1",
   "Subsection": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r62": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subparagraph": "2",
   "Subsection": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r63": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subparagraph": "3",
   "Subsection": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r64": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subsection": "5",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r65": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subparagraph": "4",
   "Subsection": "5",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r66": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subparagraph": "Instruction 2",
   "Subsection": "5",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r67": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subparagraph": "Instruction 3",
   "Subsection": "5",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r68": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subparagraph": "Instruction 4",
   "Subsection": "5",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r69": {
   "Name": "Form N-2",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subparagraph": "Instructions 4, 5",
   "Subsection": "5",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Form N-2",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r70": {
   "Name": "Form N-2",
   "Paragraph": "c",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subsection": "5",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r71": {
   "Name": "Form N-2",
   "Paragraph": "e",
   "Publisher": "SEC",
   "Section": "Item 8",
   "Subsection": "5",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r72": {
   "Name": "Form N-3",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r73": {
   "Name": "Form N-4",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r74": {
   "Name": "Form N-6",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r75": {
   "Name": "Form S-3",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r76": {
   "Name": "Investment Company Act",
   "Number": "270",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r77": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "313",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r78": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r79": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "413",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Form N-2",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subparagraph": "1",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r80": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r81": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r82": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r83": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "e",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r84": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "486",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r85": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "486",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r86": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r87": {
   "Name": "Securities Act",
   "Publisher": "SEC",
   "Section": "8",
   "Subsection": "c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Form N-2",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "Item 10",
   "Subparagraph": "2",
   "Subsection": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001193125-23-004873-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-004873-xbrl.zip
M4$L#!!0    ( '"+*5:A&*> TP(  *<*   :    8VEK,# P,3(X-S0X,"TR
M,#(S,#$P.2YX<V3-55UKVS 4?1_L/VA^ES^2=DU"T\(H'1UI&1V,PAA#D:\3
M$5OR)+E)&/OODQS;B5H[J]D&>[-\SKWGW"OIZOQRDZ7H$:1B@D^]R \]!)R*
MF/'%U"MT@D?>Y<7K5^=O,'X/'"31$*/Y%EU=W]RAAW?W,W3#E2:< KH2M,B
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MFW-^,SFKPM.)6Q5]':7[+U!+ P04    " !PBRE6_*T]$J<!  #: P  '@
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M"N(JWG&:+.F& 7'A$3RXV=\$E/<>@;CHLX9\&_4\BW >;#P[K(LGFA2G4[6
MG=-F$LN&;LVTK\]?)NNX21_/P48%M0KTT1--)RY$';HV6B!!&0&JB#G %?>)
M%#2"0=HWNF!,"%("[I,)3,_%R)JFHD-H\@ M),WE,S9R8.,SN"!FC8MDJ?DZ
M$A8+1Z!R9)8"Y?$(_O]J 1K*,E<^J-6\!VG\: '<;V,"U'VV,5%P3/4RR2\
ME1ZA3'A_&!WM_S^XLV>/])+D47KYKU_H?X^B/_??'K__]='6DR<_& OZS=Z'
MX[W#&[B;;G?K4[IU1FCB:BUP#_AOY$4@7D!':YC47,Y+H :LU33=T!-XMYO1
M'PNX3^!-V10OO$]"PHQ8=N&E(.;S6_%.W!?3C7=_SY2JMXG?=G<FN\J8%U0I
M:)F*N0V]B]\,+"+++2WCAF>9ZHM$0GKZG?<:L8'@/>U<I=NH1)!"#98?DGT,
M:/#'SFEYH<" IP^<A08/*V=#QI[ BU#U!KX&UF=6N4H4:WE:2P2K48L!DO]=
M#=+A_$2@UNX$6L+W\R,GV;F C_;(%W@?:D[*"(F$#O^$;=+F+8-.%4,,Y<W2
M53-.E-6@N[<(3U8*.54Q9394):DB5X%>0*O.\%XX$K!^)?;-)M@? (X(;A*X
M"&^C"6P0M@;<A;@DKPK&5(4_*8 3)C7RP_,D;]V?+/*6$<Y^E,Q1>&DBL:Q*
MU"A A53?F'L^7^WY/2M(^'["+?:DD"%UX)2@F:"! K8:_V0\8A[9/5Q0] .!
M 9#PS+)=[[T#>SJB];L[BWW)RE#&TX-N-,5W$5(&U@@ PSDEKW.:G)/4!]S)
MZFFE&H&G<_[Q*+3VC"1^]]B)@ ]T[AKHO8KQTI!T"/UFR13V4#/?2A69.ZCL
MD.>DBVSLH^A!&Z&J4M;%![''@LSB##U86S@"CF<5:Z-5DM76(P.\;#PR>G1?
M.^DS65\IC;*90=R:<9G.X&N:H*3Z).$CB*B[ <@/;"@.4#D[I@Q36*U\$A$!
MCB,?%.;AOB1XWW'0KK><VE.6C1HN+[R<;@BQ9</WP6[5>@_6I-L!=L^R:J[I
MB\',1CL>A+@3^IOIRH&;DO 89*>1YJ;X#+D[?)"(Z3,>::4.U^E=']X;?T5J
MI&AT_,E)50) P]Q+7R#ZO4'PLJP%O9#LLCX#(2^T1[,=RPNMMP:=M%U9R^(=
M]^ P(?A>5>>B6E"<CYVV9,DC=H"*@LY;0(N+4^12)?G,4-C?@Q4 1M:1:N!T
M<VW>,TQ]RO;=Y0 2WV03@VL*(E C1:W01P&V; U4"C<%AM=XY.-3BIA0%@)W
M"\L([Y!">&1Q&<,- V6.B]QLNF=[?12<ZSP3]W0CS1Y#C*&V/[;&8^,I)CF&
M:WIZ27<U=)TD65$WKFG21^&294#7*>!X)F+-7;WE->5UC9U[P*63==2=D!_"
M%?NTW>>E(#=)2+/Y2$Y2!S;&P4K*L>.B^OK>30_5GY+_\% MD,J+1G1PW.B?
M2849"*"OCT<.0K#WT&$.\DN RP7_@L148MU3(84VEFBV(1MVD/#/Z)L D\4O
M R20-+=WPM[(F[D+-Z_RV4 @3\?Q+H\).6&\M7=9KJX2^2LW^?Z>/7NV\?3%
MBV=;/^LE*)APV>]_WMK:>+KUXXL7Z^;-GK8;=FZXCLBU;)WBGA-,.  < ';?
MX1P@ U ( P@PZF^PH%)_MZ#42:Q3G/^=>*06> -13+2,@>+FL*T*XR\BP0 %
MU[)LG0%C]D:!6?OZ/S:/-MU($;[*1(O>6'O%AX?]PH7!4%3MDOUO\YD''$BD
M ;/GR?,SX!]:XXV9G8I'N\"O4S>MR!=VXF!OD&E'3H@UH\OA]\/W4U456I09
M=H4JO)9YK$D"B V,@6B;$MU' .II,A==,X,G%=G_($^VT?:L@1!938"ML4O%
M 35@#]JFI(%56FG7.VEKHY5_ OF"]PQ&9]]K&VMUW+RY<"R[,*QCB\$<#(Z%
M16OQQ4YZVA1P(U :%J@QDCW&OP(IF#4M^J^1ISFZII9BQOT8CT?V=R"G%>S!
M\0&\<>0<H*-:-*!& 'A%[RN06;&%=I'5AH@ T%<@V9CQU?@*7RT&O',])AFY
M7/'G1?-HAR]^6&3=94Z9SLG9$%'%_]IP?)[?LMOS6N(&=*X:28'=7UD11W.5
M8.J!FWK!FHE.5D#]^Q+\1Q,#N0+16NEQ&':(=P(Y7G9(XQDR/M7-.,Z!U%(3
MQ?OJ]58@8H]LLQ.@UTM&"(YN<A&KU[PL!A[RC.WCGJ)ADS/6MH1OH?!(RVG+
M,H@%!.4:(,PXLP4V2&;,M(135 E3.+ <@)L."7I?^@XZN:3Q:.VI?B6P_@Z_
M1<CSLL,K4:1A8?E>1YBY3+27]O'T^=ID'3: 5_D8WN)^^N.P\#)L##@.R2,$
MM+OUK-9PZ+_SV9/7$5H(^J\WPS)2.P2KYA(D%4SST4%DT3,'O -J&(/,23.R
M>!Y \L"97CS%T-+0.7QVS;+M2OS:2C.71P?)''  1!U(;(L)+EZS5I43]CCJ
MYVQ UL?\L$/TFKX95*X.=Q5,&X]NCFH9&]>XMVC6@OX!&O5E]J<HEH70OMFB
M&T)Q3^7YW&+T_!&[F*+W)"8'1A>X@//P!(,Q#"O@QTT#%@IC%NR)+LW&:/K7
M=3/8WH**OQ!H&<./)#-GMW"Y%2.M7G> G$5-<Y0YQP.AV2NMJ>U(QG16A0S;
MYHLLEO$P]XROSK)CS;/OPX4Y<4*8R%S;?'FM=%\27=?(KEV97#L>278M7*Y$
M%:>)-BH\%NMY-LCCT4_1O4*N\M6MY)]WP\;JP,H?G,V[5MN0U<HI:$-FZXJ$
MVB%3TZ'KI.BK3/"T<&_K^@@^@>\BO4O3C\.>&K;!8KUGE0Y:Q[PQ<E49_C<>
M]=,HPR=U?#YX7G1C56JJ0!ZGM$&)F*,3&+D0;)OS)H;YFZ<3_HR._)4;" :&
MKW#UFN&X[ @44INL)4&300B7D<I(?O#VYNN;L#ZJSC4K0^@=%]L5,X+QPH@:
M@&D"1$ #I7H+%4PU(I9KCI"D<!4VWXF K5B[""0#4/SJRK?W]=F:9&8,F=Y7
MO3[M2W$$1A+*G!/+Q+\]^!L=B<S4<LS<!C6MP&0Y=EA8NP5_=Z'S^.FJ2)/#
M1"W.E5B/(UFD'G9>NC92=R>Q#DS!(DOB!N3CU,1N\L*\#)"0-.[DU KCH+@^
M74+:DJRF, 0H*JYB0_G5I(H:52"HEMM80& /E*+7,0V'77*K''\W\)L-J15I
M1KYUQ[$\'G5-!C&ZD#C;HJE:U5&7[?8Q"H[W5X(0H,!80P[HS@,&E PT>BC5
MF@3^', &YC#&#^&)>7+&.HQ3ZZ&?178*/#)7%(C<QOLL!*_E-AN.5F=E2BYO
M>-\)NO,D.J62"A"S,B?G4%3/;:;A2U]WOK/(/R# (D4I:2RBT-JPN5!W@<)T
M#$S<FKEG=7$YN@25>V[D&^$R89*.(OLPBJ_%>6*CN-X5OEET(O1*645&O&*M
MO(]8Q@S(*6ZKTW*R"K1HK&> ]41%,\%BT'F4Q"OC'EYVT\2B8):8$5YIJ5A5
M(-QG(]V--#'3I:C1LB??Z6H,O*S#A$\TZ#_OVQ?P [#B,I*<[4*0.:#FN4X.
M:S$Y&DT@Y4*4ATNUU[J=;)CD<Q.J.:&[&G!F"VGW0Z/CT>W?JOW3$P7&U\QS
M78/*@7=4@Q4R8\M6(]&5(=ZM:L6G/@G> ',W8.Y7>GZ[[NEG_RSW])TD0<Y,
MB93#FE9Z.R]%L_'(Y<?]?"KM" .N(Z&O&MTT6,.(V=?$>X";9E7.Q&RWN"CK
M+&38.IH>;CZEA#Y;+84IM#EK-"4(K41J D%S/(UF6"+$\3<*,!(OHGRSTS('
MKJM385&. 1=R7ZSS)E@. LW;XD.V.74LR5BQQ-%004VTYWC8"KR:/K922=?G
M=TOMX@!K7;T1"L<"?P# Y;DN)\ S<A4$Y5U(K@1ETBQ8BT<FS@F,-3FI)TF=
MU7U5">%]7N;GF.%,?BS"%7OEA!XHBFHP7N%ON./D&J[Y:_%$2N3"C")X).=Z
M?4%#P4K6&!!8XU% CZ9@K[YK.C\?VH&"N=H@W5&'@+(\T[6\:$WZI4Y#5[7-
MZ@0= =32X.HD^)-*=95BT8&N!,QKR/2@\;(27V4-KS+4;!IUE*OM-+%JY[:?
M]&N4':)-?*T!I&Y^@/M$R6[3W6-0-^$J&I+IB'F P.25L.[]*TEZ4*8W)DF.
MI*_E/&@OJG'?M<[Z7*KJ*2@41I,:K&)3G]T(@^*F'K5V.:W?4[;GKF][KRP7
ME$0LF]Z*%U:VC2GEG2:+K$GR[+_B:W#K?E9#!Q9@I=LWK^*@&HO9!<253<!)
M^T4'=NXD?B>!\X)Z7M;L@,.M#'NN5G,HS[*Y!IPH&GT-0'6(=YNXC!S$J<)W
M7V@+,>75F$,R/>N&O;3[P>5B5C22)[USJG,X19HOW?<B YBU*'ZH/,$F4*TL
MTR_*8@/SU<$@F^2&Z-;$7T<JO:8S4NJU:!P&U7KLII;P_N 'AHLXTCW@RL5@
MN.:%>2)J!YERQ-S,<N=9F1L'/B+G M%O06X2RNZ-QR. *2(I_RDYO^2/K@CK
M9BU\3<B6 9TF%3^Q[=R(J:^C*\A1/DER39*"5J#U)^=N2-_A/.P8D-C4"9,7
M%4\O#F:LW!)JBHWWPTG.#A<JZ$RH2LEF1)QB<G>&FB#6TXQ'G>I;Q#@C,*[8
ME>;+I35[_G>+W^SUC]$?HG%;?4:%1I(XLKK?P<!&90A3,*JG._8( T-Z (WX
M0H+DB>YF0%=R46#J+M>PIJ+U*E/'W6*&GI,VYM/"=9D%?U0R L>Z1CC57AT7
MYY*:(^] )22W=42O%US[NP5 <1^/<CQ*2V^K"4)492<%I\DO!X&825;V7T!U
M-5@%[%1RD[8(%%)J:%ZA4P$X4"Q;F4ID7G53OT!%S-M*:0]CZ>Q=^(F_J8NR
MS<41BJ8*6-PM*=8<V\45DQ.0-UASK3/2'"]3DF*_'NT5U^1E\_\6%5XVLIC8
MT0)-\3Z^)6@.N?SY?O*XCRV:X*''(T= .%+!%Q:Q1 NLJ+"^Q&X./&E%,^Y!
MH%UD)HO#XX9]*12'Q<^7$3Y#2C;W%IAAO1>FZ9N.8#I[M$J '"FIP1<7->:3
M6'%1B[RH^P*#E!]78M3;GA"_8V#KHX",(XG65$*CY /$%Y^7.NF4^OG,F)U0
M+*?;3\D5)K;[">]R"@>R(7%IKK8B##19(M==_8P.2II7H=E UBL"HFJU@N>+
M.^Y;@SE5RTTNAO>T)[\94EB3$LN]'K;;,2"*?(]1;,'5B PVFY3Q98QH:W%-
MD0T1WW0:3YA@%,@SV@7*^PS)7'*EB7V1Q/2E CSSC7L?G_^SO(_73(X=5)')
MS]6Z]5^>3N<00;A=0\]/-C-F>DM-#5G/\O/MA;OXK_)]!=T4"L)7BC,TRG0?
M, D4G950?%>&<)%+AG8Q\.M[$+^GZY@P 98*<.HDCXV091AC;+ZH-8N3&@'\
M;\E^,6&ZF4K12QBSUPDTT'+*5HC6UTY*D!8%WA-_7MEN7+:,#-AO"=##?Z7+
MV%%LJ?<-,*4E!U]F' /4(4*5SS:<]<KJ)"FTUT"SYBO4[:#<=K>I);>SM-W1
MVA60T[]<#AQI2&N$<!W.?FLC=']I5$QR(/UTR99%.6'N'7MAUG P=SSJNS<Z
M!*%[+!5U.Y< FYN(J,/(3E.]OB8_P8LA"4CEV&NZ"(5)M)^7)N\>3I!DT6F,
M*=9Y\<BVB(@CIR'JPL-+*F2'HY!VL=)J=2IH*'/*1'4]8\#9N6/98R\(+*.O
MSY;:=F-51K+^76.$Y)I5$!P;>*+X1+->N2?V8LC.0[L;C_SM=34DPV:IO]T]
MES4^H[+&MRW#S*+\/?8^,_J&M.!(SE2P'QYVR]+^#Q; VHMH$:5+X:^1I>$?
MDFKFDSE7'2?CD?%LR&->XKG;@\1S@]#B7J_)2ANU+F>)25UT]CC5?2IFV6=:
MT=;#.V:6S=(V&2!^#@&I\V*H!E= @+6%V VVHP\Z*!J,K"4YM0#S=R#/.6FV
MNE1\=55?<@X&.;G;S/-=0@@KL_?2$&L\>N=7XM &_1YT3A*7#W-)@0BEB4_+
MA1 68D'8%XT^&_AR0+4GXXT; DU;- C=3<6]93O^(/)\ZC=)E->83S7Q9<Z*
M)?\4H;1.'$^TO>(="%/\3*^[)4D\["_;R7\8 %R_VP>:85Y/#0>6.H4)#6C=
M[JOFMF.]4INAJLS09G1].IJ5TMVIFS.S,A?3"ZMW+-Y%.\FS*?HN7/2733HI
M^6*U^A"OW6 65_5K?7V=#$:;;\)\K2.2NO67]YC+ZO#O*U$'/1B*EKKL.=RF
M8Q@CQR-!R:XNAD23LL@S3;)T;EVFRRPDRBEZBEZVG]G$O:K%S%;H EHL5Q[)
MQ*:U-4Z'FV "0*JPHI<*#@F1='0?FP7<8XLNYS8)HNBE16 XG2Y9Y5E*SZ2,
MR*E;(.=F(3KA&-#.F)!\M<G*'KK*CL3IQG!TPPQ?K4L"G4]=ZQ)Q1TB)2W3Z
MKF;-(A!Q3A6UI='=\E)M^:15<N$KZDZC/$1 0CC3DHK9(!"S*C@%U'^A :%"
MY%'8OJGSA*D#FI05X)[SXJ$&3YH(>XS3\GW'?V4+N7#CR0S3+T2>(#N6?@"&
M>W83I9WJ$(_L^L"]QSY(/?$=<_JC:>/Z-ZHJ?-1+.8 OYI.B:,6+2PW8LSEF
M<R*EW,=Y9P/G[5&&O:.N6*)NP2%&FU5AU=SD9$DC !2Z"G]&X2!2>1:JHHH[
MAQ=WPU($:3?N_\VG/O[XSW(^WIT9^CQ@AG8&G=RC-=KGIZDZ+QNOZS,GN&-2
M, E%S3R[:@8S:*J$F@:/ZB48VQ:>-"(&O4\Z59^*-2GQJ,[.E>Z8=(H$)J42
M5JGE/4OWD-X+B7X)3SE8"V_(,\Q"QW3S$U%:B#GHN$JG>#&CKEI17G)%%Q$^
M4S?YNH0K7M:ZM'-@[GL]'G%75%TM,EG>3[_D_4(?B3E82'_LPM7TMESD*[KZ
M=')34)G!()Q?2VUZ@EFM9RCJM E;SXQOPMU/<?MD>'0O<+J$$W#CW!/=),#I
MB3A8P_BC+@0K7#MH/+*E@J[7PB_$/LDD9]#58DI3WQ&HG:@]=RBL6W<,OF'K
M.^[9TU(% UHGMLI/&DPYT%W8.3%76V;&&D.5V5/1[LTJ"_1B2\L%^VNX0Q_W
M\TE;T\6D8V=*J:9GEUEQ+ZTDC?[.D.).F>0R'H]X.HE8SKHGBZ1847?3VO1K
MG"S-[R+YF6G(1RO;<J@I,IK<9FNU!3?QZ\Z?L3JK5W!V&8V2H]:E4CR2;I;H
M]'RAK7D_UB..QB.O$(KRCNZ!DZ5#>" V*0>#SC-UP;#%,C=)<^*8DDD$5QP#
MTGFZ1%]NK >U.>1CUC+H1J7,SSK<3Y*NS0 E=I?VB&Z-4G":K%;B4ID YIZV
MNHV7XW!UV@M3<F^G$."2FCO/2G\@?5OMZ ERYDE]AFFQZ70ST8I&MP#$4?.-
M+N*EJDJ#S)(F4N!8/J.$O^RBK3W."ZN #^KCGOZ-LQYW7Q_LZ:5>?SQ\NW>X
M 3KKP>ZGH[V7^C]6PJ@+T$<1+_/KHR>/HC=[!P>?=M^^W?_PF_G[Z-/N&_VW
MJP_S?@Y9<XY^C1XYNG9&+:!?)N=EELJ#;\V/G_U@3W7\MO/MCZ!H_ULT;8"*
MT;IS-0-@;&VZ/W&_\G[DPCOR01S=UEC9CCI[,G,6L@+)-],Q\EO5[OFQ>"2F
M;9S(^6F'S@__.,1_(#)\QZT[PJVG#Q"WDKJ6,+%XVE5QBL);E_KZO-H,ZKP1
MZLGHHMKS^7%WO^](]Z60[MD#1#H'J83_]/K3#TP<H)3(6_$]]@)B)J*T/+EM
M$;0X 5Q#*YLY6C$JP]*N7F=JH#L:U88)J/+AX[L?$@BP>A2^^TXM7Y9:GG\3
MU*+'+-CY$^Z8!3-GJS\ 0?(QKE DM +CO^/@E\7!'Q\@#E(_M>6=\$LIWAJ>
MQ:1;]0UG>WBF$RXV+2OTMY5<2D*SH19N2MW 4M\Q^<MB\HL'B,G3LD2SAYFI
M%&HL-5*&1E+<!MEYA".J K<C&<G+]D<(](I+;C?-@JHVK.OG%AL>CV3RA).]
M_)W4OBRI_?0 24VHR_4QZ+PLQXWOZ20WU$B^>RZ^+';]_ "Q2\_R1?1:E)C0
MA&&W6Z'1$(_Z=A,<7CSX!(?OQ/7+ R2N>5ED3>DV)7+3![[SZ@>,3EM/'B ^
M<:VSMA]ML!>;.173+,^D,LQVSW)Z/9TIM: 4;!T9H\1 3E8)&7B4H6G[N^H,
M[E"2"Z6*Z"Z)G2F%V56:SIOU.(."RU&^(_@71?"'&*.S".Z$<KW9%1QIL=6&
M3IC7Y.UVL^;]=)O-*[#.KY:_VL]9X)Q:32=<V67*F?YNDPH4DYR+5.<X>6M&
MARP:GCO8.S$M0"U])%#YTB^=+#CO0)>*:G":K@J!GJ<F.6R[4RII':D>#[B-
MG+,=!6BPL!Y<2B,BJ)<S%D0JC\TX6]W&NFIO9!EM4W= <39\9QQLM:OL/C(M
M3OJ89J<V<I<H9W"C/296X65<'^Q7]N6 (47-?G*=[^PA3Z]V5Y(]L64:Y6KK
M7\D0)RN/+FEQQ36FG4R:^ZEH#Q,OY>I)-4+62(M)$*3%26DS#\*MCF\7CG.F
MJ'@Y8%S(S0EOBRHCI*_KMN+6SY3_D.@"D5OM(* 64-<57>IVF\6E2RKC'=4'
M=C3I%2H-I_(Y> 6 .*F2N:X:-%(&!$R#N7A.^5Q; [X (&,'IC12ILXJPD?_
M=0X0;QH4DI-R762VD(%;*ZL/N>K.JUKIB[Q;LYW;Y<'_2'GP)M=*L.52E#@"
M0'WJ HJZ2=</*'4> 4_N DXR[R1WVHSB.C9YGCS44S=,RP:KNLQ8^-KM4FH:
MOB(WI:0VOXLD?3BIRC-5;>@,4V0R/"JH\P[;U$B)!)#F7ZZ;N['M T+(N!D=
M,2.7DW?>O69*R6_#!)P*]/&(F9T_J1X5("SGJ<Y4PR/4:[>18#]!0.?/!)(D
ML)[!!:IP5TE P!O =OX\]TARNK55)M=N\D E^YLN@+IS48^3VM:/!Z;.<U=V
MR?^V4^02[!,K5^@WI#(EU=C/49?)AD64G($#?76F2]E),9I*XS8NE-+)R95&
M#MM>++%ZD%1!ZJ+]I15$,@U'K]YIFV^+'@/8R$UQ.:H)1]8M4>ZG2B(,QW!Q
M *'AG42K+DY+.'EEP(A]2HBN:I9!?#GP%(^75]C9(-"ET.9Y4ZEQR?R(T'$"
M"KZ6$G?<O>.FN?SC40#0*U08J\'<$M98@@W*KBI.DA-;P.2H#9,[4Y(<?=9)
M/P>>1OGGH2ZN7^"";B?/7Y \9W[IC\9^&,U5%DFHGKW/A@RKZAN6W!&9[4-J
M(H)?;6T^>?)#.$", F6!U3[$"#I"$R/AWWR5YT\//@CR%0=<!,0"ZH&$>.7M
MF,3MS0@G82"H5NIB3S7GD7,\"56.8&K4[H#?63<-KG6KE%/O3*:W73A)0W\;
MS-)@7F\H7Y=ED5=$-SWK3W^+[:KN1J[Z:\I@05=5WYO&>I#/7I&E45KKO0EB
M6[<Z65[F+O+*?%$-=!V,<'(R=@)]^GWGX4R):T<Z2"#FUN4T(R=2T,[IN/90
M"YBH0LVH6<%T6K5.J6E'^0QT=0W-80120259SWF2PJ[9C"(MRG4Q!(JN,/W.
MW[ -HF#/*E3$J9T?BQUN<:@ NICMP9U8\3^X#Q"U0LKFD[8RE6&7$E.[V "D
MM70D"4[PTSH[H:9"^A,\'D],R:;V0[]<US.';)]Z[ER,74!HOBQUU'8<U^)(
M)#?N98U2^">G;GUF*7/8Y -Z;!"?C".KATJQK7+%[S66W+=;Y"=2HS[9O+,]
MV>_#T:0F*JGTN 8J=[]@;.S"UZ*V 3[@A$57_7N,2X*])$WE4XR.\_3( /$H
M*6DT]:^X@-NFRND4/(MV;7G@OALPTO&#[GI2""HV$M=7"WZ&)\D/]Y*,9#8W
M?A.>/A-?OVW9P+#"/IL$T+=5I9EDQZLL)QPH_2WT2"$=*9XG>N3P4*\7W4CY
MLQUOPR6;;I/1M96<KO':!&&:8V-*IY8+9>GT\NKUN+<]Y&3^[NYC7,-D@) H
MR;J6Z3'F!GN=D#J=?,.=!@,M9!Y$\;UA&7T,Q6Y@V/QB9>^R3D.F\*0<OWFY
M%["[96:- ;?7#: [2 291X\2X?F +TM8WGBDV_-K1QT3H5 HK09?L*]4]WB5
MYIST)04BL7.N. <=Y2-@VFI_A;S]#J8UW4[6_4RR[L"T+\;]'\A8K.4VL,U4
MS0MO7OL#<>][7E,<Y"4.4[Q!557<#/6O-CW1+>OGF)]P1MHAJ#;2H)H>S\E8
M:0-M=X<$H Y*.9W^/3V,IQW69G!(PN_@(1QF"#NJ4*"GX<YF*JFY"_$DH0%T
MV/^F$CNJ4"=Y=D*-^4ON'X*!*.WR#S2_$8K5W78J-3VC)'@0_9QOP!0?ZI5#
M&D+;H7"G'A^'K#<("./)! AR(R#:CP<&$2H\IJ):]IK6&%)LYQ0U/E=F)-O2
M"WIK-5&<]G PQ4-@IGF2S9G=<#V#^0E=+F ( IX&*."3J&.W6<-:?(.J*RCR
MBMHY8#->K2$E<_$V<O]WR<6X (6Y+G&F;@22N28-I6VD)?FP4A[KP#C G6Y!
M. 1%VE'%T0[U*(=G:+9QB;"R"(Y(1+,W>HXOMK45XEKC9$T07](][$/&+?'2
M7DY)\,+U]$:O*VR=?8[67HB!1WWBIRU=WQS >BHVRR61C@[-:J!W0$MU&P9"
MI9Y[+7$SM%AH5%9F#Z3/4W59L7Z3,[L'[:.2+E1T&Y#^S#N<=ZT9 $DP!9MV
MH@\.*<X>*:'>&'9$D-?L3C>J"FYT_4Z):B64Z:XH+RG#YB@XP!-9,OPWZCV4
M'()++EI,DSC'P4[8;8C[]N/@(@S_Z*NBR3 -MV+A.N%31;V\\NP48QW:PZ-O
M%H%P5I2V=Z6SZ:\# 4/8..^SHB&F?"0]B<G\-='-!REKRIO+/5'+$D4#6>*F
M(1OSD_R;]R;__-V;'#87=!<<2;\B]T<FVA&@8*IF2@056EL1Z*-SXO:]> <U
M:$<I@@W0=8>K6$QS1+^R<APC(O$P0B@HUO<;(]V(,C!722&FLZ?F;?UHC)?.
MN 6)U-EA3EHC<H6F(9S*G9D:1W^5F8RWY /%_NRCAWQN]@"#A:),-L*@'T$G
M#6"T'YEF7<Z2RK3@NAJPHC4*F4NK8#:'4:Q3UE _U5IDZUJV3A)1B3SDK"(<
M%9&@5X]:Q2*X0/!7:)JX,YJ !ZH3$NO=[V;N<+D9"M(;MB27^75.<:4W><4T
M=27A BH":R/X]9"]U#F;VW9/.LE>L@8V$4OUICAV2^FH=+6V<[1CQU]MH(?<
MBY,U\QJ_/SKSCN[/8\!$@95WQ_ TFH9S::ZFPZ=HI-%F]^HZ@YWIX=0\C:+9
M33RD3$@ZJSLCFI]%@0FOS16-^]SFH2/&C7_92<C/3VJTJ7'O=4:4$(4 &%6O
M(NGV7>^@8E^5-D\2#S;N]Y4<)_IZ#(?J,X*<5IN;I.8;&C%N"B=!WO7,/)!C
M#?'1K$#'$3I7R8;$+%"6A3+"SSHR4=_64E*\(,P.8X<7$EX@(W5&)7(G&8T-
MOOL"9/0V>C"TCDZS4_"#T_("8<1_^Z-+0NJA, P*#@8RJ RC%S8/ZC*S>9?+
M+YE5URZ5P(:[1-+EQ_$@IXX].R3$'>9)>LFTOA#+QEV$N-=PIUP24)QR,QZ)
MU-'N$>I3VRRM+YQ20?&5;#5Y;O^R9SR3+2PF6:!!<7G[-K*$>#R6-HF(L+S1
M)0]C< 4GD8H^Z9)NS[OL$P @C=$SIV5;.2,I<91:Q"JXHY0YM':!73,GY#CA
M@H(*YT'09$\:)H')"-.,D4_SAXIGS6N:T/Q%II4)-7GF$^Z9RU-NXO$*>[F<
M-=E;19CE?!KP>>F9HV%W5QST:#OB/J6$#*Y#H1'"OJR/S2#?2:UT_COQ. -$
M('379-19Q$QZ:ZY&)VU1+7E,FWK]>E#O;1?'"LM,->(:(EJHL[AHA'_)R#W\
MZ^^VK-JYWD%P@)5.<BRD!;0!%05_.-N=G$;*R1*.UF@,[LQ5-L/!N75JV"P+
M:&YDL3>6Q UWC@F+5AW,1)X^'NGIC>4B*\P0B/ON@^N;CP-FHW%]AB0^?:&O
M)23O:8"C%?BB,3U 2Y%:<M,KYW=BE8U'US3+HJM;99<98V$)_Y6L,6!MP[+=
MB-YOU!PQ&6(N4/6V@,JIU"95KJ82K5)4PI8E3F:4:D-7_1&XZO%ZJTAQR#CU
M_)-N"_<9V= T64%/;.8TUZ"!X_($#-%WS0"S#5-&)5R 1 %SA_JFIHA+J=C)
M_@NH_=^\ _67[P[43C?QOLHJ94)M=:['*_@=\H)9%/<7(_]%QL4X&4K'J_9[
MKU'R0'F4"%0N(".(&STN158^RRJ4YF1E:VTI,89)I7 \&-([H.)4JI(NRFBI
MDDJ8=3)KE)EU)G^R^H'SN%EQP,>1%^"_>9HJSU:TDUP,MX(?$?O&.%MPV(6I
MN^=\J'QI4UM%J[7Z:K5:T26!US8F[ 1/<3,.ZPET"U8EM]5_F5D9)YZ[2^/L
M#[,3HRV7C:_4>C=&PL!JS\*O35=)U/WAM^2HH P T?=P ARH=(KKY%%JVX%_
M=BR6/IVN=]3S:N\#62<]9)5*66?@G3/7SH[:IB/9W$Q6>L%6;99Q%+[]P9L'
MA>GJ5Q],$^?:T>QS@P'LI:X3[@R,%TU"Z@[Q^@;J&),6"YL;07<#"-.\_%S.
M3)G4-68+WPU[O+'_@G-^C=UW0Q)SYQV;M>SYPE_K;.]4#_)Q3$RDTJ Q:A[4
MZUV<PC6U==C9S)=".=7LS395\V(\&?YTF2E[WQ)LZPE7>MLDUP&A%29)2HZU
MWFC-O8B!ZV[@=L)PAVV/1X9O?QTN?0F3CE;PZ*!WX\;\6@S1+\:P[ZW.<&N+
MT.DW3)TA)\)!<F'QQTT>TFX)=IJ39P: Q0Y^3,C(ZD4K]P)/G65L:UTEX4H<
M]A<T)G(X]RJ<WQ';0J,3.@0A-XMW6T6.KYABBR[3^(0-9+IP]([J6;#DG$"[
ME&(_"+7_E-490"-8BMTILO 6B)S?QX[9*:ZO\XSKF[21B$8M+-78:4+.VL[S
MLL)0$CPE[E!*HQDCYV2SW"/;>DIX]H8:?L#F]KDIIHY6?.*6(9@Z!&)6$+ $
MX.0+.M(?FT>;<K\\W#Q#/S<Y5%M3A=U0PE=6LVMK7A8*Z#9/R.M$>4@FY3GF
M!75Q,%Z=.#OJB,*>=OXRNL>RIFW$8\*ETG&$[6)G2YT0B)A%DYQ9O;;N",XQ
MD;/JQ9U GO2P0:1&>YT2 [FSG,:#I!G8C'AU2%__.&W*B:H$U/%X]/3)DV>;
M@!FZCX53WN44*O33K<1-P0-KR9^6@Q&0+B6D((U/U@UKU6F?18)Z79*F%7=H
M!O,A^0RJ';;L\&^Z:+&,WCHJ[*5N9'5-M!KZ03\#D2HI<S ZDOHL6N/2BB5Z
MQM$JDEW#5[A;\I'8XA6W(:O?^4Q"TMW74+(Q''Q1FQ=%WGOP@8*?6$<L8>Q@
M*F[AGP7VFFF6DG@/DBZ9:EY0D^661$IJ5.Z=4)\1H?Z>U308KU!E6VN!@!67
M"_:O]E/Y4,#*Z'.6?U1=5V0Z@E(I3,KFS.=\J7UY14E\GZ,(E&>!\;UYUJQ@
MERPUG*8=IIU*5FF>;_),V53>C/;%OM!+]=4F*TAP7#<7ZY(7$J0T-RA+)"QG
MHT#HPFQQ*!TV#^BXL5G11(O;9+ .-CP!S4J/7&GTN-(!!T TR9CC&9>H'CLO
MF;#X7JF_,P 4I8>KGS2>9Y6K"(-6@M[<LJJ_><?=UI-_KN?NEM3-\Y(_49\/
MU:#K'I'A#<[?3#F5V WR6\(/3!%$7[UUC(,AJ_*9B7%A_G&YE&&##>:U\Y!/
M>8DP@(12ULU6O,FLKA5 0@F%+,N67M-*T1O/E>?JYSJZ#$U[25XB=[9IP>T6
MU#'SEQ%).'A51G+:ESJO&X\ZG8#<.;&!(@[3"4A'JIS2#&<.L*XP(9'.^>4T
MSD1+0J%<;3FX$0ZGTD5'5\QC7HY,6S@! 50*B-=9+F)Z%TGHQR3!^WUCQ)I4
MGQ=2DAQ-0;6B^,.TPC*.)-<]"ALO$(> <[+V>8!JS,:[;:Q&^?SG;7YB6OW9
MJX:CIFW.^>^D#*%W2=H7Z>P!6JXNAUJU'9_V5>JN:WOK.4,$+3]V;E_!L?TU
MS;C;9-FS&DK&K!8)-B?ZY7BTYE;\?RB+13L!4R3Z1(IKM_S720((=%IX^OSG
MS6=KS3J"[-"TE+Q"9[J-3SKUQR9NW&P!)[N# E5S0"QR2IIX]'CT&U@?\XT#
M!,S&ZSS+%=E3T1K"S;Q^U\L4B9V:?%(.+$#-)'(SS42\**Y#8('XU)A968Y/
M<;#MIQVS.I!0:7TEW?RO+ATQ$HQ'_$+2^]UIQC>\*JU!2\DVKXL\18,JNARC
M;+E3<,QN%[/-&'"&G6&C?NH?IM<XT>KQ:)I4V&M2O-!7@;!T@;1ZIUP@7_\-
M 2;X81R+W[+6M?5=ZS+<>?\#;.;XP][14?3G^[W#O8_OXI F3E:D2:CO6E1.
M;(_U)8J\48P/# 8WR#?D[G5S]0.O%\^;MLEGVJN'C\G\;/C0[>=CI2[H?[;!
M8PWVOTRK)&G8M6$=V#V]9B/Y5V_W_ZWOLD*WSR.GMWRWY7NW);P@Q'/$!Z=S
M_)VVI(>#RGB0PQWY#],@_J<?'G$;=/.%;OS.A[4HJQ_T?__+4_TY]5&W;])'
M&&AC'UWS")W-42][@ : ]@.2V\[K@]TW_W?X\<W_1>\./NX> WBCP]WCO6C_
MPYN/O^_Q91T?_G%T;/?J[]-YH?.^]WO[O[T_AM._\$_O?&ZW\=2%Q->"PL[K
MY4MW9YWK"XP&Z%[PAX]_'NY>@QUOX4<3JG*Q'WW&!G=PH'\]H?]=DQD]KA]'
M_YL4J-.<%GYG_J\&QSL!X@=@,R_Y:?>?SMF^S7,=8VO$P,'<?X)679&9?&,2
M\RCZZX-J@*'L?_CWWM'Q[R"EC^+HX.#-=P[R4#D(*.KDX7B;@:U=_A/Y2/>$
MW^;IKL)-?D^*Y(3&+4NAF:MDZ'$MKQZ#[O5-FB1'V8E$GC]A91<:?*_S9'IV
M6$[/HG=YR4'F0PS3[A>44D>) ];-B7:<U::M0?/J\>N/;_\#D'E__/O!SO\'
M4$L#!!0    ( '"+*58'YO*N2SD  )8/ 0 2    9#0R,3@V,F1E>#DY:#(N
M:'1M[7UK4]M8MNAW5_D_J#)W3D&52$)>DPYIJ@PX"3,$N)AT5]]OLBV#)K+D
M(\D0GU]_UW,_]# 0DM"9TZ?N[0FVO+7WVNO]?/OA_./1[ML/P\'!;K_W]OSP
M_&BX.UJ.MT[3:!+/XZP*!A?\WR+FO\=Q=1W'6; '3WP^RR>?@\/L*BXK_+(,
M@Z.C_2#*IL&GO=';)[P>+/Q$WA"\W3LY^"/8>[]_<G1R]NNCWS\<G@\?[0;X
MS6DP.O_C:/CKHWE47"395I4OWCQ=5#N!_#W.JRJ?\T>S/*NVRN1_XC?;]N]9
M-$_2U9OS9!Z7P7%\'9SE\RA[% R.#M\?__JH2"XNJT>[;_=VWQ[N#K]<)N.D
M"C8N-S>>;09OGQSNOGT"WSPYQ>VV;67[V3?<RP2 %1>\F7<GQ^?ZONO+I(JW
MR@4 _TV67Q?1XM'NZ-/>UNG18'_X<7A\_O8)/KX;#-[#'_#?LR%]'#S$YM=@
M &[E^]^H;N3ERWYO&)55\/(98-ZH E2M0GK^C[SX;/\5;#]]^O+EFLU]$S#M
M_C/*EE&Q^J]L7"YV?@F#9T^?/0^^]^7L L$%HWBR+)(J@6^^_RWL;C][_3(8
M7,79,@[R65!=QL%@'A?))"K7'?>;O+O]<K=_J9_9612A7-M&8Q>/=OG6:!5D
MB(.]HZ&NM7=R=C \VP+6=30X'0W?Z#_6;K5^KD<!+_/KHZ>/@OWAT='IX.#@
M\/B]^7MT.MC7OW\_/#C_\.LC.-G?'_%^SH*R6J5Q\&OP:!%=Q%OC(HX^;R59
MF4SC-]%5GDSEP0/]\8N_/PI^$X*!<QOB2>,9'/=L^ ;8]('^QOW.^Y4+T\"'
M8G#?V]P):INZD27>^,"@V@)TW/H8%9_C2GBFLLZ3V0R0-+LH@_&JW[-,[%V:
M1Q5\'IQ%50PL;9+/X^"\6 )?070@,,%_SO _B!;?E8<<15.D8I2D[X'+I2A[
MWWP5$ZGB+Q4@R!16>?/B[W?<QKLBGP<5?!I4.?_O&J:_@1S@O_ZV_>(?.R!A
M#Y*R*I+QLLH+E*XA?O%ZQWY_'>/'\FE>V"^6I?UB,[A.TC2()E40E?T>[ F0
MOD!N4\07\(*XB*?!_=$E8G29MZ%+[J!+<!ML"8,H.(C3Z#HJ8J#6J$(0K(**
M,,F'T;ME-G4.&^+!E@N$]?9V^/3I4_S__1XL/<^SH+R$!<O:"B/ZT 48+#&.
MLWB63)(H#1*4D#%N:A$5P564 J_^/T\? ZL,%@!(6C-4[HW;J:V_S^]NO.8Q
M')E^ \R>N'^YG%Q:6(5VO4N0!A%JCU.XR^J2OG!P P^;E"5L"W&]C.&VJ\LB
M7UY<]GO\;>T' -XR**,4J8-44_C=$WAR 2^>)(LHY7>/VJ!EEDG@3$:E]8[U
M%<K!O2CL]SBXA!L"W"(@P8'[O2*NHB0+6B2Z?QQ2S3NH:)4O7:S 2[B94$K0
M_!>J^2L!,)3I[@"BBQAH46[%DH8@D  =OA['?*M3OM8\G2+Y>$C6[YG-&I9<
MV[)Y'A>I(\X\6@%Z3T'=  *<U1E52+\!*!BX$A<!L!*F3B(X>%*MX#' N.4B
MS_@' (%_\PD9C8!ZYLR&)SF\"Q$'L"^NX%(+ ,@X3O/K^_/E7^Z*-:/A_OGA
MR7&P_5CTE4^[!W$Y*9(%H39<AP/23[N/?_P.-Z)-WMJYQ0MDB(P;A!"PT2B8
M1O#S8!R528GXFP/0B^L$> I2^25>#CPN_ -_NUJ/%+AFMH)55\%&'$TN\59;
M$"TX *1QD:VZC  YD$BJ D0O/(%+S) #P1OB+Y/+*+N(<7F@F\FEV03^_M5.
MZ9XP1;G$NP.>!'#% ^*J<9UW5RA(AK*VNYL- @-NBD&T\E_L_Q"W74XNX^DR
M91A-TAS@!^_.BWX/V6M5HKA<IB !P'3_C.OA,WA*))5-0:)3H*%%!9N-9E5<
MK(?S9705!],8R2/)8OY^'GU)YLMY$,WS)7",-I[@,@)W.00TWIMW/Z$<F=$@
MRXEZ\:GX"CD27$HL;Y8W1E> 3-$8U.,9'AT94)1-X@ .(><!9EJ@.@5KP)LF
M50*G."--HHB(<D8@K]G/L0$(. 4QBJ<C,M^L7=]'.>X!8?" MN )<X4;0(@>
MA!N!S:#8)9CPJNZU,J20K^%A:^!B/XS@MP>G.C?]*._CC9WB6[U]U8'/\(VF
M5TAVSJOX_MJ.:8[6\BI!II%AI-U\% 5?/@N==_)6EK /1MJHS#.ZT#'H,'AG
MP'4)ETA1P&?S&>"X!=XT+I.++$("1&293/)B2CA@= ^0;\0@IZXN8#EZPFH-
MT *)NF6Y _>67X%Y-0V#R_P:<*\(A5UD<$^"C+QQYR"X/]D3/(>X6I9K0:I4
MT($F#6CW>RZXD<M>P)Y5->)%?!(D;%): *8Q0@+(,UY@&QBV9;A,SJ@-RTIP
M7(NH]H@E2U-^@2A/_1X:DPLV5'U)$\\;@@8_<BS9<0Q  $LVO8Y6Y2,461_.
M@M'A_P.1]?R1+DG.PS=_^X7^S[>2U9#<'QZ?#\^^PK-X/Z$W%J%WG%>(<*#]
M9R1,$&IXL(L<_FI28.YP6U9KX+LE4H^!-MJJ59S&B\L\ XH'*IHEQ3Q&&2-<
M&_C$C0H>VCA):DP;>"TL.<D7*[(;(J X9 +3-KI6/=MY:!UG<.D9N9E+$.OP
MG/"IMHU^S]E'B-M&V@[^&[A[!3J<3V#^ BU;#!WY=I%<X?7HSV"CEJ3 P(FF
MS*INO+&05$CYO?(\O;C@EO?6[WW5S86P=^!5 G?5R6NT'U4D-U#<=S,T@@$O
M5I(:600LX%DVVLN,2'C21<P74<*P  ,3[136B-140 &;C]/D(F*6WV)&P+$=
M_H0R@7D4*3 *R_:+NJ^U=G<"GSA:+=\OZ:8E@07V.H\^QP1I9L/^)2R6!6HD
M<O"DA)-[+#@,'+U/K&#4'+,RFC#XD'*8#T\ >]+$BK8ST/Z"[9?/'67'L1T'
M$Y+GV[\\?T[V<P0J#B  XF.:\C4!)AH962Q3<3ZQWL@OK\S=,#U81=9[D:=K
MD/NFA 7*V8HO>V$D*PCK%%Y<K. M_[U,"M*["&8>6%X"5\48C<+2>]D#H,#4
M00&\!2 6I@^7[$/7XEY+V&ML;KQM-&((F6[ I:".2IXL'RP 62:D28V $2,I
M,?:B?P?T9-Q^FX7O4&88S)=IE< ZL=%)WY/&,2)4!XT)]?&RKHV:]QA ^4HR
M(/6R(+2?D@4[9M6-=CV%*YH"^]8SWAPK<T.7)E96BV#6G2@M;J ZD5O6!P!%
M& $])&)H$+G/@ > Q3%?Y"6#!S^\R &[,UP[2I%9@@R<;0E%H4LP+RZB+/D?
MQIX\LQ)%I(LK<  D>C?*!(G%.%NM.T<6D6LY['>CJCP?+:O+O  R<'X%#XHW
MJF,E=+RP!MZ&# U >K\U* H[)=P$/$,^E"^-]>$36.V013R)@8&4XOU1Z/FD
MX?S$\_K5T. L3LEJZ$#4QZUZ7;\'UPR8B1I>+OO-@&$7*S55F:&3P"W%,T.8
M[&P#79KJ:* (#C%UM%#RY1ANITX,R(6KO-..(\L<[!(K=7%OB NXGP48.68?
MMT,-#RW(.0G?X).^83J[Y?KFKMKP!?0H6#OMOFG04M(80[T@(5%H7,'/40@;
MET/;/89M+@SUW/APLIO6*Z&_^CWO#'"!:3)/\#V"LNA>I#V4!ID=+&[;U -(
MKKBAO##*B#X87(-<A<L-1$FE;9('J>FN24%75\.&_4UX5'&=":G6W%3P*0DS
MWW<!EC>%4=CZ]B4>+I(MYV..^'BRB'P*Z.Y%9@C/ABTHA:JXZ\7IDBJ&%C>M
M-1(B:4_;6%#D6F7HM+S6R(8C.QW^_..O>2;7/ +0ILQD$*Y?HY&R_I9/0.72
M6RUC]. $XV4)0 5HLY_4Q8<IWJMQ6%I0D'=T3GY0OF/\9HK&4^3JDF;3-1\M
M\H:4C#SK(S9^8;A;Q%[<@K E,4>$70K_/A$<K+TE]'Q(9(<8]=MC"*7]79[I
M 1"+59*)2ANW>CD]_A)=1&CF([N8.^ZV5I5*>9'J@:[3I?6N<3?.0W9_[/;D
M[<T >/V>4<(;_EJS5V65Z$XC&[\*2-^(0=M)2)/A,#FR-Q0"I*M4RR*CO<@!
MR0]6@N'!& ."NG2@):^3-VR4FZXGKPE*-=%G'4(02#X";14O"1V)/H^7MWIW
M+G[5.EXX\2#'C=FP4 C)DA8W >]F8R 4><F8I2@ KYX31BLNX!8<IR?P59"(
MDS1*YBB(I]$<[ *@HH1<]R1(\:Y+\LF4=%[&#<RX8T_<VT6'[ZO!=0*7S;RN
MI<+\L%2N+7[I,_Z?+<>C^#,[%>_$OY$D&7M;6 @*I8T]02=?P4?DF5AS#C"6
M&7!2!=?Y$N-MAF\B(T#7&0:,HG%)F@#Q,GZQ3UWBQBJ0<2)C\-57Y"-1DHH*
M;$AKH:RKG; ,1S-N^VZV^55$Z*HW3?+S(UG?B@A1-W:I,*C=HZC4YOKDT/RL
M 5B+NH6AT!P!B7Y]= 6Q)4^XL%_#!=]FY.0/#*_&4Q7@-O)%YBEFQ0;OXFE<
M@)'ZCMAR 3?T$"'CBTWC>04=(^/;5:^4AW6JFYWX"2<-UANB)33/,>Z,/K4\
M$X_S!,V&:52@#[E 9W!2#^Q:_:\1]D1O58PQ7C:/@) P[Z0R7XB+WU,47?>W
MJW3!IO0,H='#/3V!TQ5B4&9FE.K ?CFV*Z?Y9"D)6&)O8CI.J*D3O ":]@:?
M5[I)=E@[>,XNU7YO T[JA;9<SS9@-M$*07.&..3J@2"U"[1TA!FHX2@VF$VY
MB#,@_TD<C8%O5"N)"AIW)M@=<".JV S0E^J#@',P5*,AA3(RBBWZP=5WT+CD
M^3R>)@!# ,,"34J-S?1[W0@A\00&FF?R)B6]_ $T_,O[$LI <GK2E%@U!R+P
MCF=-+B*6/5P+K  \XD8G7)9G6V1"XNG@%^J',SR4+AN8+7I)W94%+WCC?"9-
M";$/":,433\*''^:(%RU:O5E(E6[N6&<7^;"QH@ Y/-)P8IR1']Z)(FLM2IM
MQEF)(:49(#.2)V;3 9H"!H>R2([_C.'(^0HC!<@S+IAHQ7D('*DD>REG_U&>
MEJ[ P,.([3J/HTSB(+ZA]G*=>_S'<O'DVR%G<$O<C+]$)DK%OE>4Q18O8,')
MZD8/++%L3%=D,2XI!!;S'!XUI?Q*6C5I.Z9SI@>X LT.>V:SP\YB8'BHZ G[
M1-#_'A4%2J^X;-&Z*&VLW;=<Z%IP7]>\1LFR;*K1, 5#OV>C(8*@9"]SY@?_
M@KYI\0SAEPU[#._HS8]GN)K,MD>*%$E$BI/5H$JR:"R!+O)%MVAS2<V1[7FE
M0^9H-B&I- E)\,>-K/==7LS%4[WU3/GNQKL$Y/N-OSU6)\GSY\^WGKUZ]7S[
MM0E'H3YTXP*OM[>WGFV_?/5JT[RYYF)O2[3R\MZ232+ ,1:8 6@7D6,2$#R9
MVD!,S V;YXOP XA-3FB8C4U;-_X*$QU]\=2-CH9\[NH6 =%:(!6TB512T\SI
M<?5:>)3X"W YPV%$8@%=;23*1@T\0,"X.=2?'H\>NV?$S1E?JQ/6:^9S\Q?N
M/MIBQD"Z#M1T]^Q*A]V9[9%[#>UKV.4DTL3;!$6>&AH[X@1OS;,KXZH4[Z]G
MW.$?N5&-R?-%*95MZ5NU7 ?.,L.H56E2."@7'O&&WS]!4Z#(U&5I\AQ!KO=[
MJM/NH!)< EL!.3%E)S0^[  7<!1U9!+)A>9AZ*++T@1M;3I92UYAJ/$^ [#,
M219K!UMHZ83SK!GLL%^K'['?D*W+98&12;9?^%>@YR35$J4<FMB:BN'FM'X&
MP@:4NXA#YW?5)=@,59Q9NK3@$/X!6!@O,%\L+F(3% /VZS@@A%X!26[!';1T
M! Z\1/:K=CXJ0VB:.Y3'"L056.?YLB07\ UP#-A* RJ78()_!^2_9-@U/0[;
MVQVLQB>YH;&W4:[4@]]T/3^YM^[Y_VIO72FJ7X0Y%G&; P>M\TFZ),:PL2V,
MD]S4:K\+<R=7+F(MBQ; +M(7)CE@8!$QK0+SB.>2#!_[7X[1N@>.&:.*6BF9
M;#S3-Y)KWN.!R"/C*5E"W2N1%NRD[=0$D<L.'<\&)22]>*;9.Y(]*)^^P$]?
MM@L>%C,"16 ;Q@GB[CTI%0[-=SY_NA>85SU_NM^=$H7%-F,.%=V*300^+8LP
M?.[ MT-W8Y!1,@67K5GQQF4G$MAI\1#Q,5X] XAU'N2QY396TJQAG?T>\4Y:
M"2016]7R,Q=96;7BV+6CB,XZI&KHN7^L1 [E_*XB=TOT>?&5Z"-*-FX-\XNR
MI+RD#; ZMT8U;[/EVG,J$4<O8G).X)/PSAGS /+.LFNC#EQ 9'B"P=@.*\"T
M"AWMM#_8$ET;[81HH'E;MP)MO_<#8!M\,]#6)*BC/8T,_+RJO4'F,BS&<J/3
M=)"T*%W.XDX45UDL+:K&+1,&ZS2NZY6<$&$W!PUOS[9#Y=L/X;D9W]G*77?=
MZXQ<XR2RAATP]&7*?ALM[+4HJ.;'+>L8*2-ENA5C=2U;HEPY3/>>6 -PP@;@
MCF-N1>QJ$C^SK30N(M?28'L!38V6Y=KV#3]%V_PV":''6Z\'[0:T6>W8V:)K
MQWV5[6QA*]6Z;=:FPZ4C=*.*/%2M>2810->OT_8$)<RQ?:TTZ'#$BHW)4+<I
M'K@V"YEW1G5+-K75I-D9I5_/MN.:K 8@>%C,Z93LLBFQ;(ET. DE)F.M0U1Y
M1L'KC7BS_G;:+$4'77]TZVTJ5^HJ2A./<2<$\R!.2"3Q%N:;.V*P7\GAT4)D
M=S.6#<;%E=BNZ&^'?S%.BP<[Y*+U.&8UU. YEXH5'C'$;/0UBZY8XG9?S0,F
M\7\?/H<^3\/HUEGPW4B@7A='-D5EL\;9I/%[2 !_DS>5W=5(Q)=H[U?BGW'C
MOZ"Y1*K/;TC0D KZ,68XCC=#7:3L=N"Z'C,R)-R=2 $ K;(BKD%;4Z8 5#2Y
ME 8"MEBNKB=XON%0F0O5V]'53I>D07"XSK-4DE(]#883-BP /VNKY?5:S6$W
M&=;9DJ'M,OPJGZ1E4VMH?YJ@?\?SI=?-$;'HD(27&=!N7-/:+1^=15R_DX,L
MH(3%BESNM0<,\*1ZMR)]1324 &ML 5)Q66+"LQ:_X+[,6TOS,/)98)YI3"FB
M.WB#F6"QW!^Q"7AY/N5(S!C D)4F:R$J  \+#PF;SC4%*"?EH<+L?&EQO4.L
M8?"X5,&%5D]A0A-UC 5,OR/*5GYP6D[Z +B+>(24GTC!ZJEC3-S 9?H]G[A5
M(?Y6^&:QB=!KRJKW&K0RQDA*:2P:^$\*4,XQ21^6$VW,9'> YA-+'FK8P,J.
MRCB682[?G^92\V4*OGSIP;R58F/-:#3=B@&4<</H66YMKU">I40D?W(7XHO_
MU2Y$4D&B=A7=]7I9:[N9[VQ2$W*G5D==^>,83-M9FP+C%K+&7Q"%RY0;7U 5
M_BTP$@O1;73#,UAX3Z="5,&A/<JZ8BLI/RA9#'BFHG>H#+49.2UP+?KEE141
MK5X##5\Y:Y84PKE$+V!T 1;8I6._73)CD!.=<NRIWW/5/?&P-?H&N"^]%MTJ
MS]+5S1=ZPRV-5W++<JE>J<U77*'=\D/X'*8_S.>@SLZ,&F-96=+OK75]WX4C
MUUR"GO\4A(7$)K592XD9?W1(3*$MTE5MBY1=W^)T<%2@TG1 LFU:.'N%'LM!
MRV  8OI=>1G,TORZY+ V1XHY*Q\U TR.!<-0RK=1\ZA6WILU99<U%S >X<Q@
MLLB;;830^!Z(F9F4F?66_.T4YIK-I"=V'C(1<%OQ_,*W4&K!.>?Y1O,6GQNO
M/P"%XX$$,8T66^A,T!Q&V'!% ]*UY(M1)L&"33-J@33!8M*2XAS<!ZFA$.,M
M7>7I53QE"X%3XBRF$%8AJ928&YPB:D2.7D'-<+X5CE,53X0509Q(B>\6]!5L
M9LVP*[.!^R()BM#Y^= .% Q&M)$K+3#.\\^:CX'>AM+#5'XYM@NLO7V']48Z
M E@?K<N3T,$':L:/Z+K31DCN7L!LU>QK:"Z_\E#;[)+;(IFMK;OHR%H4.X9V
M"&!&FR4J]G(R@7HI33?AS$6GEX.F-W)&)Z$XN:AL^ @7NM%7F\]F6^,H11ZA
M7D\0B''EOFJ3-?5&@;@+YG[/<9/%7]P05LS-GDMU,-Z_S=_7UUY^,SGG:R%>
M!EG9M)+=O,MZ<\;,EO@R+\^7E>E<,XD6216EFB,9E<U>25TATQ8G5C8-6ZTA
MTZK+!$.=/D7^QB6QSBEV;CLO&'AYR9Y=*@_N=)?>5C<*?R"<=J2S%7ULVRCV
M>^X+I1TH/"6OQDRER>=Z^-9KX.EW^K0B&R,O]<-=P6&FZ<IMXXC\9K9$\;:(
M$O[H5LG@45FB63].#85OB+N8<J&4J+D!D C>JCMRM^GF(\GVX!=M>;IM48+2
M\MHT8FV(70+$2LUR5TF>FI@/96DC%B[(VT:MY#':3:BJ?ZD+ HP70KW9LI2^
M#PDPA:C@)UB"B^N(G##HQ,$+X,:!DG483>=8C"V MU=#6AC767N%4>2RQ]/;
M2@TEJK"](/L!*Y-])HC>TQ\0832A+0(VQY="=+,IIL=?DI*#(!R/A#=<Y#EI
M5DQRUBXDQ $0:Y]?X6I('*"V7TM6AZU'P NZSD+J71 ++9-N'IN>>-CN"V64
M*:CQ:.-K6*UIK1M*NSR4]%)SYN!@5'*"'M9D5"9'1.-&78%:+)1)6?W'NK_<
MVW=$S<Z2BXS+#%<6HOV>#])$"K+_#219@B7#KDLW<Y  @]CLPD;S!]G'*UN9
M2!)*7,\_Q +%I=-[U-F[<!M_4UPN2;YV-*^NDNF2E'J+==$%8-H%9:2S"++<
M)YH"?$L-LP2*XKIUJO):Q%2;'CH:J&F+&%"&?8L)Y_+NQS^[O^_E?Y:_[]O4
M/?Z >*3'%H4!U/4 1_C[.D$HH42K$=C@0[V= :G:,RY>5:^ZR=SUQ%Y3V0B_
MC98!MOYMU(P.IKK)EBWVCL9Z7M/'7;/+L1!W2;E8OEI0^GI!*8I!V=0,2-=U
M58-RI\9P56N[-=@I4'$SW/54'+= 5&'&:U#O*M><=FH_-V.)02'?>G<E-V/<
M+^TZB"=P-*-#:7/\LBML'09[*Q2LZY_1# CS*C1ZV2'";3-5L_?K>;FY,V9Z
MKAK)()X"[;+9NC*M]R%>H;+;)X2)&!&5@-NNW)7VN]6$,==#<S>?@FOL-IP*
M.TZZ!QW/+1[V"^_M7E"W3Y #2)D%"2G2DD03N&I1!-9IW<3!EF[+&4_[=$#+
MRA.V2Z*F2I'MN.EY!*FG,SL:D Y24=:<H@QCYW1T(/)\'JW)/]H!291HD_E3
M6PAE?V&P JEQS5XZ%GD(9[O6#9]?ULO:2]9=#0IV:;$DQ;&Q0+UWD@&NUZ_2
M52S[/1YT8.(]WL]][=S*'53GP&"K&IROLRG, /CDG#JX(R[[->B\EH;[_=8W
M];86)J@2UK]$5R47SR!/(=G%7LF$]4>'-\UJKAIIX0'+F2)X+&P2+MXBS>LM
MK,F-A3521L^5V%*MJ-[)Q%/.S4D]IG,9%LI:JW@<99^+Y:*:4")KB<[F#/\-
MOW1K9%V9Q=8SIZ"@!P1N!;L!20@!K#J6>XY3''X\1_2"&UG.^?=H +"FW))X
MP-$NBD5(@I_QH!NQ)40HO=_Y\)BU87Z$_ .'Z3QD+?3WCVYE.=XF"'P<@%+O
MO #O(.6 (HE2R89MW#AKTV2*S+@+2,CN<+!6\PD[,-2:JS>T="JI;>>9,!CG
MP!WQ?Z:KT&$?4OB.6)7K%FR6RMK>F-H%X%:*H+M+HPJVM@G8N(4,\KDV%^LI
MI)7ANP$TS\5F2LJI:W(*QLITQ6PN'[/H#[U$GXXL^:9[U$^7%YF.][R<STT=
MO/66RN.=O%EFT'@-B#U3H2T)6E[>72C &ICA[-I[+*QIN37I:5QC5=NT"^FT
MO<[=!7J_U>\HI=>D%7F> F?GCD\08#G&*4GEYY5Q\Y!*+$6%KJ>B]/O&.$-
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M1AN]:R9 TZARHM"DNB] "CJY&["#+*;.MS*+P:1>D$I$<Q3;RU@/9PX=2?5
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MN_5FV!^>]-Z^BY.9%T^\TR#*IEYW)B-?^IZ(?.]<IIG(X(>!'"^2( MDZIW
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MG1U9/*E)$,'5!!OA41* CQNO3G9\_'B\T+^#;4;R.>X(HI;&$5R_1OO;R[3
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M[1'5Q_5SOE4Y)4KLIM+V];!\DY9TR;+_=M*7"L!&T>)*-Y/=2RY%2H/9(LQ
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M<RI;J.9]VS;-A/.NL&W.P3Q00":RJ5<X(!:II*P-8U\4LE=['C\++DJJ>[H
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ML(7R#>''<V=([(TATEMVO7=V;288]R,XN\$<]N%=K$;;%0V"K\R'JC%0R18
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M(7R<)C\I/\?DS3#73P(DKJC7D1F73LU5S?1RX'C\,WI#8I)Q"D3),*5_"1#
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M+O! Z_A(:;P9WWDIUK;R05?^L?JD#1K!V HUR:R9?1P2DF=M%EYM4M#K?UU
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MF$[%,$1\G5U;M(U*:@?3V3(=)\%(CX90*%"@*L:"3PRS&#/B3?_MCMR[V.O
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M&ZLH$^2[ ^6T1OOUZ<JF?^\)@X**]T1<T1G]!W1XZG,.G$H,50C!1@$, S"
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MP6/5[.W":/2H+3V&FX%,6I_1$>1"GEH5*08D+FFWZ%OKCR<_?;824"/F0:9
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MM]S9?JU;?BJR!:K"<YG&BV1L0+..<6OMD6:;(TWPRRO!ZDT@K.P1-((J&M;
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M7CAC> -GQO3\9'SHSG;GS>>W[X+OTM]52(B[;%)QN*$F%=9R4$[' 'L-;T9
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M_0=[B*OF,TH>@&=8)=]W__64+_\0B_Z3AQF/EWI:3VILO[E_\(2UOHL.G?.
M>P]#Y3VP]X'BJ0RG;,A34:WT0T_-!1O%69+^X#GKM)I-=BZ"0#QF@MWQ^&'!
MES^ZS\\RF,-H4Q5"K! !7_ 81@W1H7GR-49/Q9>T+D,?YO+TY/=7ZC(4IR9I
MK?W?_KAMBI@[0^V]CT\F@N_C+ /N2VA!C'0% PW$7(2G/]U:GP6;\4?!N)<*
MG_&$)9'P) ^J%3N/S"M@VTNL5V,\]P&6I#S-4A4O64J^_P:!WQ^_M0[?GM'#
M^/'X;+?&9 C]A*'P4@2."YG.F"?BE$/[G*>PI!-$D+E<^,%BN" 5#)Z429+Q
MT!/X8!9A:ZM5@S"/_U@R@]<2M__;R43$,.9[NF,4@7>K%7PFU^[H+ '-YG/0
MRL@ \6,1BHE$.X'BH)S 84<\9H\\@%7WCR9DFQ:+1*S?85$6HV[I*O2EP=Z#
MC7#RP3I@?Q\$AZ#66 1JL=M@%SR2*0#:OZ ->IHG+$O@XPPZE1IAAPK0-4B-
M%S(1]H85@[W3"XYHN(U*=*%/'^^$?K4R%#A5<-6=QD)K@[(OA1=PHR>,6P<P
M^)";B/G<. ZT?N FX.Z_Q8C;/'3M?:4>11SB?/5#&'N&?1BK-[[5[0]?Z_;]
ML%J)<?@Q.=!,@OZZ:*FQA5D2X@N\'&H#H;-)^*C032.IO0#'-E$!S!,*\95'
M8TJL?2<*9RN*U:-$,\/49\DI6W.N+;X %^]!P//9]J:^;Q/MFY*L&Y4T7H(I
M#@X.ZOM'1P>M8RL'!_QLO\>M5GV_]>?1T6[^6L(F,M!6^F<66%_XD[+OOE[4
M./Q[X66Q3&WTZWWQ9CR<"J@/YW-8Q*B[XS=%JUVC&<[;JJ2N1X[9.CDXJ*$F
M7'MWM>*(*C^>QQY4HI#9#Q]A+= <0-<1#Y>%[,.F*]O5<O-;11?%2^/E\[:]
MBT6]!_$)HN&CL.:E]4H]W*B&MFUKJRVJ%1S5AE>.7S#45[C>7M>J5XH*N2OD
MD^Y,+OR%N"+F8Q$;%SDV+H(!,%'65#56V'?S*G'2AQ=D/BQ#';WO8H5Y+,V2
MLEKZL2($;HO#1;^%)-/7&5OIX#Z+HL"L6;>OC4*<IW/=5_.8PL2$UT9<.5'5
MW/#B&%D/W+&RFW.&62#8X?[AFS%1$D;PRNK!A_2*!+-D 1DEP<E2,>-CE:7T
M$L9[2C)JHDWQK)?<9^/Z'0 '&G7NS%,T6)%LT%H MYZ39=;Q"R3:8*'STQ.C
M@$R;+H0('7!3K LP]V!P04;Y>'[O6@R:]?@OT8/D.",?*@_(3/_F)[2".ONF
M:BHP@Q?+Y;M8U5U >6-2=,P$]V;H4+Z$')7Q(%AB-%Q]X_6F= (!]++=L&?&
M:P'I2<!3*&DSRD!KABR$P. ;[0JAGW@L^1@<G* H=M@/)]I]<9VF@J"M,W4N
M\BPBE5E6L-JDQI!FB<0BA4(2&RA Y'?L18Y)W41#-[6H'%D"Y.A&L0Q,S&MJ
MB$2YP10;>Y?]3YWVWH7E/QC];4< HY>!*,,B,5]#1=@4\:FHCV/!'^IC 2%"
MG/( "L $>=#V]9#=]_\##G6P8T42O7KZVPG]V6&?^Y>CZW<[4$/^GI?4%[V;
M46_XE=SKCV1?7U3,_6@6S3(-['F2X;MT!R4]0"4PZSZ:EOJ*MO2UUA5S^SHN
MLVX_=*( C13H9\.*+W *1D$!&6MU6;HK"D/06JE18X0B-9P7%"K*(602J_G7
MQ0Y SQN#!V;658%7@1I#5;C='_6KM.HG64Q!__O;)O9F#O/5//DJXU0K+QS,
M)CL\^\YVJ*<U<JR0(R^ /RK(#"[1ZI\K'OMYTA!B!?!%L8"R'$PUP9SEJXAF
MED->8G,A2,&9""BIO1?CF!;R"TJFUMMZZ[AFLZZ&KBY6S=4L@<9-%;"^\RU%
M]X:<4BY,P&]A$I\HO\]<.D 7#CD=<+Z$[+9B5&$K$Z/!K9>J%2S?.EJM>396
M+]:CW?'<@*)%:=#28;7YA+]H%0M4 _?6X-2FT9,,9#XVUP!Y2;$"^'=KVRN
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M0H)GDV<M==1$3W\/5L. FX(#WJE >JC.)J9>A7[F439%"XZS1-)"(\XY\2"
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MN]@]?#=9'3RE,Q+?8"/74F!HCLDYQ-2_"6^;5 W!S6)<+!-*Q)56@,J#2"O
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MK]3!=/O)& HLN]/Y)#0-!1.W!&]-:H4>91T<88ZLZU[_ZGH$8SAR1_#3M/]
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MX<25H&K )ZC;68SZ.I^2T(#(9IPW1T"0@8A[<4)"BX)9L0,D>AV-BSB!VXS
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MX.DV@6H>E;OH]\^?3O[U\?=/WLGIGT=@=$[1V"(*Q=VX",D,I-8OXW$0(DC
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MKJ&5,E@0 UYMFJP, I/8W\M <8W(%SA21]UUI,Z(&9SR$2!RET;D?K<L!8Z
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M6.V?A4AAB8=S[R8542:8$,;X:1N+L:BO\+JOG_W]GC&7JK=XU/ 6D>V+"X?
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M,0-;5B 2@V-QD<3>T/3$P=#*M+NGNCFZ176?1?6\NXOJ<XS=ND:FPVP)-[L
M4V8BN-^Y6V>-=>;#M8/QG%RB6ILQ#!36+T%[9V4A,2E706T7T)6"7^-,UL=B
M/R=(U5F4]ZN\&+<6[[<67W1W+;XORWXN=-E/5];>1W2HBQ1;0&9-5$ KJ7R0
M,0M=DLJ\=/XSK&>!(3$T+N"(O,1<L>UX5802[FQE3O^YV-.!P ,,#%K=4E1
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M:VFEI))NS++QH<(]?]XJG" %;KJ2%3WTK2R=;!DZPA:H$J1/F$K%6AM4G/L
MM'A[T_)=/SA\ZCJ1^)3H&E*_^K26>:G'@WO'VXS\_F&M'WUBZN^V'T5^3W[4
M@15MALY_Q&$]_;O#>XX[.+R#\PK9I7AB-WZ/>Y_HNR?AW'>CP[;OVI]P+YO<
M=>X]T'9A9\':42MD'<<5-GMRHBZ+NH+="C E'.1)C'LV.P5#@7OW@IWXO9X3
M(CHP^-\OW(MY,/CK7^J[M4\'%8; 92DLWF!' 7ZZ=F0LOV5%[ PVQ\P5T3EL
MAGUN"5"'G@+>3PXE.9-+ORHW-D'KP\'A.T#E*36Q9K.YV=C=;=;WA]4Q!-U*
M0/#<>Q1AA/2(9][GWF"9D$QG4Y/!7#/#=;]>WVS4=W9WIP9K"K-M %D.R$,P
M7CM2NQ@:!_>YV97PK%=K4XSUJ>V#$ CT)_7^,PM]U['97VKTWW1S-2?/U7C)
M7,;(VY/1;G\1K.A;];;*;D]/OMV<WYV?WK+6Y1=V^OO)SZW+GT[9R=77K^>W
MM^=7ER^FD<8B%OM;Z_;G\\N?[JXN*^Q+]:0*#'!G^V LHM'$\V-:P2)&(<?N
M7,A1K<%C6?SX].384?>P4?]A& 9Z0%=THD/&X\C7GQ ?D1_EMC/NY.2YO *>
MG5W=?)V9D8WD7U]\*T;N19Z&Z;C5Y69C#CY5HL]JH,^-N'?"*""? KN-0'\D
M4;D27&D8<_#W0R>"QZQAI ;M%-1\$[CHH^-M$/26<-T^MV50HK9&?R.%Z+_5
M),=7-U].;S9/KBXN6M>WIX?ZE_%;R>];HDF]5OM!(=5A32'#84WA 2XLH'_M
MA&SIK8.]'V#?6Y&=_?(1S6J+NPI $NAZHL(W%*[J[^ ?.5^@'^CS>['9#@1_
MP* $V%.'_-$'9)]^KT2@XY8)N%) *47GFL!NF%/EGS5Q9O+3XS$F9R"@7NAW
M6/V@V<R0J/IWJD/1-*XI?<)+ *(IN+%)I F-3L>>F71U_[BFW..P3-]M<]?U
MH[;_C*L]V-O>_33,P4ND&8$TL\K:ZT!LGG8ZPHJ<1Z$D8^+W9F!2K :NP3*3
M52;+6R".;9<X-CV.7?MAE")-%ETF6*#XZO!!SF1_UHOUN3?'T,*=?>]L<"S:
M<<_>\H/E']F;@4EI0C,0\_[+B;E89UX^>>B7E@7N_05!>_5-A6]H*DQAAA4L
MO[X"RT>]=81?D_37[=HK(N,LKE"3<F9GW(<=YUG8FU$0BU?GV(NBC<6J%;,H
M!D/G81[&?(K"P7A%8370KG";RT8^^ <=#Z7S:TG.K\;V0MCN^("8QAR@"OAF
M2IJ8+ATLBS=O&RC3T%@_?>8@07"O*$;2W3,>LMN^L##>;C/'8R=='L K&Z6'
M=[D>WH4<ZP0D5XD/ZL<%@+4^K9E8J[%CX;KB,1;LF@</3WRPFI@]'0A.X->K
MX,Y_FE(U.?K-<7M WY'OY;==8=--2<;#57 =^(\.97G/9<N&.$H?QL!9A+=V
M]$6X_(D'0UF24ZX*#6WN_L/IG_CVM&RO?K!?&U('7GKZ"XEPK*M=(4^[#@#,
M3I^[[/196#$Y5ZXZ'<<281$S>PMR3=GN7_^RWZCO?0K9G7!%O^M[@DGMK (\
MV')CC&:P%NBT#,_ID*V//%W$;'QPAO/<KPUE\6XL+LQXX8-&=XU;FBTQ8K^Q
M6:OM3!]O7"E^JY+(KD40^IXGW*F5BGE3[XY^\;L>^UIE,*7K/X4/3@4H0(24
M/+>:G'H:[6DU5KHDL3KW6>_LL%,.P-EI>#:[C0(A5O2(ER*,YP8;KOWO?O#P
MFA)\[E3:B8)_U&Z6)OCGACLHCSL[JZDOD &$R:*&XM"Z1R<+P)_=BN 1](72
M]GD7ML]L?M43OX]Y '#>CI>4B+'(/V13;&KWE?;T%:80P8#]6H47N2LJ[#3\
ML[H:O/W4=1T_8K]4V4]N;#VLTM+ 6',?','.>! HCR/O]3^QG[CK\ONN"-C%
MQ?5J+'5O?P_8S"/\U64M^ 'F]4JL2TN7"M._,6#C]3)/](U9X<Q1@S[H#,].
M#Q5KK!A!AH?U$%A$1<$$LI3]OA\*FUW';>"5:"6#B/;N#[6M-;*D,QT<Q[[J
MF"-?=?2XM\"Y[OR[KI#C3VD G@5^CT6P>V#*\B?OP*%0I8=(TB5LM:>HZX2L
M.%A;G4WU6,PIG7=HH;[G#EB8IIVU!9HY :U3! !RE#FX]#,008P'0CWAXQ'
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M^6*QNBJJ0G[7GI3:9N1A5)444 F& '60%>;%3',<3F68"Q46S<,^5S0(HUI
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MKOXS]H.X)]$61&LJZPCO8=^>< A*B6TF552AB3K4Q4-9(P^V;*M+D&&9&3=
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M%5!43D$S;<?!?1=^_;G)]H\O*NR;1V#_%::S_9X<GCA UHMM, O>]N-H#&>
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M(JOT.HK<OD;U;"R\L Q]->J>S'[<!L-;]EBEBWC$,Y9<&A5EHR*1&+N33M*
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MX1>R]3/J 7B=ME'[0HR[R$C?R!UFQE3_O-7V[0%\ ?.Z1_\?4$L! A0#%
M  @ <(LI5J$8IX#3 @  IPH  !H              ( !     &-I:S P,#$R
M.#<T.# M,C R,S Q,#DN>'-D4$L! A0#%     @ <(LI5HFQH]'P 0  P@4
M !X              ( !"P,  &-I:S P,#$R.#<T.# M,C R,S Q,#E?9&5F
M+GAM;%!+ 0(4 Q0    ( '"+*5;/@4'MI0$  ,,&   >              "
M 3<%  !C:6LP,# Q,C@W-#@P+3(P,C,P,3 Y7VQA8BYX;6Q02P$"% ,4
M" !PBRE6_*T]$J<!  #: P  '@              @ $8!P  8VEK,# P,3(X
M-S0X,"TR,#(S,#$P.5]P<F4N>&UL4$L! A0#%     @ <(LI5A432!42,@
M?_8  !(              ( !^P@  &0T,C$X-C)D97@Y.6@Q+FAT;5!+ 0(4
M Q0    ( '"+*58'YO*N2SD  )8/ 0 2              "  3T[  !D-#(Q
M.#8R9&5X.3EH,BYH=&U02P$"% ,4    " !PBRE6Q04:^"]0  #'90( $@
M            @ &X=   9#0R,3@V,F1E>#DY:S@N:'1M4$L! A0#%     @
M<(LI5O2"Y!IL$@  ID8  !(              ( !%\4  &0T,C$X-C)D97@Y
M.6PR+FAT;5!+ 0(4 Q0    ( '"+*59ONDPFD3P   -2 @ 1
M  "  ;/7  !D-#(Q.#8R9&5X.3ER+FAT;5!+ 0(4 Q0    ( '"+*5;QM)OH
MKP(  /P&   2              "  7,4 0!D-#(Q.#8R9&5X.3ES,RYH=&U0
M2P$"% ,4    " !PBRE66&*W63E"   =;0( $0              @ %2%P$
G9#0R,3@V,F1P;W-E>"YH=&U02P4&      L "P#J @  NED!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
